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Abstract
Background: Preterm birth is the most common cause of childhood mortality and morbidity
in the United Kingdom. Placental insufficiency is significant in the aetiology of preterm
delivery and implicit to fetal growth restriction. Preterm growth restricted infants show
reduced cerebral cortical volume which correlates with poor neurodevelopmental outcome.
Respiratory support in the form of supplemental oxygen or mechanical ventilation is
inevitably required by preterm infants with acute and chronic respiratory morbidities which
are commonly experienced by growth restricted preterm infants. Postnatal oxygen therapy is
also associated with markers of cortical injury in the developing brain.
Aims: To define the independent and combined effects of growth restriction and a clinically
derived postnatal fluctuating oxygen profile on markers of cortical integrity including (1)
laminar thickness (2) cortical transcription factor expression and (3) cerebral growth factor
expression, within a rodent model.
Methods: Sprague-Dawley rat dams received a normal or protein restricted diet to induce
growth restriction. Litters were reared in air or fluctuating hyperoxia for 7 days. Pup brains
were weighed, sections through the motor cortex stained with cresyl violet and the thickness
of the corpus callosum, superficial (Il-IV) and deep (V-VI) cortical layers were measured.
Neuronal subtypes (callosal, superficial, corticospinal and corticothalamic) were
immunofluorescently stained using neuronal subtype-specific transcription factors (Satb2,
Cuxl, Ctip2, Tbrl respectively). Cerebral expression of trophic factors Insulin-like growth
factor-I (IGF-I), Brain derived neurotrophic factor (BDNF), Fibroblast growth factor-2
(FGF-2) and Vascular endothelial growth factor (VEGF) were analysed and circulating
serum IGF-I determined. Comparisons were made between study groups.
Results: Growth restricted pups had smaller brain weights than normally grown pups but
cortical thickness was preserved. Fluctuating hyperoxia did not affect brain weight but
cortical thickness was reduced in both normally grown and growth restricted groups.
Cortical thinning was observed in the later born superficial cortical layers of both fluctuating
oxygen study groups and in the deep layers of pups who were also growth restricted. Cell
density and corpus callosum thickness was preserved. Fluctuating oxygen did not affect
proportions of neurons expressing Satb2, Ctip2, or Tbrl but was associated with a reduced
proportion of superficial neurons expressing Cuxl, intrinsic to cortico-cortical connectivity
within the superficial cortex. Circulating IGF-I was reduced in all study groups in
comparison to control, most significantly in the growth restricted group exposed to
fluctuating oxygen Cerebral expression of IGF-I and FGF-2 were conserved across the
groups. VEGF expression was reduced in the dual group. An increased expression of
BDNF was observed in the brainstem in all study groups, most significantly the growth
restricted group exposed to oxygen.
Conclusions: The developing brain is dynamically influenced by the antenatal and postnatal
environment. In a rodent model, normal cortical growth is inhibited by in utero growth
restriction and postnatal oxygen fluctuation, in part associated with adverse effects on
transcription factors and trophic factors instrumental to normal development. In utero
growth restriction may permanently alter elements of cerebral development and postnatal
oxygen fluctuation,a modifiable factor in neonatal care, may further impair cerebral growth
with a preferential disadvantage to later born superficial neurons. Specific effects on neurons
intrinsic to cortical circuitry suggest cortical development exposed to pre- and postnatal
growth restriction may be particularly vulnerable to oxygen induced injury.
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The definition of human infant prematurity is birth before 37 completed weeks of
gestation. In the UK, prematurity affects between 6-8% of pregnancies (Bliss,
National Charity for the newborn, UK). Preterm birth is the leading cause of
perinatal morbidity and mortality in developed countries (Marlow et al. 2005) and
the challenges increase as gestational age decreases. Although late preterm infants
born between 32 and 37 weeks have a more favourable outcome, there is emerging
evidence of subtle deficits in cognition and other health morbidities in this group
(Odd et al. 2012). A significant proportion of preterm neonates born at less than 32
weeks gestation face a range of challenges in the ante- and postnatal period which
may have lifelong impact. When evaluated at 30 months corrected, 50% of infants
born at 25 weeks gestational age or less have identifiable functional impairments
(Wood, Marlow et al. 2000). In the UK, 1-2% of infants are born <32weeks
gestation including very preterm births at 28+0 to 31+6 (incidence 0.7%) and
extremely preterm births at 23+0 to 27+6 weeks (incidence 0.4%) (McParland et al.
2004). The risk of poor outcome is also proportional to birth weight. Low birth
weight (LBW) is defined as less than 2500g and this can be subdivided into very low
birth weight (VLBW, less than 1500g) and extremely low birth weight (ELBW, less
than lOOOg).
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1.1.1 Causes of Prematurity
Infants may be born prematurely following either spontaneous labour with intact or
ruptured membranes, accounting for two thirds of preterm deliveries (McParland et
al. 2004) or following induction / Caesarean delivery for fetal or maternal indications
which accounts for approximately one third (McParland et al. 2004). Common fetal
and maternal indications for preterm delivery include intrauterine growth restriction
and pregnancy induced hypertension. Spontaneous preterm births result from a
number of causes, the most common being intrauterine inflammation and infection
which are often clinically asymptomatic. Multiple gestation carries a significant risk
of preterm delivery and accounts for 15-20% of preterm births (Goldenberg et al.
2008).
1.1.2 The Economic cost of Prematurity
There are economic implications of providing neonatal care to an increasing number
of infants, and as a consequence of the social and economic cost of preterm-related
disabilities, there is an ongoing debate regarding whether intensive care is justified
for infants of borderline viability. Total public sector costs per survivor to 18 years
are estimated at £40,000 for term infants, £104,000 for <33 week gestation infants,
£140,000 for <28 weeks and £210-£275,000 for 23-24 week gestation infants
(Mangham et al. 2009). Improving understanding of how the intrauterine and
postnatal environments interact to impact on development may lead to modification
of care practices and new therapies to minimise long term morbidity and reduce the
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economic burden of prematurity. Social costs exist in providing ongoing medical
care, special needs schooling, financial and psychological support to parents caring
for a child with disabilities and / or additional support needs. As a society, some
question the use of resources to resuscitate and care for increasingly premature
infants over channelling resources to improve prenatal care and prevention of
prematurity (Moster 2008).
1.2 Consequences of Prematurity
Advancing knowledge in the field of perinatology continues to improve the care
provided to preterm infants before and after birth. The disturbance to fetal
development caused by removal from the in utero environment is demonstrated by
the significant number of survivors who suffer consequences of their prematurity.
Such consequences affect many organ systems, most significantly the brain, the
respiratory system, retinal maturation and gastrointestinal function (Saigal et al.
2008). The ultimate goal in caring for each preterm infant is intact survival without
neonatal morbidity or future impairment. However, significant mortality and
morbidity rates continue to be associated with preterm birth.
4
1.2.1 Neonatal Mortality
The neonatal mortality rate in England and Wales has fallen from 7.7 per 1000 live
births in 1980 to 3.1 deaths per 1000 live births in 2009 (Office for National
Statistics, UK, 2011). This is a combined effect of advances in technology and the
collaborative efforts of obstetric and neonatal care. The preterm birth rates in the
United States and Europe have been reported as 11% and 5-7% respectively
(Goldenberg et al. 2002; Goldenberg et al. 2008). The EPICure study considered
mortality and outcomes specifically for extreme preterm infants born before 26
completed weeks of gestation in the United Kingdom and Republic of Ireland in
1995. This study reported a survival rate at discharge from in-patient neonatal care
at 39%. Within this cohort, survival to discharge improved with increasing
gestation; 19.9% at 23 weeks, 33.6% at 24 weeks and 52.1% at 25 weeks gestation
(Costeloe et al. 2000). The EPICure 2 study launched in 2006 includes babies born
between 22 and 26+6 weeks and demonstrated improved survival rates to discharge
at each gestation for current neonatal care; 26% at 23 weeks, 47% for 24 weeks and
67% for 25 week infants (Costeloe et al. 2008, Moore et al. 2012). The EPIPAGE
study carried out in France in 1997 reported on survival of preterm infants born
between 22 weeks and 32 weeks (Larroque et al. 2004). Survival was 67% for all
births between 22 and 32 weeks and increased with gestational age: 31% at 24
weeks, 78% at 28 weeks and 97% at 32 weeks. Survival was lower for male infants
and infants born small for gestational age.
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1.2.2 Neonatal Morbidity
Despite the improvements observed in preterm infant survival, rates of many of the
morbidities associated with preterm birth have remained static (Fanaroff et al. 2003).
It is well recognised that morbidity is inversely related to gestational age (Doyle
2004). The most significant morbidities that impact long-term outcome for preterm
infants, in particular neurodevelopmental outcome, include: bronchopulmonary
dysplasia (BPD), retinopathy of prematurity (ROP), necrotising enterocolitis (NEC),
infection and inflammation, poor growth and brain injury. Extra-cerebral morbidities
are first considered and then brain injury and subsequent neurological outcomes are
discussed in the following sections (l .2.3 & 1.2.4).
1.2.2.1 Bronchopulmonary Dysplasia (BPD)
BPD is defined as an oxygen dependency at 36 postmenstrual weeks. It most
commonly affects ELBW infants less than 26 weeks gestation (Coalson 2003). The
pathogenesis of BPD includes oxygen-induced injury, volume trauma from
mechanical ventilation, impaired alveolarisation and pre- and post-natal
inflammatory response (Coalson 2006). The EPICure study reports that 74% of their
cohort required oxygen at 36 weeks and no significant difference was noted between
gestational ages. However at 40 weeks postmenstrual age, 51% of infants required
oxygen and this was inversely related to gestational age; at < 23 weeks gestation,
78% of infants required oxygen, whilst at 25 weeks, 44% of infants required oxygen
(Hennessy et al. 2008). In the same study, 36% of infants were discharged home
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with supplemental oxygen and this was continued for a median of 2.5 months.
Infants who develop significant BPD are more likely to suffer ongoing respiratory
morbidity in childhood including recurrent hospital admissions for infection, wheeze
and in some cases pulmonary hypertension (Fawke et al. 2010).
In addition to respiratory disease, preterm infants who develop BPD are more likely
to experience other complications including infection (Hack et al. 2000), inadequate
nutrition and poor postnatal growth (O'Shea et al. 1996). Infants with BPD, by
definition are exposed to ongoing oxygen therapy which may be damaging to
multiple body systems including the brain (Askie et al. 2003). Episodes of hypoxia
are more frequent in infants with BPD (Garg et al. 1988) and the combination of
these factors place these infants at higher risk of brain injury (Volpe, 2001) and
neurodevelopmental impairment (Anderson et al. 2006). Infants with BPD are more
likely to have a grade 111 or IV intraventricular haemorrhage but BPD is itself an
independent risk factor for cerebral palsy (Skidmore et al. 1990). Children with BPD
have poorer fine and gross motor skills than preterm infants without BPD (Short et
al. 2003). Some studies report that school-aged children with BPD have lower IQ
than children without BPD (Short et al. 2003; Gray et al. 2004) however other
studies have found no significant difference (Bohm et al. 2003). It has also been
reported that preschool BPD children have receptive and expressive language skills
which are less developed compared to preterm children without BPD (Singer et al.
2001) and have increased problems with articulation which, as mentioned above,
may be part of a general motor deficit (Lewis et al. 2002). Finally, BPD has been
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suggested as a strong predictor for attention deficit and hyperactivity (ADHD)
behaviours (Farel et al. 1998; Short et al. 2003).
1.2.2.2 Retinopathy of Prematurity (ROP)
ROP is caused by disorganised growth of retinal blood vessels mediated by vascular
endothelial growth factor (VEGF). ROP is more prevalent in lower gestations and in
lower birth weight and growth restricted infants (Palmer et al. 1991; Dhaliwal et al.
2009). Liberal oxygen exposure and fluctuations in oxygen are established risk
factors in the development of ROP (York et al. 2004). ROP can lead to retinal
scarring, detachment and blindness. The EPICure study reported that 14% of infants
in the 1995 cohort required treatment for ROP. Blindness as a consequence of ROP
has fallen from 8-10% in the early 1990s to 3% in current practice (Chow et al. 2003;
Hintz et al. 2005). This is a consequence of greater awareness of the harm caused
by oxygen therapy and the success of cryotherapy and, most recently, laser therapy in
treating threshold disease (Gilbert 2008). However, the complications of these
therapies include clinically significant visual field loss and myopia caused by the
permanent destruction of the peripheral retina in the pursuit of eradicating VEGF-
producing cells (Smith 2008). Recent studies have considered the use of anti-VEGF
agents, primarily intravitreal bevacizumab in treating ROP as a monotherapy or in
combination with conventional laser therapy and some promising results have been
reported (Mintz-Hitter et al. 2011).
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1.2.2.3 Necrotising Enterocolitis (NEC)
The prevalence of NEC in infants of birth weight 500-1500g is approximately 7%
(Holman et al. 2006) and the associated mortality rate is between 20-30% (Rowe et
al. 1994; Fitzgibbons et al. 2009). The exact pathogenesis of NEC remains to be
fully elucidated, however a combination of intestinal immaturity, abnormal bacterial
colonisation, increased immunoreactivity of the intestinal mucosal cells and
abnormal microvascular tone are all considered contributory factors (Neu et al.
2011). NEC is an inflammatory process and, in preterm infants with minimal
reserve, can rapidly become a systemic inflammatory process with implications for
other organs such as the brain. In particular, infants who require surgery for
management of NEC, as opposed to medical management, are at increased risk of
adverse neurodevelopmental outcome (Hintz et al. 2005).
1.2.2.4 Inflammation and Infection
Maternal and intrauterine infection is long-established as playing a significant role in
neonatal brain injury, irrespective of gestational age. Raised levels of pro¬
inflammatory cytokines measured in amniotic fluid and umbilical cord blood have
been associated with white matter lesions in the neonate (Dammann et al. 1997).
The source of the circulating cytokines is thought to be ascending micro-organisms
from the vagina and cervix which have invaded the amniotic cavity, induced
inflammation of the chorioamniotic membranes and led to the production of pro¬
inflammatory cytokines which then reach the fetal membranes (Rees et al. 2005).
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The fetus develops an inflammatory response through an alteration of pro¬
inflammatory cytokines (Svigos 2001). Elevated levels of circulating cytokines have
been linked to dramatic increases in the risk of periventricular leukomalacia and
cerebral palsy (Nelson et al. 1999). Recent evidence has also suggested that
intrauterine inflammation results in fetal neuronal injury in animal models (Burd et
al. 2010) and in humans, the fetal inflammatory response mediated by raised
cytokines has been implicated in neurodevelopmental delay and disorders such as
autism and schizophrenia (Meyer et al. 2006; Goines et al. 2011).
1.2.2.5 Postnatal Growth
Extreme preterm infants are at an increased risk of poor postnatal growth (Yanney et
al. 2004). When the EPICure cohort of children was examined at 30 months, they
were found to have significantly lower weight and smaller head circumference than
the full term control children (Wood et al. 2003). Factors exacerbating this risk
include BPD, nutrition problems secondary to NEC, related surgery and infection
(Cooke et al. 2004). Studies have observed a positive correlation between reduced
head circumference of VLBW infants at school age and adverse neurodevelopmental
outcome (Tan et al. 2008). The benefit of catch up growth however is controversial
(Thureen 2007). It has been shown that infants with low birth weights, particularly
those that have been growth restricted in utero, have a particular predisposition to
gain weight rapidly in the first two years of life (Ong et al. 2002). At school age,
such infants have reduced adipose tissue in their extremities but increased central
adiposity. This altered fat distribution is thought to underlie the link between low
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birth weight and the increased risk of developing cardiovascular disease,
hypertension and glucose intolerance in adulthood (Gianni et al. 2008).
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1.2.3 Effects of Preterm Delivery on the Brain
Up to 50% of preterm infants born less than 25 weeks gestation have neurological
deficits that affect motor, visual, behavioural and cognitive function (Wood et al.
2000). There is an established but overly simplistic view that motor deficits correlate
with white matter damage whereas cognitive deficits correlate with grey matter
damage (Ajayi-Obe et al. 2000; Abernethy et al. 2002; Nosarti et al. 2002).
Traditionally, brain injury associated with preterm delivery was considered a discrete
lesion causing damage to the affected brain region and deficit in the associated body
part (Volpe 2009b). Historically, the two major brain lesions considered to cause
such discrete injury have been (1) periventricular hemorrhagic infarction secondary
to germinal matrix or intraventricular haemorrhage and, (2) periventricular
leukomalacia. The most established neuropathology associated with preterm
delivery is spastic diplegic cerebral palsy, caused by non-progressive damage to the
motor tracts of the developing brain and affecting 5-10% of VLBW infants (Piatt et
al. 2007). The neonatal imaging correlate of this form of cerebral palsy is cystic
periventricular leucomalacia observed in 5% of very preterm infants (Volpe 2009a).
Despite the advancements made in reducing mortality, the prevalence of cerebral
palsy has remained largely unchanged at 8-10% (Hintz et al. 2005), although reports
on this do vary in both directions depending on the definitions used (Vincer et al.
2006; Piatt et al. 2007). There is emerging evidence that more subtle brain injury
associated with preterm birth may underlie the milder deficits in neurological
function. Improvements in imaging techniques have allowed more detailed
examination.
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Preterm brain injury was traditionally assessed by cranial ultrasound scan. The
presence of Grade III and IV intraventricular haemorrhage, hydrocephalus or
periventricular leukomalacia were associated with a higher likelihood of subsequent
neurodevelopmental concerns (Hack et al. 2000). The presence of a normal cranial
ultrasound scan however, does not exclude long-term disability.
The increasing use of MRI imaging of preterm infants has identified a range of
features noted on the preterm infant brain which are not noted in term born controls
and therefore provide crucial insights of the effects of premature delivery and
neonatal care on the developing brain (Counsell et al. 2003). Such features include
diffuse white matter abnormalities known as diffuse excessive high signal intensity
(DEHSI), occurring most commonly around the ventricles but also seen throughout
the white matter and affecting the majority of preterm infants (Maalouf et al. 1999).
DEHSI is thought to represent white matter microstructural damage (Volpe 2003)
and is associated with astrogliosis and microgliosis (Volpe 2009a). In addition,
DESHI is associated with a reduction in premyelinating oligodendrocytes (Riddle
2011, Volpe 2009a) in keeping with observations made in preterm neonates where
episodes of oxidative stress appear to selectively target premyelinating
oligodendrocytes (. MRI studies examining the effect of lipopolysaccharide (LPS)
on white matter of fetal sheep who are gyrencephalic, demonstrate a decrease in
white matter volume and corpus callosal thickness at 10 days post LPS exposure
(Looij 2012). Other work confirms this post-LPS diffuse white matter injury in fetal
sheep is accompanied by reduced cortical volume on MRI and histological
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confirmation of reduced numbers of subplate and cortical neurons (Dean 2011). The
long term clinical correlate of such diffuse injury is not fully established but
diffusion tensor imaging studies measuring apparent diffusion coefficient have
suggested associations with neurodevelopmental impairment in preterm infants
(Counsell et al. 2008; Boardman et al. 2010). Anisotropy is the term used to describe
directional dependence of water in tissues and represents the crux of diffusion MRI.
Quantitative MRI imaging allows volumetric analysis and it has been shown that
preterm infants with PVL have reduced cortical grey matter at term compared to
infants without PVL (Inder et al. 1999, Nosarti et al. 2002, Inder et al. 2005). This
suggests that PVL affects cerebral cortical development and may indicate why PVL
is associated with deficits in cognitive as well as motor function.
Although the mechanism of preterm neurological deficit has been traditionally
regarded as secondary to brain injury, there have been recent shifts in opinion which
focus on the disruption caused by the interruption of normal development. Volpe
proposed the term "Encephalopathy of Prematurity" (Volpe 2009b) to describe the
association between focal and diffuse white matter damage, found in 50% of very
low birth weight infants (Volpe 2001), and decreased grey matter volume identified
by imaging and neuropathology of the thalamus and basal ganglia (Inder et al. 2005;
Pierson et al. 2007). In addition, the "Encephalopathy" may include the associated
disruptive effects on myelination of developing axons (Deguchi et al. 1999) and
reduced volume and complexity of the cerebral cortex beyond the preterm period
(Ajayi-Obe et al. 2000; Nosarti et al. 2002). Despite the widely accepted findings of
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cortical volume effects into childhood and adolescence, it is reported that gross
cerebral volume is not generally reduced during the neonatal period (Boardman et al.
2007). Recent imaging studies support the concept that preterm birth has specific
effects on developing neural systems such as the thalamocortical system where
volume reduction in the thalamus is inextricably linked to volume loss in the cortex
and hippocampus (Ball et al. 2011). Specific effects may be linked to damage in
cortical proliferating zones and damage to the subplate synaptic compartment, both
of which are areas undergoing significant developmental maturation at the time of
preterm birth (Volpe 2009b). Cortical development will be discussed in more detail
in section 1.5.
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1.2.4 Neurodevelopmental Outcome following preterm birth
As described above, each of the major morbidities associated with preterm birth
including bronchopulmonary dysplasia, retinopathy of prematurity, necrotising
enterocolitis, poor postnatal growth and brain injury, have all been shown to impact
negatively on infant neurodevelopment. Data from follow-up studies across Western
countries suggest approximately 25% of infants born less than 28 weeks develop
significant neurodevelopmental impairments in early childhood (Saigal et al. 2008)
including cerebral palsy, developmental delay and sensory impairments of vision and
hearing. For infants at the lowest gestations, the EPICure study reported that 19% of
infants born less than 25 weeks had severely delayed development at 30 months
corrected with developmental scores more than 3 standard deviations (SD) below the
mean (Wood et al. 2000). This is supported by studies showing a strong trend of
increased special educational need with lower gestation at birth (MacKay et al.
2010).
There is evidence from follow-up studies that even when preterm infants have
progressed through early childhood without manifesting any of the major associated
morbidities, there are often underlying neurological effects of their prematurity
which become apparent during childhood, particularly at school age. In comparison
to their peers, children born preterm have reduced scores on general cognitive tests
(Marlow et al. 2005), impaired executive function skills (Anderson et al. 2004;
Taylor et al. 2004), memory deficits and lower academic performance (Bhutta et al.
2002; Marlow et al. 2005; Johnson et al. 2009). Furthermore, these children have an
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increased prevalence of mild dysfunction of neuromotor and coordination skills
(Saigal et al. 2003), behavioural problems including inattention and hyperactivity
(Reijneveld et al. 2006), and psychiatric disturbance including autism and anxiety
disorders (Grunau et al. 2004; Johnson et al. 2010).
The adverse outcomes associated with late prematurity are often underappreciated.
Research demonstrates that a third of children born at 32-35 weeks gestation have
increased difficulties with motor skills, speaking, writing, mathematics and
behaviour (Huddy et al. 2001), again indicating that subtle effects on brain function
are associated with premature delivery. Furthermore amongst term infants (37-40
weeks gestation), the risk of special educational need is lowest at 40 weeks compared
to 37-39 weeks (MacKay et al. 2010).
In summary the effect of preterm birth can be life-long with significant effects on
neurodevelopment. Active reproductive biology research continues to explore the
mechanisms underlying preterm birth (lams et al. 2008) whilst key aims in perinatal
research are to prevent or modify brain injury from exogenous processes (sections
1.3 and 1.4) and minimise the interruption of normal brain development and growth
(sections 1.5 & 1.6). It is important to identify at-risk infants, understand
pathophysiology of organ damage, identify early biomarkers of injury and investigate
strategies to improve outcome.
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1.3 Growth Restriction and the Preterm Infant
Intrauterine growth restriction secondary to placental failure is one of the major
precipitants of preterm delivery (Goldenberg et al. 2008). Fetal growth restriction is
reported to occur in approximately 5% of the general obstetric population (Neerhof
et al. 1995). Placental insufficiency is significant in the aetiology of preterm birth as
it causes chronic hypoxia, deprivation of nutrients and reduced perfusion of the fetus.
Infants delivered preterm are ten times more likely to have suffered intrauterine
growth restriction than infants delivered at term (Gilbert et al. 2003).
1.3.1 Growth restriction definitions
Intrauterine growth restriction (IUGR) can be defined as a reduced fetal growth
velocity causing a fetus to fail to attain its genetic growth potential (de Bie et al.
2010). This is a prenatal clinical diagnosis made by serial ultrasound scans (Bertino
et al. 2007). IUGR can lead to infants being small for their gestational age (SGA),
meaning birth weight less than a predefined centile for gestation. The British
Association for Perinatal Medicine defines SGA as birth weight below the 5th centile
for gestational age. There are, however, a wide range of definitions used in the
literature, including a birth weight less than the 10th centile, a birth weight greater
than two standard deviation below the mean and a birth weight less than 2500g
(Hokken-Koelega et al. 1995). Importantly, not all SGA infants will be IUGR, as up
to 20% (Mamelle et al. 2001) will be constitutionally small, in accordance with their
genetic growth potential. In addition, some infants who are deemed appropriate
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weight for gestation may have experienced curtailment of their growth potential in
utero. Growth restriction may be symmetrical, where onset is much earlier in the
course of pregnancy and weight, length and head circumference are equally affected,
or more commonly, asymmetrical, where there is relative brain-sparing and head
circumference is preserved whilst weight and possibly length are reduced.
Associated morbidity tends to be higher in the symmetrical group where there is an
innate fetal abnormality or a prolonged inhibitory insult to fetal growth (Lin et al.
1991). A variety of physiological mechanisms may interact to cause IUGR,
including:
Table 1 - Causes of intrauterine growth restriction
















1.3.2 Growth restriction and neonatal outcome
It is likely that fetal growth restriction of different aetiologies have different
outcomes. Overall however, preterm SGA neonates have a higher fetal and neonatal
mortality rate at each gestational age in comparison with 'appropriate' weight for
gestational age (AGA) infants (Piper et al. 1996; Simchen et al. 2000). Some studies
report that below 32 weeks, the effects of morbidities associated with prematurity
19
outweigh the effects of growth restriction (Yanney et al. 2004). The risk of cerebral
palsy is higher in growth restricted infants after 33 weeks gestation but there is no
clear risk posed by growth restriction at earlier gestations (Blair et al. 1990; Topp et
al. 1996). The confounding factor in many studies examining the effect of growth
restriction is the use of neonatal as opposed to fetal growth standards which use
intrauterine growth curves to define growth restriction (Ley et al. 1997). Using
neonatal standards, 10% of the 'normal' population will have a birth weight below
the 10th centile. When fetal growth standards that track in utero growth were used in
one study, the proportion of infants meeting the criteria for growth restriction in the
cohort increased from 11.6% to 23.3% (Zaw et al. 2003). This group found that the
growth restricted infants had an increased risk of acute respiratory distress syndrome,
bronchopulmonary dysplasia and retinopathy of prematurity. A recent retrospective
study examining growth restricted infants born between 25 and 36 weeks gestation,
found that in addition to the increased risk of respiratory compromise, preterm
growth restricted infants were also at increased risk of thrombocytopenia, neonatal
sepsis and NEC. The increased risk of sepsis was the most significant underlying
factor accounting for the associated increased mortality rate in this cohort (Engineer
et al. 2010).
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1.3.3 Growth restriction, the developing brain and
neurodevelopment
Infants who are born SGA are reported to have long-term cognitive impairments,
lower intelligence, poorer memory, lower academic attainment and increased
behavioural problems (O'Keeffe et al. 2003; Noeker 2005; Geva et al. 2006). Other
groups have reported reduced motor scores, impaired short-term memory but
preservation of recognition memory (Leitner et al. 2007). Notably, research suggests
that whilst SGA infants score lower on cognitive testing, extreme prematurity and
neonatal complications have a greater detrimental effect on a child's
neurodevelopmental outcome than IUGR alone. Such studies have included control
groups matched both for gestation and birth weight (Sung et al. 1993; McCarton et
al. 1996; Gutbrod et al. 2000).
Preterm growth restricted infants were evaluated postnatally by MRI and were found
to have specific structural and functional effects on brain development (Tolsa et al.
2004). In comparison to gestation matched controls, the growth restricted infants
had reduced intracranial and cerebral cortical grey matter volumes. These changes
were associated with reduced attention-interaction scores on behaviour testing in
comparison to gestation matched appropriately grown preterm infants (Tolsa et al.
2004). The hippocampus is particularly vulnerable to volume loss following
placental insufficiency induced intrauterine growth restriction in preterm infants.
This volume loss is reported in association with altered behavioural score as
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evaluated by the Assessment of Preterm Infants' Behaviour at term corrected
(Lodygensky et al. 2008). Quantitative MRI studies have shown that preterm growth
restricted infants have abnormalities in molecular diffusion values in the posterior
limb of the internal capsule and altered regional anisotropy in the thalamus and
cortical grey matter in comparison to appropriately grown preterm infants, thereby
suggesting altered development in these regions (Thompson et al. 2007).
The main method of monitoring fetal wellbeing in utero is by using Doppler
ultrasound to measure fetal blood flow velocity. As stated above, the most common
type of growth restriction seen is asymmetrical growth restriction, suggestive of third
trimester placental insufficiency and relative brain-sparing (Lackman et al. 2001).
Brain-sparing is a continuum where there is initial increased brain perfusion followed
by a decrease in the cerebroplacental ratio (Hernandez-Andrade et al. 2008). A
recent study documented that 55% of intrauterine growth restricted fetuses had
abnormal middle cerebral artery (MCA) Doppler scores and that neurobehavioural
disruption at term was more prevalent in growth restricted infants with abnormal
MCA Doppler (Figueras et al. 2011). A large cohort study showed that brain-sparing
during the third trimester was associated with a 23% higher prevalence of
behavioural problems at 18 months in comparison to infants with normal MCA
Doppler (Roza et al. 2008). A further study that included preterm infants found
significant cognitive differences between infants with and without brain-sparing at
age 2, however these differences were not significant after adjustment for brain
volume (Leppanen et al. 2010). This suggests that the effect on brain structure, as
opposed to absolute blood flow, may be most important in determining outcome.
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1.3.4 Growth restriction and metabolic effects
Postnatal growth is generally poor in growth restricted preterm infants with
approximately 15% of infants demonstrating any degree of catch up growth at 3
months of age (Hokken-Koelega et al. 1995). Beyond infancy into childhood and
adulthood, growth restricted infants have been shown to have shorter heights and
reduced weights (McCarton et al. 1996). In addition such infants have an increased
risk of insulin resistance, metabolic syndrome, type 2 diabetes mellitus,
cardiovascular disease and end-stage renal failure (Hales et al. 1991; Gluckman et al.
2005), in keeping with the Barker hypothesis:
"Environmental influences that impair growth and development in early
life may be risk factors for metabolic disease".
(Barker et al. 1989; Hales et al. 1991).
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1.4 The Effect of Oxygen Therapy
The primary cause of preterm neonatal death is respiratory failure due to a
combination of surfactant deficiency, interrupted anatomical lung development and
immaturity of other organ systems. In addition to the use of oxygen, there are a
number of key respiratory interventions in neonatal care which have contributed to
the reduction in mortality and these will be briefly summarised before the discussion
focuses on the use of oxygen therapy.
The use of a single course of antenatal steroids for threatened preterm delivery has
become widespread practice since the late 1990s and been shown in a Cochrane
review to reduce rates of: neonatal mortality, respiratory distress syndrome (RDS),
cerebrovascular haemorrhage, necrotising enterocolitis (NEC), requirement for
respiratory support, intensive care unit (ITU) admission and onset of systemic
infection in the first 48 hours of a preterm infant's life (Roberts et al. 2006). There is
no evidence that multiple courses of antenatal steroids have a beneficial effect,
however multiple antenatal doses are often given in practice (Banks et al. 1999).
Although this is associated with beneficial effects on lung function, there are
concerns from animal data that multiple courses may lead to a reduction in brain
volume (Carlos et al. 1992), which in turn, has implications for neurodevelopment
(Peterson et al. 2000).
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The use of exogenous surfactant, administered following intra-tracheal intubation,
was first shown in the 1970s to reduce the incidence of respiratory distress syndrome
(RDS), intraventricular haemorrhage (IVH) and neonatal mortality (Liggins et al.
1972). The beneficial effect and safety for preterm infants was reinforced by the Ten
Centre Trial which reported a 30% reduction in RDS and a 48% reduction in
neonatal mortality in comparison to control infants (Ten Centre Trial 1987). A
recent Cochrane review suggests for preterm infants who are stabilised on nasal
continuous positive airway pressure (NCPAP), selective as opposed to prophylactic
use of surfactant, is associated with reduced risk of chronic lung disease and death
(Rojas-Reyes et al. 2012). This suggests intra-tracheal intubation of such stable
infants for the purposes of administering prophylactic surfactant is not required.
Studies have looked at nebulised surfactant administration; however a Cochrane
review has suggested further trials are required to ascertain any beneficial effect
(Abdel-Latif et al. 2012).
The use of oxygen in neonatal care began in the 1950s and improvements in assisted
ventilation and the development of intensive care practice of preterm infants led to a
significant increase in survival in the mid-1990s (Gultom et al. 1997). Respiratory
support in the form of supplemental oxygen or mechanical ventilation is inevitably
required by preterm infants with respiratory morbidity. These therapies are
associated with the development of bronchopulmonary dysplasia (BPD) which is
characterised by ventilation/perfusion mismatch, variable oxygen saturations and
fluctuations of inspired oxygen titrated to a target oxygen saturation range (Doyle et
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al. 2006). The presence of BPD is an independent predictor of adverse
neurodevelopmental outcome (Short et al. 2003) although the mechanism is unclear.
Recent MRI studies in preterm infants indicate that supplemental oxygen is an
independent risk factor for impaired brain growth and loss of brain tissue volume at
term (Boardman et al. 2007). Even preterm infants who do not receive supplemental
oxygen are exposed to partial pressures of oxygen ex utero which are four times
higher than the intrauterine environment (Felderhoff-Mueser et al. 2004).
Oxygen was first used in newborn resuscitation by Chaussier in 1780 (Silverman
2004). Its use became more widespread in newborn care over the 20th century and
early 21st century. Until the 1950s, 100% oxygen was regularly administered, and
between the 1930s and the 1950s, there had been a steady decline in neonatal deaths
(Bolton et al. 1974). In the 1950s, a number of units in both the USA and the UK
noted that a significant proportion of preterm survivors developed visual problems
linked to the use of high oxygen concentrations (Bolton et al. 1974). This eye
disease was termed retrolental fibroplasia to describe the pathological process now
more commonly known as retinopathy of prematurity (ROP). There was then a trend
toward reducing oxygen use in neonatal care during the 1950s and 1960s. However
this was met by an increase in neonatal deaths between birth and day three of life
secondary to hypoxia (Bolton et al. 1974). This was the beginning of the ongoing
major dilemma in neonatal care; the balance between giving sufficient oxygen to
prevent hypoxia-driven mortality and giving excess oxygen causing hyperoxia-
related morbidity. It is now clear that oxygen therapy is not benign when used in
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resuscitation or in the ongoing management of term or preterm infants (Saugstad et
al. 1998). Recent evidence suggests that maintenance of oxygen saturations within a
higher targeted range (90-95%, equivalent to 5.9-8.9 kPa) is associated with
significantly less mortality than a lower targeted range (Stenson et al. 2011).
There is a substantial medical literature across specialties noting the organ damage
caused by high concentrations of oxygen (Kones 2011; Brenner et al. 2012).
Reactive oxygen species are formed as a natural by-product of oxygen metabolism
and can damage all components of cells including protein, DNA and enzyme systems
(Maltepe et al. 2009). Studies have demonstrated that short exposure of preterm
infants to oxygen during resuscitation increases circulating oxidative stress
biomarkers, potentially harmful to all body systems, not least the developing brain
(Vento et al. 2003; Vento et al. 2005). There is evidence that preterm infants have
lower antioxidant reserves (Taglialatela et al. 1998; Kuster et al. 2011).
In animal studies, a fluctuating oxygen profile increases short and long term indices
of brain injury (Felderhoff-Mueser et al. 2004; Loeliger et al. 2006; Ratner et al.
2007). Oxygen fluctuations have been studied extensively in animal models of
retinopathy of prematurity where exposure of newborn rats to fluctuating oxygen was
found to be a more effective stimulus for proliferative, and therefore more severe
retinopathy, than constant hyperoxia (Penn et al. 1993). The proposed underlying
mechanism for the proliferation is that hyperoxia causes an initial cessation of retinal
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vessel development by down-regulating VEGF. Retinal neurons continue to develop
but the impaired blood vessel development is unable to supply adequate oxygen to
these developing neurons. The resulting hypoxia induces the release of hypoxic-
inducible factor (see 1.4.3), causing VEGF expression and rapid formation of new,
less robust vessels which are prone to leakage and therefore bleeding. The hyperoxic
fluctuations then switch off this mechanism again leading to cessation of vessel
development and further retinal hypoxia (York et al. 2004). There is evidence that
this HIF-1 alpha / VEGF mechanism is active in protecting the brain from injury in
mice (Sheldon et al. 2009). These oxygen fluctuations and subsequent aberrant
retinal vascularisation can be replicated in animal studies where effects on
myelination of the optic nerve and white matter of the brain are also observed
(Bhushan et al. 2007; Sedowofia et al. 2008; Pilley et al. 2010).
The partial pressure of oxygen in arterial blood can fluctuate rapidly in preterm
infants causing alternating episodes of hyperoxemia and hypoxemia despite clinical
staff adjustments of inspired oxygen in an attempt to maintain saturations within a
target range (Quine et al. 2009). Preterm infants experiencing fluctuating Pa02 are
at higher risk of developing more severe proliferative ROP (York et al. 2004) and
therefore, fluctuations between hyperoxia and hypoxia may have specific effects on
the brain.
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1.5 Cortical brain development
Both brain injury and disrupted brain development both play a role in explaining why
many preterm infants have neurological impairment. During the third trimester in
intrauterine development, cortical grey matter volume increases fourfold and white
matter volume increases fivefold (Huppi et al. 1998). For infants born preterm, this
development is ongoing whilst the infant fights for survival in the neonatal unit. The
major phases of brain development occurring during the third trimester include
dendritic and axonal growth, synaptogenesis, glial proliferation, differentiation and
myelination (Volpe 2001). These processes are therefore vulnerable to the effects of
neonatal care and the effects of other morbidities experienced by preterm infants.
1.5.1 Human Cortical Development
"The cerebrum is the primary seat of the rationale soul in man, and of the
sensitive soul in animals. It is the source ofmovements and ideas."
Thomas Willis, 1664
In the 17th century, the eminent anatomist and physician, Thomas Willis, conjectured
that human higher cortical function originated in the folds of the cerebral cortex. He
had noted the significant size difference between the cortex of various animals such
as sheep and cats in comparison to the human and believed this explained why an
animal "thinks or remembers scarce anything but what the instincts and needs of
nature suggest" (from Willis' Cerebri Artatome translated in 1681 by Samual
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Pordage). He also believed the smooth, lissencephalic cortices of birds and fish
explained why such creatures have a limited capacity for learning and
comprehension.
The human cerebral cortex is a complex convoluted structure, yet it is highly
organised into six distinct layers. Each layer contains neurons with specific
morphological features to support their individual function. There are significant
uncertainties regarding the intricacies of cortical development, therefore the
regulation and underlying mechanisms continue to be a focus of current scientific
research. The summary given below represents current understanding of the major
developmental events in humans. In all mammals, there is a common basic pattern
of cortical development. The growing brain becomes progressively populated with
neurons by neuronal progenitor proliferation, differentiation, migration, maturation
and neuronal cell survival. Differences do exist between humans and other more
extensively researched animal models such as rodents. These differences will be
discussed in section 1.5.2.
Cortical Embryology
By the third week of development, the three major regions of the forming brain are
distinguishable in the neural tube: the prosencephalon (forebrain), mesencephalon
(midbrain) and rhombencephalon (hindbrain). From the prosencephalon, the
telencephalon and diencephalon arise. The dorsal telencephalon has two lateral
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Figure 1 - Early development of the Human Brain, adapted from Price et al, 2011.
A - Schematic of the neural tube at 3 weeks showing developing prosencephalon, mesencephalon and
rhombencephalon.
B - By 5 weeks of gestation the cephalic flexure at the level of the mesencephalon has driven the
shape of the developing brain. The two lateral outpouchings at the rostral end of the telencephalon are
the cerebral vesicles, the primitive cerebral hemispheres.
C - Cross-section through the telencephalon at 5 weeks shows cells of developing neocortex.
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The human cerebral cortex, or neocortex as it is phytogenetically known, develops
by proliferation of cells at the outer surface of the cerebral vesicles. Initially the
telencephalic cells are all neuroepithelial cells, derived from the neural plate. They
continue to proliferate and increase both the surface area and depth of this initial
layer of the cerebral cortex which is called the ventricular zone (VZ). At this point,
all replications are symmetrical and the VZ is composed entirely of pseudostratified
epithelial cells (Bystron et al. 2008).
Human E30 E31-32 E45 E55 E98
Rat E11 E12.5 E13 E15 E18*
('Relatively smaller
SVZ and SP in rat)
Figure 2 - Cerebral Cortical Expansion
VZ - ventricular zone. PP - preplate. SVZ — subvcntricular zone. SP - subplate. IZ - intermediate
zone. CP - cortical plate. MZ - marginal zone. Embryonic day in humans determined from first day
of mother's last menstrual period. Embryonic day in rats determined from day of conception.
The Preplate (PP)
As shown in Figure 2, in humans at embryonic day 31 (E31), there is evidence of a
complex layer of cells developing dorsal to the VZ. This is called the preplate and
the function of the cells in this layer is largely unknown. There is evidence that these
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cells may provide a guidance scaffold for developing cortical cells. In addition, a
specific subtype of preplate cells, called Cajal-Retzius cells, produce a protein called
reelin, thought to regulate the formation of the cortical layers (Tissir et al. 2003). At
E50-51 the cortical plate, the precursor to neocortex, develops within the preplate
and splits the preplate into an upper zone called the marginal zone which becomes
layer I of the cortex, and a lower zone which develops into the subplate (SP).
The Subplate (SP)
The SP is initially a thin region with a small number of cells present before the
cortical plate forms. It thickens considerably after 9 weeks gestation. The SP has 2
main functions: 1) a temporary waiting and synaptic interaction compartment for
thalamic axons intending to transmit sensory information to the cortical neurons once
they have completed development in the cortical plate, and 2) SP cells have long
axons which act as guides to other afferent and efferent axons in the developing
cortex. The network formed by these axons is particularly elaborate in primates.
The SP reaches its maximum thickness at approx. 24 weeks gestation when it is four
times thicker than the CP (Kostovic et al. 2002a). Once thalamic afferents have
moved on from the SP into the cortical plate, programmed cell death is initiated
within the SP. The SP can still be identified at 6 months postnatal age, but only as
scattered cells in subcortical white matter.
33
Clearly insults from 24 weeks gestation which affect the integrity of the SP synaptic
interaction compartment, may have profound consequences for neural development
and there are indications that hypoxic-ischaemic insults which cause selective
damage to subplate neurons contribute significantly to cognitive dysfunction in
preterm infants (McQuillen et al. 2003).
Neurogenesis
In humans at 5 weeks gestation, there is a pivotal molecular-driven switch directing
the onset of neurogenesis (Iacopetti et al. 1999). From this point, divisions of the VZ
cells first start to become asymmetrical and produce one daughter cell which remains
a progenitor and another which is a postmitotic differentiated cell, committed to
becoming a cortical neuron or a glial cell (Pasko 1995; Iacopetti et al. 1999) as
shown in Figure 3. The cells which remain as neural progenitors (also called neural
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Figure 3 - Neuroepithelial cell differentiation
Schematic diagram showing the proliferating cells within the VZ and SVZ and the origins of the
major cell types of the brain. This illustrates some of the lines of development, however the lineage
process is not fully understood. The VZ progenitors take a number of forms including Radial Glial
Cells (RGCs) and Intermediate Progenitors (IPs).
Radial Glial Cells (RGCs) are an important subtype of neural progenitor in the VZ.
These cells divide to produce both further precursors and a number of differentiated
postmitotic cells (Mo et al. 2007) as shown in Figure 3. In addition it has been
demonstrated that these cells may also function as a 'migratory scaffold' to direct
cortical neurons to their laminar fates (Rakic 2003).
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The Intermediate Progenitor (IP) cell also develops from VZ progenitor cells at E40-
41 (Bystron et al. 2008). These IP cells migrate to the dorsal aspect of the
ventricular zone and form a new layer of cells called the Subventricular Zone (SVZ)
at 7-8 weeks gestation, refer Figure 2. These cells proliferate and also function as
progenitors for postmitotic neurons and glial cells. The SVZ grows to become
particularly thick and complex in humans in comparison to other species.
Proliferation continues until 26-27 weeks gestation by which time the VZ is a thin
layer of cells. In humans, the SVZ is the major source of cortical neurons,
particularly those neurons that are later born and migrate to the superficial layers
(Zecevic et al. 2005; Bystron et al. 2008).
The Cortical Plate
The first cells accumulating to form the cortical plate are visible in the rostral
telencephalon preplate from 7-8 gestational weeks (Bystron et al. 2008; Sidman RL,
Rakic P, 1973). These neurons migrate radially from the ventricular zone and take
their position in an 'inside out' pattern such that neurons destined for layer VI take
position first and then successively committed neuronal subtypes from the VZ and
progressively the SVZ, destined for layers V, IV, III and II take their positions in a
deep to superficial direction, see Figure 4.
Neurons within the deep layers of the cortex, layers V and VI, are large projection
neurons whose axons project to subcortical targets such as the thalamus, striatum,
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pons, spinal cord and the other cerebral hemisphere (Molnar et al. 2006). Layer IV
neurons receive the major sensory information from the thalamus. The superficial
cortical layers (II-IV) contain smaller neurons that form more localised intra-cortical
connections (Gilbert et al. 1979). Each cortical layer can contain several neuronal
subtypes, expressing specific marker transcription factors (Molyneaux et al. 2007),
discussed further in section 1.5.3.
The peak period of cortical neuronal migration is between 12 and 20 weeks
gestation. However migration for the most superficial layers continues during the
third trimester (Uylings 2000). As shown in Figure 4, migration is succeeded by
further neuronal cell development including synaptogenesis which involves the
development of dendritic spines and the formation of synapses between neural cells
(Kostovic et al. 2002; Kostovic et al. 2007). After synapsing on subplate neurons,
axon terminals from thalamic, callosal, and association fibres enter the cortex and
together with the neuronal cell development, contribute to a four-fold increase in
cerebral cortical volume between 28 and 40 weeks gestation (Huppi et al. 1998).
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Key:
MZ - Marginal Zone
CP - Cortical Plate
SP - Subplate
IZ - Intermediate Zone
SVZ - Subventricular Zone
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Figure 4 - Schematic Illustration of cortical development in rats and humans
Migration to deep layers V and VI is complete by 24 weeks gestation and synapses
begin to appear as thalamocortical axons exit the subplate and enter the cortex at this
time (Kostovic et al. 2006; Bystron et al. 2008). The superficial layers undergo a
disproportionate increase in thickness in humans and this is partly due to late arriving
GABA-ergic interneurons, critical for cortico-cortical communication (Letinic et al.
2002; Tan 2002). Concurrently, neurons within superficial layers II to IV continue to
develop dendrites and synapses. Furthermore, arealisation of the cortex and final
differentiation of specialist neuronal cell subtype function will also occur during the
third trimester.
38
It therefore follows that for an infant born preterm at 23-24 weeks
significant ongoing cortical developmental processes may be vulnerable to
caused by premature birth and neonatal intensive care practices.
gestation,
disruption
24 weeks 40 weeks
Figure 5 - Human brain at 24 weeks gestation and 40 weeks gestation
The cortex of the human 24 week gestation brain is smooth. The expansion of the superficial layers in
the third trimester underpins the extensive increase in surface area and the development of gyri and
sulci, illustrating the significant degree of development and maturation between 24 and 40 weeks
which is vulnerable during neonatal care. The brain at 40 weeks morphologically resembles the adult
brain.
Photographs supplied with kind permission from Dr JC Becher.
39
1.5.2 Similarities and differences in rodent cortical
development
The species where cortical development has been most well described and
understood is the rodent. The main sequence of events is broadly similar to humans;
the cortex develops from proliferating ventricular zone cells at the outer surface of
two lateral vesicles of the telencephalon and the six layered cortical plate forms in a
deep to superficial direction. Significant similarities and differences are discussed
below.
A - The SVZ and SP
Both the SVZ and SP are not as large in rodents as in the human. In general, rodent
precursors for the deep cortical layers originate in the ventricular zone (VZ) and
precursors for the superficial layers originate in the subventricular zone (SVZ). In
humans, the SVZ is the main cell proliferating layer from mid-gestation and so gives
rise to the vast majority of the late born superficial layer neurons which are involved
in localised intracortical connections, as described above. It is also however, thought
to be more complex than this in humans (Bystron et al. 2008). The SVZ also gives
rise to subplate neurons and some interneurons throughout the third trimester
(Zecevic et al. 2005). By contrast, all cortical interneurons in rodents originate in the
medial ganglionic eminence. Furthermore, oligodendrocytes, glia and astrocytes are
also generated, proliferate, migrate and differentiate within the SVZ, providing
significant opportunities for interaction between all these cell types (Jakovcevski et
al. 2005). The significance of the large SVZ containing numerous different cell
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types means that insults to this area during prenatal development may have
significant effects on a number of neuronal functions.
The large SVZ in humans generates the large SP. As described above, the SP acts as
a temporary synaptic compartment and the SP neuronal axons guide other afferent
and efferent axons. The smaller rodent SP may reflect fewer requirements for
complex connectivity.
B - Neurogenesis
Gestation in a rat is 21-22 days from day of conception. The onset of neurogenesis
in rodents is E10 (Garcia-Moreno et al. 2007; Rakic 1995), midway through
gestation and continues until El8. Neurogenesis in humans begins at around 5-6
weeks gestation and continues throughout gestation, slowing around 18 weeks
(Uylings 2000). This reflects an extended period of neuronal formation during
human fetal development. Each cortical progenitor undergoes more divisions in the
human, amplifying cellular numbers and generating a much larger cortex (Uylings
2000).
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C • The Developed brain: Rodent Vs Human
The adult rat brain is lissencephalic whilst that of the term neonate has extensive gyri
and sulci to support a much enlarged cortical surface area. This occurs concurrently
with substantially expanded underlying upper cortical layers in all mammals, most
impressively humans, and it is thought these thicker superficial cortical layers
underpin enhanced cognitive function.
In the adult mammalian brain, including humans, there are small populations of
neuronal precursor cells in the remaining subventricular zone and in the dentate
gyrus of the hippocampus (Gage 2000) that can give rise to new neurons and glia.
These neuronal precursor cells are important to learning and memory and contribute
to recovery from neuronal injury.
42
1.5.3 The Control of Cortical Development
Newly generated multipotent precursor cells will eventually commit and develop into
a neuronal subtype as shown in Figure 3. Particular transcription factors, specific to
neuronal subtype and function, are expressed in neural cells (Molyneaux et al. 2007).
Transcription factors are proteins that bind to specific regions of DNA (promoters
and enhancers) and alter transcription of mRNA and therefore alter gene expression.
They may achieve this by, for example, recruiting histone-modifying enzymes that
alter chromatin and make conditions more favourable for transcription, or, by
recruiting kinases that phosphorylate RNA polymerase, activating RNA synthesis
(Price et al. 2011).
Some transcription factors may only be expressed in a particular projection neuron or
interneuron at a discrete developmental time and therefore direct a specific
developmental event. A differentiated neuron has restricted potential from birth as
the subtype it will become is influenced by the transcription factors expressed in its
progenitor (Molnar et al. 2011). These early transcription factors influence the key
cellular events in cortical development; proliferation, migration, differentiation,
dendritic morphology, synaptogenesis and neurotransmitter release. Different
transcription factors can be expressed in neural progenitors at different times in
development, allowing such progenitors to give rise to a number of different post¬
mitotic neural types including projection and interneurons, astrocytes and
oligodendrocytes (Dominguez et al. 2012). As in Figure 3, early progenitors have a
higher multipotency and late born progenitors are more restricted in their fate. As
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indicated previously, many of the intricacies of cortical development are not yet
understood and remain the focus of ongoing research.
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1.6 Fetal brain growth
The growth and development of the brain from conception to birth involves a
complex interplay of neuronal proliferation and migration, growth and extension of
axons toward target zones and development of dendrites, synapses and
communication networks between neurons. Neuronal development of this nature is
highly dependent on the surrounding environment and in particular on the presence
or absence of trophic factors. Many trophic/growth factors are involved in overall
brain growth. Four key factors have been selected for this study; (1) Insulin-like
growth factor-1, (2) Brain Derived Neurotrophic Factor, (3) Fibroblast Growth Factor
and (4) Vascular Endothelial Growth Factor. The following review summarises the
literature surrounding the role of each of these factors in brain development. Further
details of literature surrounding the effect of specific perinatal factors on each of the
factors are given in the introduction to Chapter 7.
1.6.1 The Insulin-Like Growth Factor (IGF) system
The Insulin-Like Growth Factor (IGF) system is key to several aspects of nervous
system development and is expressed in the rodent brain from embryonic day 14
(E14). Peak levels in the cerebral cortex are seen at postnatal days 8 and 13 (Bach et
al. 1991). The two peptides of the IGF system, IGF -I and IGF-II act predominantly
through the IGF-I receptor (IGF-IR) and their actions are modulated by six IGF
binding proteins that can either inhibit or augment IGF ligand activity (Rajaram et al.
1997). Animal experiments involving null mutations in transgenic mice have
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demonstrated that the IGF system controls overall growth during intrauterine
development (Baker et al. 1993). In such experiments, IGF-I and IGF-IR knock-out
mice have birth weights 60% and 45% of normal, respectively (Lui et al. 1993).
Within the brain, IGF-I stimulates the proliferation of neural progenitors. IGF-I
overexpression results in an increased number of progenitors in the VZ and SVZ, an
increased number of neurons in the cortical plate of the telencephalon at E16 and an
increased number of neurons and glia in the cortex postnatally (Popken et al. 2004).
It is thought to achieve this by reducing G1 phase length, thereby reducing cell cycle
length and increasing cell cycle re-entry of the progenitor cells (Hodge et al. 2004).
In addition, IGF-I has a neurotrophic effect in maintaining survival and inhibiting
apoptosis of neurons and oligodendrocytes in rodents, therefore representing a
second mechanism by how IGF-I increases neuronal cell number (D'Ercole et al.
1996; D'Ercole et al. 2002). Furthermore, IGF-I supports neuronal development by
stimulating neuritic outgrowth, dendritic branching and synaptogenesis in rodent
cerebral cortex (Niblock et al. 2000). Brain IGF-I overexpression results in an
increased brain size (Popken et al. 2004) and IGF-I null mutant mice have restricted
body and brain growth of around 60% and 30% respectively (Beck et al. 1995). The
hippocampus, cerebellum and cerebral cortex are reduced in the null mutant mice in
comparison to control.
In humans, deletions or mutations in IGF-I cause severe intrauterine growth
restriction (Walenkamp et al. 2005), microcephaly and severe learning difficulties
(Woods et al. 1996). Microcephaly also occurs in patients with IGF-I insensitivity
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secondary to a heterozygous IGF-IR mutation and learning impairment ranges from
severe to no impairment (Walenkamp et al. 2006). This suggests that different IGF-
IR mutations cause variable quantities of functional IGF-IR.
IGF-I is produced in the liver and released into the circulation. IGF-I is able to cross
the blood-brain barrier (Reinhardt et al. 1994; Pulford et al. 1999), but it is thought
that local production of IGF-I is the primary source for neural cells (Russo et al.
2005). This is supported by studies confirming that IGF-I is produced by cortical
and other CNS neurons (Niblock et al. 1998) and by endothelial cells of the cerebral
vasculature (Sonntag et al. 1997).
Control of Insulin-like Growth Factor-I
Postnatally in humans, IGF-I influence on somatic growth is under the control of
Growth Hormone (GH), the major regulating hormone of postnatal growth.
However, prenatally during brain development, IGF-I is significantly less dependent
on GH but is influenced by a number of growth factors which modulate biological
activity and cellular responses to IGF-I as described below.
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1.6.2 Brain-Derived Neurotrophic Factor (BDNF)
BDNF is part of the neurotrophin family of peptides which also includes nerve
growth factor (NGF) and Neurotrophic 3, 4 and 5. Within the developing brain,
BDNF plays a key role in neuroprotection. It also contributes to cell proliferation,
migration, differentiation, axonal outgrowth, regulation of neurotransmitter secretion
and synaptic plasticity (Rao et al. 2009).
BDNF is produced predominantly by several neuronal and glial cell populations
(Radka et al. 1996). Several other tissues including immune cells and vascular
endothelium produced smaller amounts of BDNF (Noga et al. 2003). All
neurotrophins exert effects by binding with the tropomyosin receptor kinase family
(Trk) of tyrosine kinase receptors. Specifically BDNF and NT4 interact with the
TrkB receptor. BDNF is also known to increase VEGF secretion (Nakamura et al.
2006).
Preterm infants have lower circulating levels of BDNF than term infants and levels
increase with increasing gestational age (Malamitsi-Puchner et al. 2004). Serum
levels of BDNF increase into adulthood. Recent research suggests that serum BDNF
concentration correlates with a number of antenatal and postnatal factors that
influence neurodevelopmental outcome (Rao et al. 2009). This includes increased
measured levels of BDNF in association with antenatal steroid use, linked to
improved outcome (Roberts et al. 2006) and reduced levels of BDNF measured in
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association with postnatal steroid use which, at some doses, have been linked to
detrimental effects on the developing brain (Murphy et al. 2001).
Within the developed brain, BDNF plays important roles in learning and memory
(Hashimoto et al. 2008). Furthermore, there is literature to support reduced
circulating BDNF in patients with depression (Karege et al. 2002) and schizophrenia
(Durany et al. 2001; Toyooka et al. 2002).
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1.6.3 Fibroblast Growth Factor (FGF)
There are 22 FGF ligands in both humans and rodents. The ligands signal via one of
4 transmembrane receptor tyrosine kinases, Fibroblast Growth Factor Receptors 1-4,
FGFR 1-4 (Johnson et al. 1993; Mason 2007). The fibroblast growth factors (FGF)
have key roles in early brain patterning, cell proliferation, differentiation and synapse
organisation. Members of the FGF family are expressed very early in the developing
brain from involvement in neural induction (Streit et al. 2000). The FGF family of
trophic factors are also involved in cortical patterning, a crucial aspect of cerebral
development not studied in this thesis. The cerebral cortex of all mammals is
patterned so that each area connects to a specific area of the body and within the
cortex (Rakic 1988). FGF signalling is key to midbrain / hindbrain region
specification as demonstrated by experiments where tissue from the midbrain-
hindbrain boundary is grafted into the posterior forebrain, and FGF signalling re-
specifies the forebrain tissue as midbrain tissue (Crossley et al. 1996; Chi et al. 2003;
Zervas et al. 2005). Later in brain development, one of the ligands, FGF-2 has
proliferative effects on precursor populations in the SVZ and hippocampus (Kuhn et
al. 1997; Tao et al. 1997). FGF-2 is reported in a number of early studies to be
inhibitory to differentiation of cortical progenitors and the hippocampus (Gritti et al.
1996; Qian et al. 1997). This inhibitory property could however be overridden by
the addition of another tropic factor, Neutrophin-3 (NT3) in vitro which blocks
cortical proliferation, enhancing cell differentiation (Ghosh et al. 1995), thus
supporting the concept that extracellular trophic factors interact in regulating
neuronal development. Recent studies confirm that in certain brain regions, FGF
signalling directs cell differentiation. It has been shown that during rodent forebrain
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development, FGF signalling stimulates release of the Foxgl transcription factor
from the nucleus leading to cell differentiation within the forebrain (Regad et al.
2007). In the absence of FGF signalling, Foxgl remains in the nucleus and the
forebrain neurons continue to proliferate undifferentiated (Regad et al. 2007). The
roles FGF-2 and FGF-22 play in synaptogenesis is now appreciated as these ligands
lead to presynaptic vesicle clustering and organisation in the developing synapse (Li
et al. 2002).
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1.6.4 Vascular Endothelial Growth Factor (VEGF)
Vascular Endothelial Growth Factor (VEGF) is a crucial signalling protein involved
in new blood vessel formation (vasculogenesis) and subsequent vascular
development (angiogenesis) (Ruhrberg 2003). VEGF acts through one of three
VEGF receptor (VEGFR) subtypes, all tyrosine kinase receptors. VEGF-stimulated
blood vessel development is required for normal nerve growth in fetal development.
Low VEGF expression in the developing rodent brain causes decreased angiogenesis,
major defects in blood vessel formation and reduced neuronal proliferation, increased
apoptosis and aberrant neuronal migration in the VZ and SVZ reflected in a
decreased cortical thickness (Haigh et al. 2003).
Studies reveal that VEGF has significant nonvascular functions within the
developing brain. In explanted brain cortex, VEGF enhanced neuronal survival and
neurite outgrowth (Rosenstein et al. 2003). In hypoxic tissues, VEGF transcription
was induced by hypoxia-inducible-factor-1 (HIF-1), activated by the dimerization of
subunits HIF-1 a and HIF-1 P and binding to the VEGF receptors (Neufeld et al.
1999). Cerebral VEGF expression is up-regulated in hypoxic driven ischaemia in
rodents (Jin et al. 2000) and in vitro, VEGF reduced associated cell death in cortical
and hippocampal neurons in a model of cerebral hypoxic-ischaemia, demonstrating
an important neuroprotective role (Jin et al. 2000). VEGF also promotes the survival
of primary motor neurons following oxidative stress (Oosthuyse et al. 2001).
Evidence also exists that blood vessel branching influences axon guidance and vice
versa (Eichmann et al. 2005).
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1.7 Summary
In summary, the preterm infant's brain is undergoing significant maturational
processes at a point when antenatal factors may expedite preterm delivery and
postnatal therapies may adversely impact this process and ultimately impair long
term neurodevelopment. There is evidence that preterm infants with pre- and
postnatal growth restriction are at risk of long term adverse neurodevelopmental
outcome. Preterm infants who have ongoing oxygen requirements or who suffer
from chronic respiratory morbidity such as BPD, have abnormal imaging at term
which correlates with abnormal neurodevelopmental outcome.
1.8 Research Objectives
This study aims to examine the independent and combined effects of growth
restriction (GR) and postnatal fluctuating hyperoxia (A02), on cerebral cortex
lamination, transcription factor quantities and on the expression of growth factors





The animals involved in this work were studied in accordance with institutional
guidelines and UK Home Office legislation under the Animal Scientific Procedure
Act 1986 and the Code of Practice for the Housing and Care of Animals used in
Scientific Procedures, HMSO, 1989 (Project Licence PPL60/12624) and following
approval by the Local Ethics Committee. All animal studies were conducted under
an Animal Handling Licence (PIL 60/12624) awarded to EW (author) by the Home
Office following successful completion of training and assessment by the Scottish
Accreditation Board.
2.1 Introduction
There is a common agreement in the scientific world that no single animal model can
replicate the human condition. The use of animals in research is however important
to the development of new and more effective methods for understanding
mechanisms and diagnosing and treating diseases that affect humans. Small animals
such as the rat are easily housed and cared for in appropriately sized cages, have
short gestation lengths, are relatively economical and are capable of producing
multiple offspring. Rats have an equivalent maturation period and can be studied
over a short time period. Rats share 98% of their genes with humans, equivalent to
that of the mouse and pig, also common choices in studying neonatal disease.
The gross anatomy of the rat and human brain are very different. The rat brain has a
smooth lissencephalic surface, whereas the human brain is gyrencephalic. At birth
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the rat brain, like the human brain, is at a relatively early stage of maturation and this
classifies both species as postnatal brain developers. Dobbing and Sands published
the much referenced paper that illustrated the perinatal brain growth spurt of seven
mammalian species (Dobbing et al. 1979). In humans, total brain weight gain as a
percentage of adult weight peaks around birth. In the rat, where length of gestation is
21-22 days, the peak brain growth spurt is at postnatal day 7 (P7). By P7, all 6 layers
of the cortex are complete in the rodent. The cortical anatomy at this stage has been
compared as developmentally equivalent to a 35 - 36 week gestation human infant
(Rice et al. 1981; Romijn et al. 1991). Similarities and differences have been
discussed in section 1.5.2.
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2.2 Growth Restriction
Several models have been described to induce growth restriction in rodent offspring
to assess effects of intrauterine growth restriction and fetal programming, including
various nutrition manipulation models, mid-gestation surgical procedures e.g. uterine
artery ligation and models administering growth inhibiting substances e.g.
glucocorticoids (Snoeck et al. 1990; Woodall et al. 1996; Holemans et al. 1998;
Holemans et al. 2003). A nutritional manipulation model of protein restriction was
used from day 15 of gestation. In each study of this work, Sprague-Dawley rat dams
were fed either 18% or 9% casein isocaloric protein diet from embryonic day 15
(El5) of gestation until postnatal day 7 (P7). Both diets were of the same colour and
texture. Diet compositions were supplied by Dr Simon Langley-Evans, University of
Nottingham. Special Diet Services, Edinburgh University, then composed and
supplied the diets. The casein protein content was checked in each batch. The
properties of the diets are summarised in the following table:






Casein (dry acid free) 180 90








Dam intake of the 9% casein protein isocaloric diet has been previously shown to
result in significantly smaller offspring pups (Langley-Evans et al. 1994), who
developed hypertension at 4 weeks of age (Langley-Evans et al. 1998) secondary to
fetal exposure to higher levels of maternal glucocorticoids. Glucocorticoids are well
established to impair skeletal growth (Avioli 1993; Ahmed et al. 2002; Mushtaq et al.
2002). Gestational protein restriction in rodent models also impairs uterine artery
blood flow possibly through an increase in circulating angiotensin (Gao et al. 2012).
In addition poor maternal nutrition of the mother in pregnancy causes reduced
substrate delivery to the fetoplacental unit and a reduction in total milk volume
during lactation (Rosso et al. 1980; Holemans et al. 1998). The combination of these
factors therefore hampers fetal and neonatal growth of the pups in response to low
maternal protein intake.
This model has also been validated in previous studies by investigating retinopathy
of prematurity where pups from dams fed on the 9% diet, were on average 5% lighter
at birth and 36% lighter at postnatal day 14 (Dhaliwal et al. 2011). The method is
therefore simple and effective at inducing growth restriction but does not cause
increased early mortality in the pups. The 9% diet during pregnancy has however
been associated with reduced adult lifespan (Aihie Sayer et al. 2001) linked to a
higher resting blood pressure in the 9% pups at 4 weeks of age (Langley-Evans et al.
1998). A further advantage of this method is that postnatal growth restriction can be
induced by continuing the diet postnatally. This is relevant to the clinical situation
where growth restricted preterm infants often fail to grow adequately (Hokken-
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Koelega et al. 1995). This method induces asymmetrical growth restriction with
relative brain-sparing, again reflective of the most common type of growth restriction
seen in the clinical situation.
The main limitation of this model is that the aetiology underlying the growth
restriction is not typical of the clinical correlate of placental vascular insufficiency
although the low protein diet has been associated with decreased uteroplacental flow
secondary to impaired uterine artery blood flow as described above (Gao et al. 2012).
The body and brain weight results obtained from this animal model are discussed
further in the context of the literature in Chapter 4.
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2.3 Postnatal Oxygen Exposure
The use of oxygen in neonatal care has been subject to much controversy over the
last decade, as described in Chapter 1. Due to the nature of the lung disease
associated with prematurity, the amount of oxygen required by a preterm neonate
will often fluctuate. The severity of a particular infant's lung disease will influence
the amount of oxygen absorbed into the circulation and transported to the brain.
Preterm infants on the neonatal intensive care unit have their circulating oxygen
levels monitored, directly, by arterial blood gas sampling and indirectly, by pulse
oximetry or by transcutaneous p02 monitoring (Quine et al. 2008). The oxygen
delivered can then be titrated accordingly.
Many of the experimental oxygen profiles used to study the effects of oxygen on
developing body systems employ high, constant levels of oxygen or step-wise
fluctuations in oxygen which are not accurately reflective of what preterm infants
experience in the clinical situation. An established fluctuating model was therefore
used to deliver more clinically relevant doses of oxygen and examine its effects on
the developing brain.
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2.3.1 Background to the Oxygen Profile
The profile delivered to the rat pups in this study was adapted from the
transcutaneous oxygen profile of a preterm infant cared for in a tertiary neonatal unit,
Edinburgh. This oxygen profile has been used in previous work in studies of
retinopathy of prematurity (ROP) and white matter injury (Cunningham et al. 1995;
Cunningham et al. 2000; Sedowofia et al. 2008; Dhaliwal et al. 2011). The details
regarding the particular infant have been anonymised, however, the infant had the
most marked variability in oxygen levels from a cohort of 31 infants (Cunningham et
al. 1995), was between 26 and 27 weeks gestation with respiratory distress syndrome
and had severe ROP. The profile was recorded over the first 7 days of life and shows
a fluctuating pattern of transcutaneous oxygen. Recordings were made every second
and averages taken to give a value for each minute as illustrated in Figure 6. The
minute-to-minute fluctuations were then adapted for use in the rodent (see below).
Many studies examining the effect of oxygen on the developing brain in the context
of neonatal care use high levels of inspired oxygen, e.g. a Fi02 of 80-100%, which
result in high oxygen saturations in the organism studied (Taglialatela et al. 1998;
Gerstner et al. 2008; Yis et al. 2008). These studies allow conclusions to be drawn
regarding the detrimental effect of high levels of oxygen on the developing brain,
including the generation of reactive oxygen species and increased apoptosis observed
in response to high levels of oxygen. Such profiles no longer reflect current clinical
practice where a more targeted use of oxygen is employed.
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Transcutaneous oxygen measurements (Tc02) correlate well with arterial oxygen
partial pressure (Pa02) in very low birth weight infants (Sandberg et al. 2011). In
the clinical setting, Tc02 values can be used as a measure of Pa02 and calibrated
against the infant's arterial blood gases. An electrode placed on the upper right area
of the thorax avoids the effect of ductal shunting and measures the Tc02. Safety
concerns relating to epidermal burning (Poets et al. 1994) and relative ease of pulse
oximetry as an alternative monitoring method has resulted in widespread adoption of
the pulse oximeter in neonatal intensive care units. Recent studies have
demonstrated that pulse oximetry readings often show a significant discrepancy with
target Pa02 by underestimating the Pa02. Pulse oximetry measurements can be also
be associated with a higher degree of variability than Tc02 (Quine et al. 2008).
2.3.2 Adaptations for the Rodent Model
The oxygen profile applied to the rat litters was adapted from transcutaneous
recordings of the oxygen profile from the infant who developed severe retinopathy of
prematurity (ROP) and has been validated in animal studies of ROP as described
above. The rat pups were born at term and therefore have mature lungs in contrast to
preterm infants receiving oxygen. To adjust for the difference in rat physiology, the
profile was adapted as previously published (McColm et al. 2000); a rat breathing
room air (21% oxygen) has a circulating Pa02 of 12.9kPa. Infants requiring oxygen
have their Pa02 maintained within a range of 6 - 10 kPa; mean 8kPa, 4.9kPa lower
than rat pups. Therefore, to each minute-to-minute fluctuation of the infant
transcutaneous profile, 4.9kPa was added to simulate fluctuations in the rodent.
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There is a linear relationship between rat pup Pa02 and inspired oxygen
concentration (Fi02) (Penn et al. 1995). The transcutaneous profile was transformed
into Fi02 values, see Figure 6. By altering the inspired oxygen concentration in this
way, the blood oxygen profile recorded in the preterm infant who developed severe
ROP can be replicated in the rat pups within a specialised oxygen chamber.
Studies of ROP using this model have shown that the greatest changes in retinal
vessel formation were found when the mean of the simulated profile was raised from
8kPa to lOkPa (McColm et al. 2004), the upper limit accepted in the neonatal clinical
setting. The mean of the fluctuating profile applied to the rat pups was therefore
14.9kPa and this hyperoxic profile was the one used in this work. The mean inspired
oxygen concentration delivered was 24.9% and ranged from 12.57% to 44.86%. The






Figure 6 - Oxygen Profile
Y axis shows the percentage oxygen delivered to the rodent chamber. X axis shows time in minutes
for 7 days (10,080 minutes). Recordings were made every second and plots show average value for
each minute.
The main strength of this oxygen profile is that it is physiological and developed
from a preterm infant with significant neonatal morbidity. Previous work has shown
that the fluctuations can be more damaging to the developing brain than constant
hyperoxia (Loeliger et al. 2006; Ratner et al. 2007). In addition, this profile has been
validated for study in the brain where the fluctuating profile was associated with
markers of cerebral injury (Sedowofia et al. 2008).
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A weakness of the model is that the profile used may rest in higher oxygen
concentrations than typically observed in the clinical situation. Recent evidence
however suggests that maintenance of oxygen saturations within a higher targeted
range (90-95%, equivalent to 5.9-8.9 kPa) is associated with significantly less
mortality than a lower targeted range and there is evidence that this has already
influenced neonatal practice (Stenson et al. 2011). Where Tc02 monitoring is used
in neonatal units, published recommendations advise limits of 6.7 - 10.7kPa
(American Academy of Pediatrics Guidelines, 1997). In addition, arterial oxygen
saturations were not confirmed during the experiments. Previous researchers had
confirmed that rat Pa02 and Fi02 were linear (Penn et al. 1995) and the rodent pups
were term born with no reason to suspect abnormal lung function.
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2.3.3 The Complete Experimental Circuit
The complete experimental circuit used in the studies is shown below. The computer
controlled delivery system for the oxygen profile, illustrated in Figure 7 was
designed by McColm and Cunningham (McColm et al. 2000) and developed by
Biospherix, Redfield, New York, USA.
Figure 7 - The computer controlled system for delivery of the oxygen profile.
The oxygen profile determined how much atmospheric oxygen was delivered to the rats in a closed
circuit, monitored cage. Oxygen and nitrogen gas were delivered to the chamber in quantities
determined by the oxygen profile and the control box.
Oxygen and nitrogen gases are released into the specially designed closed animal
chamber on a minute-by-minute basis to cause the required change in atmospheric
oxygen as prescribed by the oxygen profile. Accurate changes up to 50% oxygen
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within 1 minute were possible in the rat cage (McColm et al. 2000). To maintain the
carbon dioxide at normal atmospheric levels, soda lime (Medisorb GE healthcare,
UK) was placed in the oxygen chamber.
2.4 Study Groups
From E15 of gestation until P7 rat dams were fed 18% or 9% casein protein diet.
From birth until P7, litters were allocated randomly and reared in air or fluctuating
hyperoxia. Four study groups were formed and the conditions of each group are
summarised in Table 3.
Table 3 - The Study Groups
Group
Dam protein
feed (E15-P71 Pup Growth
Environment
Litter Reared
1. Control 18% Normal Room Air
2. Oxygen Fluctuation (A02) 18% Normal Fluctuation Oxygen
3. Growth Restricted (GR) 9% Restricted Room Air
4. Dual Exposed (A02+GR) 9% Restricted Fluctuating Oxygen
The following diagram summarises the animal model, incorporating both the growth










Figure 8 - The Animal Model
Until E15 all rat dams were maintained on standard animal house chow. Diet was changed at E15 and
continued until the experimental end at P7. Litters of 10 pups with dam were placed in room air or
oxygen chamber immediately after birth until P7.
The room air chamber was placed next to the closed circuit oxygen chamber to
ensure that noise exposure was similar and all animals underwent 12 hour light/dark
cycle. The room temperature was maintained at 21°C. Immediately after birth,
litters were limited to 10 pups of equal numbers of males and females. The pups
were weighed; their paws tattooed with Indian ink for identification and placed with
their mother in the room air or oxygen chamber.
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2.5 Collection of Tissue
2.5.1 Serum Collection
At P7, all pups were weighed and anaesthetized by intraperitoneal injection of 0.2ml
Sodium Pentobarbital, 54.7mg/ml (CEVA Santa Animal). The thoracic cavity was
opened by a vertical incision and blood 30-40 microlitres (^l) was aspirated from the
left ventricle using a 25 gauge orange needle and a lml syringe. Blood was pushed
into a labelled eppendorf with the needle removed to avoid inducing haemolysis.
2.5.2 Brain Tissue Collection for Immunohistochemistry
Five pups from each litter then underwent perfusion with 20ml 4%
Paraformalydehyde fixative (Sigma Aldrich) and then an intracardiac injection of
0.2ml Sodium Pentobarbital 200mg/ml (CEVA Sante Animal). The head was
removed and whole brain was dissected from the skull with olfactory bulbs attached
and rotated in 15mls of 4% Paraformaldehyde for 24hours at 4°C. The brains were
later used in staining and immunohistochemistry studies of the cerebral cortex
(Chapters 5 & 6).
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2.5.3 Brain Tissue Collection for Molecular Biology
The other five pups from each litter were perfused with 20 mis of saline/PBS
(phosphate buffered saline 1:1000). These pups had an intracardiac injection of
0.2ml Sodium Pentobarbital 200mg/ml (CEVA Sante Animal) before removal of the
brain from the skull. These brains were placed on a clean, RNAse free cold surface
and cut into 5 sections: the olfactory bulbs, anterior and posterior cerebrum,
brainstem and cerebellum as shown in Figure 9. These were placed in pre-labelled
sterile eppendorfs and kept on dry ice (approx. -60°C). These brains were later used




Whole blood was allowed to clot at room temperature and then centrifuged at
3000rpm for 20mins. Serum was carefully pipetted into clean eppendorf and the
centrifuge cycle was repeated. Supernatant serum was again carefully pipetted into
clean eppendorf and stored at -80°C until analysis.
2.6.2 Brain tissue for Immunohistochemistry
The 4% paraformaldehyde perfused brains for immunohistochemistry were rotated in
I5mls 4% paraformaldehyde at 4°C for 24 hours. The brains then underwent 2
washes in PBS and were cryoprotected by initially soaking in 10% sucrose for
approximately 1 hour until the brain sank. The lower concentration of sucrose was
initially used, and then brains were soaked in 20% sucrose for 24 hours. The
cryoprotection in sucrose prevents the formation of ice crystal artefact which is
important in the brain where the cellular grey matter freezes at a different rate to the
lipid white matter. The initial soak in the lower concentration of 10% sucrose
prevents osmotic shock caused by high water content secondary to a high diffusion
gradient. The brains were then frozen in 2-methylbutane at -30°C. Temperature was
monitored by a low reading thermometer and careful titration with dry ice. Once
frozen, the brains were stored at -80°C until use.
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2.6.3 Brain Tissue for Molecular Biology
The saline perfused brains which were cut into the 5 sections shown below were
stored at -80°C until thawed for molecular biology analysis (see Sections 3.1-3.4).
Attempts had been previously made to dissect out discrete regions of the brain, e.g.
hippocampus, thalamus, hypothalamus. Due to the excessive friability of the P7
brains, these dissections could not be accurately replicated.
Olfactory bulbs
Figure 9 - Cut positions in sectioning brain tissue for molecular biology
The red lines represent the cuts made from a dorsal and ventral perspective to obtain the 5 sections:
olfactory bulbs, anterior cerebrum, posterior cerebrum, brainstem and cerebellum.
72
The brains were carefully cut with a fresh blade per brain into 4 sections for further
analysis:
1. Anterior Cerebrum - containing rostral cerebral cortex, partial dorsal
hippocampus, and rostral corpus callosum.
2. Posterior Cerebrum - containing caudal cerebral cortex, thalamus,
hypothalamus, partial midbrain, majority of hippocampus and caudal corpus
callosum.






3.1 Ribose Nucleic Acid (RNA) Extraction
Obtaining high quality intact RNA is the first step in successful quantitative real-time
Polymerase Chain Reaction (qPCR) for detection and measurement of specific gene
expression.
The four brain sections described in Section 2.6.3 were stored at -80°C until analysis,
and then thawed gradually to room temperature.
Anterior Cerebrum - containing rostral cerebral cortex, partial dorsal
hippocampus, and rostral corpus callosum.
Posterior Cerebrum - containing caudal cerebral cortex, thalamus,
hypothalamus, partial midbrain, majority of hippocampus and caudal corpus
callosum.
Brainstem - containing partial midbrain, pons and medulla.
Cerebellum.
To ensure optimal RNA yield, the tissue was weighed and the anterior cerebrum cut
into 2 sections and the posterior cerebrum, 3 sections, to ensure each section of tissue
weighed less than lOOg, the limit of the RNeasy spin column binding capacity.
RNeasy Lipid Tissue Minikits (Qiagen Sciences, Maryland, USA) were used to
perform phenol-choloform RNA extraction using the Qiagen standard protocol.
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3.1.1 Disruption and Homogenisation
Simultaneous disruption and homogenisation of the tissue was achieved by adding
QIAzol Lysis Reagent (Qiagen Sciences, Maryland, USA) and stainless steel beads
to the tissue which was placed into the TissueLyser (Qiagen, manufactured Retsch)
at 25Hz, 2x2 minutes to ensure complete disruption of cell plasma membranes and
organelles. The lysis buffer and beads homogenize high molecular weight cellular
components including genomic DNA. The QIAzol Lysis Reagent (Qiagen Sciences,
Maryland, USA) is composed of guanidine thiosulphate and phenol to optimise lysis
of fatty tissues including the brain. Guanidine thiosulphate is a chaotropic agent and
therefore disrupts and denatures the structure of proteins including RNAses.
Following lysis, bromochloropropane was added to each tissue sample before
centrifugation. This resulted in phase separation of an upper aqueous phase, a lower
organic phase and a middle white interphase. The upper aqueous phase contains
RNA and the lower organic phase contains protein dissolved in phenol and lipid
dissolved in chloroform.
3.1.2 Isolation of RNA
To provide the conditions such that RNA will stick to the RNeasy membrane,
ethanol is added to the aqueous phase before transferring the solution to the RNeasy
mini spin column. On-column DNase digestion was performed to ensure removal of
residual DNA from the membrane. The RNA is then eluted from the membrane by
the addition of RNase free water.
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3.2 RNA Quantification and Quality Check
3.2.1 Spectrophotometer - Nanodrop
All RNA samples were analysed using the Nanodrop Spectrophotometer (Nanodrop
products, Thermo Fisher Scientific, 3411 Silverside Rd, Wilmington, DE 19810
USA) to quantify the concentration of RNA and assess the purity of the sample.
Readings were taken at wavelengths of 260nm and 280nm. The 260nm reading
allows calculation of the nucleic acid concentration within the sample and the 280
reading indicates the amount of protein. Pure preparations of RNA have 260/280
ratios of >2.0. Samples with ratios below 2.0 may have been contaminated with
protein or phenol and were excluded from further analysis.
Wavelength nm
Figure 10 - Graph plot of Nanodrop
The four pieces of brain from which RNA was extracted are shown by a different colour. The
olfactory bulbs (OB) and liver (L1V) were also extracted and used for optimising methodology only.
The absorbance at wavelengths 260nm and 280nm are recorded to give a 260:280 ratio.
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3.2.2 Agilent bioanalyser
Gene expression data can only be informative if the initial RNA to be transcribed is
intact. To assess RNA integrity, the Agilent 2100 Bioanalyzer (Agilent
Technologies) was used. Random RNA samples were selected from each RNA
preparation batch for integrity analysis. For each Bioanalyser run, the RNA 6000
LabChip (Caliper Technologies Corporation), was first loaded with RNA 6000 Nano
gel matrix, labelled with fluorescent RNA 6000 Nano dye. Thereafter, 1//I of RNA
from selected samples was loaded onto the chip with Agilent RNA 6000 Nano
marker. To assess the integrity of extracted RNA, the integrity of ribosomal RNA
(rRNA) fragments 18S and 28S were examined in each sample as rRNA is one of the
only gene products present in all cells (Smit et al. 2007). An RNA ladder with
concentrations and sizes of individual base pairs preset within the assay was used as
a mass and size standard. In reading the chip, the Bioanalyser uses electrophoresis to
separate RNA which is then detected by laser induced detection. This gives an
electropherogram (Figure 11) and a densiometry plot gel image (Figure 12). The
area under the electropherogram is determined and the ladder information is used to





Figure 11 - Electropherogram
Fluorescence intensity against migration time (seconds). Marker, 18S fragment and 28S fragment
peaks shown respectively. The 18S and the 28S fragment represent the small and large subunits of
ribosomal RNA respectively. This electropherogram shows 2 clear peaks at 18S and 28S, representing
intact fragments.
This ratio of fragments is calculated to give a RNA Integrity Number (RIN). A RIN
score of 1 represents a degraded sample and a RIN of 10, an intact sample.
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Figure 12 - Densiometry gel image
From left to right: RNA ladder, Sample 1 - RIN score 10, Sample
score 1, degraded sample which was excluded from further analysis.
RIN score 10, Sample 3 - RIN
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Only samples with RIN scores of 9 or 10 were used in the experiments.
3.3 Complementary DNA (cDNA) Synthesis
Reverse transcription of the extracted RNA was performed using a standard Applied
Biosystems protocol (Life Technologies Corporation, 5791 Van Allen Way,
California 92008).
The process of Reverse Transcription involves:
• mRNA mixed with components of Master Mix (Table 4).
• Oligo (dT) primer and random primers attach to mRNA.
• In the presence of reverse transcriptase and deoxyribonucleotide
triphosphates (dNTPs), single stranded cDNA forms.
3.3.1 Laboratory Technique
Each RNA sample was diluted to 300ng/10/rl using the concentration data from the
Nanodrop Spectrophotometer (See section 3.2.1). For each sample, 10/H of RNA
was added to an eppendorf with 6/H nuclease free water (Qiagen) and 4/H of High
capacity RNA-to-cDNA Master Mix (Applied Biosystems, Life Technologies
Corporation, 5791 Van Allen Way, California 92008). This Master Mix contained
the components listed in Table 4. In batches of 96, eppendorfs containing the sample
RNA, Master Mix and water were loaded into the same G-storm thermal cycler
(Gene Technologies Ltd, Braintree, Essex, UK) and the underwent:
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• 5 minutes at 25 degree Celsius (°C),
• 30 minutes at 42 °C,
• 5 minutes at 85 °C and held at 4 °C until samples were removed.
Table 4 - Components of RNA-to-cDNA Master Mix
Applied Biosystems RNA-to-cDNA Master Mix
Component Role in RT Reaction
Magnesium
Chloride





The building blocks of DNA. Each deoxyribonucleotide has 3 parts:
A deoxyribose / pentose sugar, 1 or more phosphate groups, a




Required to inhibit any Ribonuclease contamination and therefore





This is an RNA-dependant-DNA polymerase. This enzyme catalyzes
the transcription of single stranded RNA to single stranded cDNA.
Random Primers
Short segments of single-stranded DNA (ssDNA) called
oligonucleotides. These consist of every possible combination of
bases and can therefore bind to any section of DNA thus allowing the
production of many short copies of every section of DNA.
Oligo (dT) Primer
A short sequence of deoxy-thymine nucleotides tagged as a
complementary primer to bind to the poly-A tail providing a free 3'-
OH end that can be extended by reverse transcriptase to create the
complementary DNA strand.
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Each batch of samples included the following negative controls:
1. RNA negative (RNA replaced with nuclease free water - 16/d water + 4pi\
Master mix).
2. RT negatives (no Master Mix - 10//1 RNA, 10//I water). This negative was
performed for a random representative of each of the 5 sections of brain
tissue.
The cDNA was then stored at -20 °C until use.
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3.4 Quantitative Real-Time Polymerase Chain Reaction
Quantitative Real-time Polymerase Chain Reaction (qPCR) was used to quantify
gene-specific RNA and compare expression between the control group and three
study groups. TaqMan qPCR quantifies transcription of a specific gene by detecting
the release of a fluorescent reporter dye. For each gene of interest, validated primers
and probes for rat specific to gene of interest were used (TaqMan Gene Expression
Assays, Life Technologies). Each assay contained unlabelled forward and reverse
primers that recognise the target DNA sequence, and a probe that recognises a
sequence between the annealing sequences of the two primers. The probe is labelled
with two dyes: a 5' fluorescent reporter dye and a 3' quencher dye (Figure 13).
When the probe anneals to the target DNA, the fluorescence of the reporter dye is
suppressed by the quencher dye. When the target sequence is amplified during the
PCR reaction, the probe is cleaved by Taq polymerase and this separates the two
dyes. The quencher can no longer suppress the reporter fluorescence and
fluorescence can therefore be quantitatively measured and is representative of PCR
product. Detection of nonspecific amplification is avoided because fluorescence is


















Figure 13 - Quantitative PCR reaction
1 - Polymerisation: Primers and probe polymerise to template cDNA. Quencher (Q) suppresses
fluorescence of reporter dye (R).
2 - Displacement: Primer extends along template, displacing the probe.
3 - Cleavage: Probe is cleaved by Taq polymerase, separating the reporter dye from the quencher
resulting in increased fluorescence of the reporter.
4 - Fluorescence: As fluorescence increases, this reflects the amount of PCR product generated and
can be measured.
(Adapted from Taqman Real-time PCR Systems, Applied Biosystems).
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3.4.1 qPCR Method
A reaction mix was made from Taqman Universal Master Mix containing Taq
polymerase, dNTPs and optimised buffer components) with either Beta-Actin
primers and probe or gene of interest (i.e. IGF-1, BDNF, VEGF, FGF) forward and
reverse primers and specific hybridisation probe. Beta-Actin was used as the
reference gene for each qPCR plate (further details in section 3.4.2). Samples were
pipetted carefully in at least duplicate onto 384 well TaqMan Fast optical PCR plates
(Applied Biosystems), with each replicate comprising of 5[Jl Universal Master Mix,
0.5|Jl gene probe, lpl cDNA (15ng), 3.5|Jl RNA free water. Three negative controls
were included on each plate; (i) An RNA-negative sample generated at reverse
transcription (water in place of RNA) and was used to ensure specificity of reverse
transcription, e.g. no contamination of the water, (ii) A RT-negative sample, also
generated at the time of reverse transcription (no reverse transcriptase enzyme) was
used to exclude genomic DNA contamination, and (iii) A Taqman reaction negative
where cDNA was replaced with RNA free water to ensure no nonspecific
amplification. Wells were covered and sealed with an optical cover (Applied
Biosystems) and the PCR reaction run on ABI Prism 7900.
The PCR reaction consists of four kinetic stages Freeman et al. 1999). Firstly, a lag
phase where exponential amplification is already ongoing within the PCR tube but
no fluorescence signal above background is measurable. Secondly, in the
logarithmic, exponential phase, there is doubling of PCR product every cycle and
this is measured as a fluorescent signal released by the reporter dye. Thirdly, there is
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a deceleration phase, where accumulation of PCR inhibiting factors and loss of
enzyme and substrates, decelerates the reaction. Fourthly, the PCR reaches a steady
state in the stationary phase and no more amplicons are produced. For data analysis,
the second log phase is the most crucial.
3.4.2 qPCR Analysis
The amount of target mRNA was normalised to the amount of Beta-Actin and this
value was related to the mean of control group (pups who were normally grown and
exposed to room air) using the formula 2"AACt. The threshold cycle, Ct, is the cycle at
which the PCR signal crosses a set threshold.
Beta-Actin was used as the reference gene for each qPCR plate. The amount of
Beta-Actin in samples is constant relative to the amount of cDNA present. Beta-
Actin is a highly conserved protein involved in cell motility, structure and integrity.
Its use as an internal control was validated by demonstrating stable expression across
the four groups (Figure 14). Concurrent measurement of the Beta-actin reference
gene and gene of interest is possible by labelling with reporter dyes emitting different
wavelengths. Quantification of the specific gene of interest can then be related to the
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RA18% RA 9% 10kPa 18% 10kPa 9%
Figure 14 - Beta-Actin Ct in 4 study groups
Invariant expression of Beta-actin under each experimental condition, validating the use of Beta-actin
as an internal control in all 4 regions of brain.
Another reference gene, Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) had
been considered, however this showed variation in the lOkPa 9% group as shown in
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Figure 15 - GAPDH Ct in 4 study groups
Reduced expression of GAPDH in dual study group, therefore cannot be used as internal normalising
control.
The difference between the Ct value for a specific amplicon and Beta-Actin is ACt
and AACt refers to the difference between the ACt value of the sample and the
average ACt of the control group. Therefore 2~AACl is the value showing the fold
difference in the amount of amplicon compared to the control group. Significance
analysis was performed on raw ACt values. Data is plotted as fold change 2"AACt in
comparison to control group.
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3.5 Enzyme-Linked Immunosorbance Assay (ELISA)
An Enzyme-Linked Immunosorbance Assay (ELISA) is used to quantify the amount
of a selected antigen, in this case, protein, in a solution by comparison to a standard
curve created from samples of known concentration of the protein. A sandwich
ELISA was used to measure IGF-1 protein in 7d pup serum (IGF-1 ELISA kit for
mouse / rat, Mediagnost, Germany) containing pre-coated plates, all reagents and
buffers. All determinations were assayed in duplicate. To accurately measure total
IGF-1 in the serum, an Insulin-Like Growth Factor Binding Protein (IGFBP) -
blocked assay was used. Figure 16 summarises the technique.
3.5.1 Method
To dissociate IGF-1 from the IGFBP, serum samples, standards and controls were
first diluted in an acidic buffer; 1 in 50 dilution, 5|Jl serum and 245|JL buffer. A
sandwich ELISA involves microtitre plates coated with immobilised 1st antibody
raised against one epitope of the protein (IGF-1) to be measured. 50[Jl of standard,
control or sample is added to each well. Following dissociation in the wells, the
IGF-1 protein binds to the immobilised antibody. Wells were incubated for 1 hour at
room temperature. The pH neutralises and this allowed IGF-II present in the serum
to occupy the IGFBP binding sites. IGFBPs are therefore not removed but do not
interfere with the assay. There is extremely low cross-reactivity between IGF-1
antibody and IGF-II. Protein not bound to the immobilised 1st antibody was then
removed by washing five times on an automated plate washer with wash buffer.
50|Jl of the detector 2nd antibody labelled with biotin was added and binds to IGF-1
by a different epitope. Further washes removed unbound antibody-enzyme reagents.
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100|Jl of Streptavidin bound to Horseradisch-peroxidase (HRP) was added to each
well and binds to the biotin. Further washes were performed. 100|Jl HRP substrate
(Tetramethylbenzidine, TMB) was then added to each well to detect the HRP bound
to Streptavidin and biotin. During the incubation periods of 30 minutes, the
Streptavidin-HRP reacted with the TMB to produce a colour reaction. The colour
develops in proportion to the amount of IGF-1 bound to the immobilised 1st
antibody. The reaction was stopped with sulphuric acid solution and the absorbance

















Figure 16 - IGF-I sandwich ELISA
ELISA plate wells are coated with immobilised 1st antibody to IGF-1. Standard, control or sample
(IGF-I bound to serum protein IGFBP) is added to each well. Following dissociation from IGFBP,
the IGF-1 protein binds to the immobilised antibody. Unbound protein is removed by washing. The
biolinylated 2"" detector antibody is added and binds to IGF-I. Streptavidin bound to Horseradish-
peroxidase (HRP) is then added and binds to the biotin. (Tetramethylbenzidine, TMB (HRP
substrate) is then added to detect the HRP bound to Streplavidin and biotin. The Streptavidin-HRP
reacts with the TMB to produce a colour reaction. The colour develops in proportion to the amount of
IGF-1 bound to the immobilised 1st antibody and this can be quantitively measured.
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Standard curves were constructed for each plate. Test and control samples were
loaded onto the microtitre plate and analysed in duplicate. Controls were at top and
bottom of the standard curve. Assays were validated by performing serial dilutions
of a sample and confirming when absorbance was plotted, a linear response was
obtained which was parallel to the standard curve.
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3.6 Immunohistochemistry
The technique of immunohistochemistry involves localisation of an antigen within a
section of tissue by a specific primary antibody. Fluorescently labelled secondary
antibodies specific to the primary antibody can then be applied.
Immunohistochemistry with fluorescent labelling of secondary antibodies
(immunofluorescence) was used to identify specific transcription factor proteins
within sections of brain tissue from the animal model.
3.6.1 Cryostat Sections
Following fixation and freezing (see sections 2.3.1 and 2.3.2), whole P7 pup brains
were serially sectioned in the coronal plane at 20 micron thickness using a Leica CM
1900 Cryostat, chamber temperature -25°C, block temperature -23°C. Sections were
mounted flat onto Superfrost Plus slides (Thermoscientific, Menzel-Glaser), 5-6
sequential coronal sections were mounted per slide, allowed to air dry at room
temperature for 30 mins and stored at -20°C until use.
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3.6.2 Immunofluorescence
Four transcription factors were selected as markers of the major neuronal subtypes in
the motor cortex:
1) Transcription factor Cut-like-1 (Cux-1),
2) Special AT-rich sequence-binding protein 2 (Satb2),
3) Chicken ovalbumin upstream promoter transcription factor-2 (Ctip2), and
4) Transcription factor T-box brainl (Tbrl).
These transcription factors and the neuronal subtype they represent are fully
described in section 6.1. Cryosections at the level of the motor cortex corresponding
to immediately before (for Ctip2/Tbrl) and just at the level of the corpus callosum
decussation (for Cuxl/Satb2) were selected and matched for each of the animal
groups. Figure 17 shows the location of the motor cortex in the rodent brain.
somatosensory
auditory
Figure 17 - Arealisation of the rodent cortex.
The P7 brain cryosections were air dried at room temperature for 30 mins and then
hydrated by washing twice in phosphate buffered saline (PBS) for a total of 30 mins.
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For the purposes of antigen retrieval, the sections were first placed in 0.01M sodium
citrate, pH6.0 for 10 mins on a rocker platform before being microwave-treated in
the same solution for a total of 20 mins to achieve optimal retrieval (1x5 min 50%
power, lx 5min 30% power and 2x 5 min 10% power). A range of microwave
power levels and timings were investigated during the optimisation of this technique.
The sections were allowed to cool for 20 mins at room temperature, then washed
with PBS, followed by PBS-Triton X (1:1000) for 15 mins on the rocker platform. A
PAP pen was used to outline a hydrophobic circle around the sections. Blocking
serum, either 20% normal goat serum or 20% normal donkey serum (Vector Labs) in
PBS Triton X-100 (1:1000, Sigma-Aldrich) was applied to the sections for 1 hour at
room temperature on a flat metal slide holder. Primary antibodies were as follows:
• Goat polyclonal antibody to Cux-1 (Santa Cruz Biotechnology, 1:50
concentration in donkey serum).
• Mouse monoclonal antibody to Satb2 (Abeam, 1:25 in donkey serum).
• Rat monoclonal antibody to Ctip2 (Abeam, 1:250 in goat serum).
• Rabbit polyclonal antibody to Tbrl (Abeam, 1:100 in goat serum).
Sections were incubated overnight with primary antibody in cold room at 4°C.
Following this, the sections were washed with PBS Triton X (1:1000).
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To achieve fluorescent staining, the following secondary antibodies were used:
• Donkey anti-goat (Alexa Fluor-568, 1:200 in donkey serum for Cuxl).
• Donkey anti-mouse (Alexa Fluor-488, 1:200 in donkey serum for Satb2).
• Goat anti-rat (Alexa Fluor-568, 1:200 in goat serum for Ctip2).
• Goat anti-rabbit (Alexa Fluor-488, 1:200 in goat serum for Tbrl).
Sections were incubated with the appropriate secondary antibodies for 1 hour.
Tissue was dual stained for Cux 1 / Satb2 on the same slide and for Ctip2 / Tbrl on
the same slide and the interpretation of staining made possible due to the differing
wavelengths of secondary antibody Alexa Fluor as listed above. Further washes with
PBS-Triton X (1:1000) were performed with samples in darkness achieved by
covering with foil. To-Pro3 nuclear counterstain (Molecular Probes, Invitrogen)
diluted 1:1000 in PBS was applied to all samples for 20 mins. Cover slips were
mounted with Vectashield Hard Set, Mounting Medium for fluorescence (Vector
Labs). The slides were kept in darkness and stored at 4°C for at least 2 hours before
transferring to the Leica Confocal Microscope (IMPACT imaging facility, Hugh
Robson Building, University of Edinburgh).
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3.6.3 Imaging of Immunofluorescent staining
Tissue sections images were acquired on a Leica TCS NT confocal laser scanning
microscope (Leica Microsystems, Germany). FITC (Alexa Fluor 488), TRITC
(Alexa Fluor 569) and Topro-3 were imaged sequentially to minimise bleed through.
FTIC was excited at 488nm light and emitted photons were collected between 500-
550nm. TRITC was excited at 568nm light and emitted photons collected between
570 and 625nm. To-Pro3 was excited at 647nm and signal collected above 650nm.
For Ctip2 / Tbrl deep layer nuclei, images were acquired using a xlO / 0.3 Plan
Flourtar lens. Z sections were acquired at a distance of 4/<m between each optical
slice through the entire depth of the tissue section. For Satb2 images were acquired
at xlO magnification for deep layer nuclei and x20 magnification for superficial
cortical layer nuclei (Cuxl and Satb2) using the 20x/0.7 Plan Apochromat oil
immersion lens with a distance of 1.2/^m between optical slices in Z. Maximum
intensity projections were made from each Z stack using the Leica Lite image
analysis software. Adobe photoshop was used to overlay the Topro-3 nuclear staining
and the nuclear staining for each of the 4 transcription factors of interest. Numbers of
labelled nuclei were counted within a 100pm diameter box in the centre of the motor
cortex. The height of the box was that of the cortical layers selected. A minimum of 3
sections from each brain were averaged to give each data point for the animal. The
single observer (EW) was blinded to the study group. Accuracy of counts was
confirmed on twenty blinded randomly selected recounts by a 2nd competent observer
(PG). Inter-observer consistency was at least 95%. Cell counts and proportions were
compared between each of the 4 study groups.
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Figure 18 - Immunofluorescent labelling of rat brain sections
Deep cortical layers V & VI - images were taken at xlO magnification. 100|Jm box created in
photoshop at xlO magnification and placed over centre of motor cortex. Blue staining is Topro3
nuclear counterstain, red is Ctip2 (layer V), green is Tbrl (layer VI).
Superficial cortical layers II - IV - images taken at x20 magnification. lOOpm box created in
photoshop at x20 magnification and placed over the centre of the motor cortex. Blue is Topro-3
nuclear counterstain, red is Cuxl and green is Satb2.
3.7 Tissue Staining for Laminar & Corpus Callosal
Thickness
3.7.1 Cresyl Violet Staining
Cryosections (sections 3.6.1) on slides immediately past the decussation of the
corpus callosum were selected and matched for each of the animal groups. The
slides were air dried at room temperature for 30 mins and then hydrated by washing
twice in phosphate buffered saline (PBS) for a total of 30 mins. Cresyl Violet
0.125% solution was filtered 2 hours before the technique. The slides were placed
into Cresyl Violet for 30-60 seconds then washed in running tap water for 5 mins.
The brain sections were examined under light microscopy for quality of staining and
returned to the Cresyl Violet if necessary. Alcohol dehydration was completed as
follows:
70% alcohol - 1 min
80% alcohol - 30secs
95% alcohol with acetic acid - 15secs
100% alcohol - 2 mins with light microscope examination to ensure adequate
staining. The slides were finally placed in Xylene for clearing of the dehydrant for
1-2 mins and then mounted with Pertex mounting medium (Histolab products AB,
Gothenburg) and allowed to dry at room temperature.
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3.7.2 Imaging of Cresyl Violet Stained Sections
Images were acquired on a bright field microscope (Olympus). Three sections per
brain of the motor cortex and corpus callosum were taken at x5 magnification.
Image J analysis was used to measure the thickness of the motor cortex and corpus
callosum in the 3 images and an average taken to give each data point per animal for
statistical analysis. Sections were blinded to a single observer (EW) and a random
sample re-measured by a 2nd competent observer (JW). An inter-observer





Figure 19 - Cortical thickness of motor cortex stained with cresyl violet
Left hemisphere.
Measurement line was applied in Adobe photoshop to identify accurately layers: VI, V, IV - II and I.




Figure 20 - Corpus callosum thickness stained with cresyl violet
Measurements obtained by image J analysis at mid-point of corpus callosum decussation.
3.8 Statistical Analysis
Continuous variables are reported as mean ± standard deviation (SD) and were
analysed for normality by D'Agostino and Pearson omnibus normality test where n
number would allow. Statistical analyses were performed using student unpaired t-
test or 2-way analysis of variance (ANOVA) with Bonferroni post-test for multiple
comparisons. The 2-way ANOVA was used to confirm the presence of variation
within the dataset at statistical significance level of 5% (p>0.05). The Bonferroni
correction for multiple comparisons was then applied. The Bonferroni correction
lowers the p value considered significant to 0.05 divided by the number of
comparisons, thereby ensuring that the 5% probability applies to the entire family of
comparisons and not separately to each individual comparison. Non-parametric data




Characterisation of the Experimental Model:
Birth weight, initial growth & brain weight
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4.1 Introduction
Normal fetal growth in any mammalian species is a complex process dependent on
the genetic profile of the embryo, adequate nutrient and oxygen supply via the
placenta and a healthy feto-maternal environment.
A common cause of fetal growth restriction is fetal adaptation in response to an
inadequate supply of oxygen and / or nutrients. A variety of animal models have
been used in experiments investigating the genetic, cellular and metabolic events that
determine fetal growth and the association between poor fetal growth and
development of adult disease.
Nutritional models of inducing growth restriction affect the fetal nutrient supply. In
this study we have used a low protein diet from E15 until P7. Used preconception,
protein restriction adversely affects fertilisation and early egg development in mice
(Munoz et al. 1979). When protein restriction is started mid-gestation, glucose,
insulin and progesterone levels are significantly lower in mothers fed a low protein
diet in comparison to control (Fernandez-Twinn et al. 2003). Litter size is not
affected by low protein diet and the pups are consistently growth restricted in
comparison to control. Previous work has also shown that a 9% diet is associated
with a large placenta, higher circulating levels of maternal glucocorticoids and
increased blood pressure in offspring at 4 weeks (Levy et al. 1993; Langley-Evans et
al. 1994; Langley-Evans et al. 1998). This is consistent with observations made by
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Barker in 1990 where small babies with large placentas were found to have the
highest blood pressure in adulthood, suggesting circulatory changes in the feto¬
placental unit. This formed the basis of the Barker hypothesis where infants with low
birth weights are at increased risk of developing cardiovascular disease in later life
(Barker 1990). Other work has shown an association between 9% low protein diet
and preterm retinal pathology where growth restricted rat pups had an increased area
of avascular retina indicating that retinal vascularisation was delayed (Dhaliwal et al.
2011) in keeping with stage 1 of the pathological changes observed in preterm
infants who develop ROP. Growth restricted preterm infants are more likely to
develop ROP and more severe disease than appropriately grown infants (Dhaliwal et
al. 2009).
The low protein diet used in this experimental model is isocaloric. Caloric restriction
has been utilised in studies of intrauterine growth restriction. In rodents, caloric
restriction from days E7 to E21 or from E15 to E21 does not affect length of
gestation, litter size, or mortality rate but significantly reduces birth weight (Vickers
et al. 2000; Ozaki et al. 2001; Jimenez-Chillaron et al. 2005). In contrast, caloric
restriction from E7 to E14 does not affect pup weight (Garofano et al. 1998; Ergaz et
al. 2005). Despite a reduction in body weight seen with calorie restriction continuing
later in gestation, brain weight was not significantly different to the control pups by
60% calorie restriction (Agale et al. 2010). Studies have however noted that caloric
restriction reduces the occurrence of late onset chronic disease and extends the
lifespan in experimental animals (Fontana et al. 2004; Varady et al. 2008).
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Maternal exposure to glucocorticoids has been associated with reduced birth weight
and the development of hypertension in the offspring particularly when given in the
latter stages of pregnancy (Nyirenda et al. 1998). As described in Chapter 2, one of
the underlying mechanisms for the growth restriction caused by the low protein diet
is fetal exposure to higher levels of maternal glucocorticoids which impair long bone
growth and normal trabeculae formation (Avioli 1993; Ahmed et al. 2002; Mushtaq
et al. 2002). These skeletal effects have been noted to normalise in the first postnatal
month and catch up body weight achieved (Ornoy et al. 1972). The low protein diet
has been found to cause a reduction in the placental enzyme 1 lB-hydroxysteroid
dehydrogenase which usually regulates the transfer of maternal glucocorticoids to the
fetus (Gardner et al. 1997).
Surgical interventions such as uterine artery occlusion have been used commonly for
decades in animal models of growth restriction. Uni- or bilateral uterine artery
occlusion induces hypoxia, hypoglycaemia and decreased growth factor availability
and is associated with offspring mortality rates of up to 30% (Wigglesworth 1964).
The fetuses will then undergo transient hypoglycaemia, hypoxia and acidosis in utero
and long-term consequences for pups include obesity, hyperglycaemia induced by an
observed reduction in pancreatic B-cell mass in postnatal life (Simmons et al. 2001)
and hypertension caused by a reduction in glomerular filtration rate and effects on
sodium tubular reabsorption (Alexander 2003).
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The fluctuating oxygen profile used in the experimental model is described fully in
Chapter 2. The main strength of this oxygen profile is that it is developed from a
preterm infant with significant neonatal morbidity and replicates the rapid
fluctuations commonly observed in the clinical setting. Previous work has shown
that the fluctuations in oxygen are more damaging than constant hyperoxia (McColm
et al. 2004; Loeliger et al. 2006; Ratner et al. 2007) and this profile has been
validated for studies in the brain where the fluctuating profile was associated with
markers of cerebral injury (Sedowofia et al. 2008). Reactive oxygen species are
formed as a natural by-product of oxygen metabolism and can damage all
components of cells including protein, DNA and enzyme systems (Maltepe et al.
2009). Highly metabolic organs such as the brain are most vulnerable to oxidative
damage and preterm infants have lower antioxidant reserve (Taglialatela et al. 1998;
Kuster et al. 2011). In addition, relevant to this study, growth restricted infants also
have lower total antioxidant capacity (Toy et al. 2009).
It was hypothesised that antenatal and postnatal growth restriction would adversely
affect body and brain weight of pups and a fluctuating hyperoxic profile would
negatively impact brain growth.
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4.2 Methods
The animal model, tissue collection and processing methods described in Chapter 2
were used. At PI and P7 pups were weighed by placing in a weighing bowl and
using the same calibrated digital scales (Kern 573 precision weight scale) for each
measurement. Brain weights at P7 were achieved by weighing an allocated universal




4.3.1 Body weight at birth
The mean birth weight of pups from the dams fed the 18% normal protein diet was
6.00g (SD ± 0.68) and the mean birth weight of pups from the dams fed the 9%
protein restricted diet was 5.26g (SD ± 0.64). The pups from dams fed the low
protein diet weighed on average 13% lighter at birth p < 0.001. Maternal weight at
delivery was not recorded. This is discussed further in section 4.4.
P0 Pup Weight
81
6- I I , T .
18% 9%
Protein
Figure 21 - Birth weight of pups
Birth weight in grams on y axis, dam dietary protein on x axis.
Box and whiskers plot, bars = minimum to maximum value, n=60 per group.
Unpaired t test comparing mean birth weight *** p < 0.001.
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4.3.2 Body weights at P7
Accounting for diet only, pups fed on the normal 18% protein diet had a mean
weight of 16.05g (SD ±1.52) and those fed on the low protein diet had a mean weight
of 10.51 g (SD ± 1.22). The pups from dams fed the low protein diet weighed on
average 35% lighter at P7 (p<0.001) demonstrating ongoing postnatal growth











Figure 22 - P7 body weight based on diet group
Pup weight (grams) on y axis, dam dietary protein on x axis.
Box and whiskers plot, bars = minimum to maximum.
For the 18% plot n=60 (Both room air and oxygen groups fed 18% diet) and for the 9% plot, n=60
(Both room air and oxygen groups fed 9% diet).
Unpaired t test *** p < 0.001.
Pups from dams fed 18% protein can therefore be considered "normally grown" and
pups from dams fed 9% protein are therefore "growth restricted".
The mean P7 weight of pups in the four experimental groups are given in Table 5
and summarised in Figure 23.
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Table 5 - Body Weight at P7
Study Group Body weight (g) (meanlSD)




There was a reduction in body weight in both growth restricted groups and a further
reduction in P7 body weight in the growth restricted pups also exposed to fluctuating











Normally grown Growth restricted
Figure 23 - Body Weight at 7 days
Pup weight (grams) on y axis, pup growth according to dam dietary protein on x axis.
Data shows mean ± standard deviation (SD), n=30 per group.
2-way ANOVA confirms variation present in dataset p <0.05. Bonferroni post-test analysis confirms
significant difference in weights between both normally grown groups, both growth restricted groups,
and within growth restricted groups *** p < 0.001.
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4.3.3 Brain weight at P7
Whole brain weight was measured as wet weight immediately following dissection
from skull and submersion in PFA. Brains from growth restricted pups were smaller
than normally grown pups; however there was no independent effect of oxygen on
brain weight in normally grown or growth restricted pups.
Table 6- Brain weight at P7
Study Group Brain weight (g) (meaniSD)
RA 18% 0.64 ±0.03
A02 18% 0.6410.03
RA 9% 0.58 ± 0.04
A02 9% 0.55 ± 0.04
Figure 24 - Brain from normally grown and growth restricted rat pup









Normally grown Growth restricted
Figure 25 - P7 brain weight
Brain weight is reduced in both growth restricted groups in comparison to the normally grown groups
with no additional effect of oxygen.
Pup weight (grams) on y axis, pup growth according to dam dietary protein on x axis.
Data shows mean ± standard deviation (SD), n=30 per group.
2-way ANOVA confirms variation present in dataset p <0.05. Bonferroni post-test analysis to
compare groups, ***p< 0.001.
When brain weight is considered as a percentage of body weight (see Figure 26), the
growth restricted pups demonstrate a greater preservation of brain weight relative to
body weight. The dual group exposed to both growth restriction and oxygen
preserve brain weight to a greater extent in view of the reduced P7 total body weight










Figure 26 - Brain as a percentage of body weight
Growth restricted groups demonstrate relative preservation of brain growth and are therefore
asymmetrically growth restricted.
Pup weight (grams) on y axis, pup growth according to dam dietary protein on x axis.
Data shows mean ± standard deviation (SD), n=30 per group.
2-way ANOVA confirms variation present in dataset p <0.05. Bonferroni post-test analysis to
compare groups, * p < 0.05, ***p<0.001.
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4.4 Discussion
It has been shown that a 9% isocaloric low protein diet fed to dams from El5 until
P7 caused prenatal and postnatal growth restriction in the offspring with an additive
effect of postnatal oxygen. Brain weight was reduced (p < 0.001) in growth
restricted pups irrespective of postnatal oxygen exposure. As a percentage of body
weight, both growth restricted groups preserved their brain weight relative to their
body weight and this was most evident in those exposed to fluctuating hyperoxia.
There was no independent effect of oxygen on actual brain weight at P7.
Several models have been described to induce growth restriction in rodent offspring
and assess effects of intrauterine growth restriction and fetal programming, including
various nutrition manipulation models, mid-gestation surgical procedures e.g. uterine
artery ligation, and models administering growth prohibiting substances e.g.
glucocorticoids (Snoeck et al. 1990; Woodall et al. 1996; Holemans et al. 1998;
Holemans et al. 2003). We used a protein restriction model from day 15 of gestation
as this has been previously successfully shown to induce fetal growth restriction in
rodent pups with a greater effect on truncal growth relative to brain growth (Dhaliwal
et al. 2011; Langley-Evans et al. 1994). This mirrors the clinical situation where
asymmetrical growth restriction in preterm infants is most common. Although the
commonest cause of human IUGR is placental insufficiency due to placental vascular
disease, maternal under nutrition in rodent models results in reduced substrate
delivery to the fetoplacental unit, decreased uteroplacental flow and reduction in total
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milk volume during lactation, all of which hamper fetal and neonatal growth of the
pups (Langley-Evans et al. 1998; Holemans et al. 2003; Gao et al. 2012). Preterm
infants have a high metabolic rate and catabolise high amounts of protein in the
initial postnatal period. Preterm infant nutrition within the intensive care unit tends
to be high in carbohydrate and fat and low in protein (Vasu et al. 2007). One of the
consequences of this is that postnatal growth failure of preterm infants is common
(Cooke et al. 2004) and therefore the experimental model demonstrating pre- and
post-natal growth restriction reflects a number of features of the clinical situation.
A weakness of the current study is that maternal weight was not documented at
conception, delivery or in the postnatal period. Maternal weight has an important
influence on pup weight and a protein restricted diet has been shown to reduce
maternal body and brain weight (Bennis-Taleb et al. 1999). In all experiments, 2nd
time mothers were used to provide consistency across experimental groups.
Low protein diet in animal pregnancy has previously been shown to cause lower
body and brain weights in pups (Snoeck et al. 1990; Bennis-Taleb et al. 1999). To
determine if antenatal growth restriction alone is sufficient to cause a reduction in
brain weight, cross-fostering experiments where pups from a 9% dam are reared until
P7 by an 18% dam could be performed using our model. Evidence from the
literature suggests there may be a graded effect of protein restriction.
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One study demonstrated that if the low protein diet was continued after weaning,
adult rats similarly had lower brain weights. If pups exposed to low protein in utero
were then fed by dams on a normal diet and the normal diet continued after weaning,
brain weight in adulthood was not reduced (Bennis-Taleb et al. 1999). A previous
study however, showed that if a 6% low protein diet was used in pregnancy, and a
normal 20% diet continued after birth, brain weight of pups remained reduced at P21
(Resnick et al. 1982). This suggests there is a fetal programming element to the
effect of growth restriction on the developing brain.
In keeping with this, protein restriction during gestation was found to reduce cerebral
cortex vascularisation and this did not recover when a normal diet was introduced
after birth (Bennis-Taleb et al. 1999). This effect on vascularisation seems specific
to the brain as similar experiments examining the pancreas and duodenum showed
recovery of vasculature when a normal diet was restored after birth (Iglesias-Barreira
et al. 1996). A previous study reported that offspring of rats fed a low protein diet
during gestation, had lower numbers of dendrites as well as lower sensory cortico-
cortical and thalamo-cortical evoked potentials (Resnick et al. 1982). Taken
together, these studies suggest there may be implications for cerebral function in
pups of dams when low protein diet is given ante- and postnatally.
The mechanism underlying the 'brain-sparing' effect in response to protein
restriction has been suggested as a consequence of increased carotid blood flow
(Hawkins et al. 1999).
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This would appear contradictory to the study above (Bennis-Taleb et al. 1999), that
also reported forebrain weight recovered after the normal diet was reinstated despite
the ongoing effects seen in cortical vasculature and conjectured that blood perfusion
to the brain may have been normal despite the reduced vascular density (Bennis-
Taleb et al. 1999). A more recent study has shown that low protein in gestation
causes a reduction in brain oxygen consumption in utero at E21 (Gallagher et al.
2005). This suggests a reduction in cerebral metabolism as a further method by
which brain-sparing may be mediated. Adaptive changes by a fetus to an altered
intrauterine environment may improve immediate chances of survival despite
detrimental effects in later life. The 'Predictive Adaptive Response' theory suggests
that although these changes may have no immediate benefit, the adaptations allow
the fetus to develop a phenotype based on the predicted postnatal environment
(Gluckman et al. 2004).
These findings are supported in the human situation by imaging studies in preterm
SGA infants showing reduced intracranial volume (Tolsa et al. 2004) and
behavioural observations of poorer neurodevelopmental outcome than their
appropriately grown peers (Yanney et al. 2004).
Previous work employing the clinically derived oxygen profile used in this study
induced vascular changes in the rat pup retina comparable to those seen in
retinopathy of prematurity (Cunningham et al. 2000; McColm et al. 2000b; McColm
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et al. 2004; Dhaliwal et al. 2011). Within the brain, increased cell death, astrocytosis
and reduced expression of myelin basic protein have been reported (Sedowofia et al.
2008). Reactive oxygen species are formed as a natural by-product of oxygen
metabolism and can damage all components of cells including protein, DNA and
enzyme systems (Maltepe et al. 2009). Growth restricted and preterm infants have
lower total antioxidant capacity (Toy et al. 2009). In this model, the pups exposed to
growth restriction and then oxygen fluctuation had a lower body weight and
conserved brain weight in comparison to growth restriction alone. The additional
reduction in body weight caused by oxygen in this group may represent reduced
antioxidant capacity and a reduction in growth factors key to somatic growth as
discussed further in Chapter 7.
The following Chapters will now examine the effects of ante- and postnatal growth
restriction and the clinically relevant oxygen fluctuations on cortical development,
neuronal subtypes and on brain growth in the animal model.
117
Chapter 5:
Growth Restriction and Fluctuating Hyperoxia




In humans, cerebral cortical volume increases nearly four-fold between 29 and 35
weeks gestation and this is a critical period for neuronal migration and cortical
growth. Infants born during this time period have decreased cortical grey and white
matter at term equivalent which persists in to adolescence (Inder et al. 1999; Nosarti
et al. 2002). The cerebral cortex is the source of cognition and therefore damage
incurred will potentially result in altered cognitive function. As described
previously, the rat cerebral cortex is smooth whilst the human cortex is highly
convoluted and supports a greater surface area. During development the rat cerebral
cortex follows a similar sequence to that of the human cortex (Sidman et al. 1973).
In both species, the cortex is composed radially of six layers (Figure 27), each layer
characterised by distinct cell types. Migration of neurons from the proliferating
zones (ventricular zone, VZ and subventricular zone, SVZ) to the deep layers of the
cerebral cortex is largely complete by El8 in the rat and 24 weeks gestation in the
human, although maturational events including synaptogenesis continue into the
third trimester (Kostovic et al. 2006). From 24 weeks, the superficial layers continue
to expand radially as they receive migrating neurons throughout the third trimester
and maturational changes continue into infancy. Broadly, the deep layers contain
neurons that project extra-cortically to structures such as the thalamus and spinal
cord, whilst the superficial layers contain neurons that project locally within the
cortex and are involved in intracortical circuitry (Hill et al. 2005). Layer IV is




MZ - Marginal Zone
CP - Cortical Plate
SP - Subplate
IZ - Intermediate Zone
SVZ - Subventricular Zone
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Figure 27 - Schematic Illustration of cortical development in rats and humans
The cerebral cortex, developing from the cortical plate (CP) is shown in yellow. By 24 weeks
gestation in the human fetus, and embryonic day 18 in the rat (E18), deep layers VI and V have
mainly formed. The superficial layers IV-II undergo growth and maturational changes such as
differentiation, dendritic branching and synaptogenesis during the latter weeks of gestation and
continuing after birth.
As discussed in Chapter 1, periventricular leukomalacia (PVL) diagnosed by
ultrasound or MRI imaging, has long been associated with preterm brain injury and
impaired neurodevelopmental outcome. Volumetric MRI imaging studies have
demonstrated that preterm infants with PVL have a reduced cortical grey matter at
term in comparison to infants without PVL (Inder et al. 1999; Thompson et al. 2007;
Nagasunder et al. 2012).
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In particular, the posterior periventricular white matter underlying the motor cortex is
frequently associated with diffuse and cystic white matter change (Volpe 2009b).
Previous work has shown that in the context of fluctuating hyperoxia, there is
disruption of white matter myelination in the region of the internal capsule
(Sedowofia et al. 2008; Pilley 2010) underlying the motor cortex. Furthermore, in
studies of growth restriction, preterm infants with a higher risk of cerebral palsy
score less well on motor and memory skills testing in childhood (Yanney et al.
2004). For these reasons, the motor cortex was selected as an initial region of
interest in an exploratory study to determine the effects of growth restriction and
fluctuating oxygen.
The corpus callosum is the largest white motor tract in the mammalian brain and is
key to interhemispheric communication of motor and sensory signals. Although the
basic structure of the corpus callosum is established by 20 weeks gestation, it
continues to grow in size, receiving more axonal fibres during the third trimester
(Malinger et al. 1993) with myelination occurring in the postnatal period in both
humans and rodents. Preterm birth during the third trimester may therefore disturb
normal corpus callosum development through disruption of normal axonal trajectory
processes or myelination of nerve fibres. Recent studies have shown that preterm
infants have a reduced cross sectional area of corpus callosum in comparison to term
infants (Thompson et al. 2010).
121
Fractional anisotropy within the corpus callosum has also been linked to intelligence
and coordination scores (Counsell et al. 2008) and corpus callosum deficits have
been linked to delayed motor functioning (Rademaker et al. 2004).
It was hypothesised that pre- and postnatal growth restriction and postnatal exposure
to oxygen will result in reduced thickness of the late born superficial cortical layers
and reduced thickness of the corpus callosum.
5.2 Methods
Brains were removed from the animals in each study group as described in Chapter
2. Pups were perfused with fixative, the brains soaked in fixative, cryoprotected and
then snap-frozen in 2-methylbutane (section 2.6.2). Coronal cryosections at 20
micron thickness were obtained (section 3.6.1) and comparable sections caudal to the
level of the corpus callosum decussation were matched for each group. Sections
were hydrated, stained with cresyl violet and imaged on a bright field microscope as
described in sections 3.7.1.
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5.3 Results
5.3.1 Thickness of Motor Cortex (M1) Laminae
1. Total Cortical Thickness (Layers I-VI)
In comparison to control, cortical thickness was preserved in the growth restricted
pups. This was despite the decrease in brain weight observed in the growth
restriction study group (section 4.3.3). In contrast, despite preservation of brain
weight (section 4.3.3) postnatal fluctuating hyperoxia caused cortical thinning,
particularly in the context of growth restriction (Figures 28, 29, Table 7). In Figure
28 below, each data point represents the average of 3 measurements made for each
pup and each colour represents a different litter within each group. This graph
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Figure 28 - Mean cortical thickness ±SD for each study group
Cortical Thickness in microns measured at the centre of primary motor cortex, against study group on
x axis. Each data-point represents an average of 3 counts per pup. Each different colour represents a
different litter, confirming no major outliers between the litters in each study group.
The values for each group are normally distributed by D'Agostino and Pearson omnibus normality
test. Data shows mean ± standard deviation (SD), n=9 per group.
Figure 28 shows spread of data. Statistical analysis not shown - see Figure 29.
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The following table summarises the mean cortical thickness and standard deviation
for each group.
Table 7 - Total Cortical Thickness (microns, pm) per group
Study Group Total Cortex (Vl-I) Thickness (meaniSD)
RA 18% (Control) 1606 ±118.2
AO2 18% (A02 only) 1484 ±120.1
RA 9% (GR only) 1610 ±71.22
A02 9% (Dual) 1310 ±72.56
Statistical analysis by 2-way analysis of variance (2-way ANOVA) confirmed
variation between study groups and is illustrated in Figure 29. Bonferroni post-tests
defined a significant effect of fluctuating hyperoxia (A02) on cortical thickness
(1606|Jm ± 118.2 versus 1484pm ± 120.1), p<0.05. There was no effect of growth
restriction (GR) alone. The dual group demonstrated particularly significant cortical
thinning in comparison to both the A02 group (1484pm ± 120.1 versus 1310pm ±
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Figure 29 - Comparison of Total Cortical Thickness (layers I-VI) between study groups
Total cortical thickness, layers I-VI (microns) against study group on x axis.
Data shows mean ± standard deviation (SD), n=9 per group.
2-way ANOVA confirms variation present in dataset p <0.05. Bonferroni post-test analysis to
compare groups, * p < 0.05, **p<0.01, ***p<0.00l.
2. Deep Layer (V & VI) Thickness
When thickness of the early born deep cortical layers was considered alone, there
was relative conservation of deep layer thickness in the A02 only and GR only
groups. Mild thinning was seen in the dual group. The raw data is presented as
mean ± standard deviation in Table 8.
Table 8 - Deep cortical layer thickness (microns)
Study Group Deep layer (VI & V) Thickness (mean±SD)
RA 18% (Control) 988.8 ± 107.7
A02 18% (A02 only) 970.3 ± 88.75
RA 9% (GR only) 1059 ±48.78
AQ2 9% (Dual) 895.9181.31
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Statistical analysis by 2-way ANOVA and Bonferroni post-test demonstrates
significant cortical thinning in the dual study group in comparison to the GR group,
p<0.01. This may not represent a true difference as the 'GR only' group had a higher










Figure 30 - Deep cortical layer (V +VI) thickness
Deep layer cortical thickness, layers V+Vl (microns) against study group on x axis.
Data shows mean ± standard deviation (SD), n=9 per group.
2-way ANOVA confirms variation present in dataset p <0.05. Bonferroni post-test analysis to
compare groups, **p<0.0l.
There was no effect of A02 or GR alone. Reduced thickness in dual group in comparison to GR
group only.
3. Superficial Layer (II-IV) Thickness
The late born superficial layers were adversely affected by hyperoxia in both
normally grown and growth restricted pups as shown by the mean values and SD in
Table 9.
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Table 9 - Superficial cortical layer thickness (microns)
Study Group Superficial layers (IV-II) Thickness (meaniSD)
RA 18% (Control)







Figure 31 shows 2 cresyl violet stained images from the control group (A) and the
dual group (B), with total diameter marker and horizontal markers to define layer
boundaries. Roman numerals indicate the relevant layer of cortex. Superficial layers





Figure 31 - Cresyl violet stained section from Control versus Dual group
A - Control group: Cortical diameter in at centre of motor cortex.
B - Dual group: Cortical diameter in at centre of motor cortex.
Thickness of superficial layers (II-IV) and to a lesser extent, deep layers (V &VI), were reduced in the
dual group.
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Statistical analysis by 2-way ANOVA confirmed variation between the groups and
Bonferroni post-tests indicated significant differences in both groups exposed to
fluctuating oxygen. Superficial cortical thinning was observed in the 'A02 only'
group compared to control (401.1±61.6 versus 476.1±33.61), p<0.01. The reduction
observed in the 'GR only' group in comparison to control did not reach statistical
significance (428±53.52 versus 476.1 ±33.61), p >0.05. Within the growth restricted
groups, the dual group demonstrated the most significant thinning (328.5±26.04






















Normally grown Growth restricted
Figure 32 - Superficial cortical layer thickness
Superficial layer cortical thickness, layers II-IV (microns) against study group on x axis.
Data shows mean ± standard deviation (SD), n=9 per group.
2-way ANOVA confirms variation present in dataset p <0.05. Bonferroni post-test analysis to
compare groups, **p<0.01, ***p<0.001.
There was no effect of growth restriction alone. Superficial cortical thinning was seen in the
fluctuating oxygen group and in the dual group exposed to both growth restriction and fluctuating
oxygen.
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5.3.2 Superficial Cortical Cell Density
To set the scene for the effects of growth restriction and fluctuating hyperoxia noted
on cell density within the superficial layers, the information in Figure 32 can be
presented as a line graph and the order of the study groups changed to show the

























Figure 33 - Line graph of superficial layer thickness II-IV (microns)
Study group against superficial laminar thickness layers IV-II (microns).
GR = growth restriction only, 02 = oxygen only, GR + 02 = Dual.
Data shows mean ± standard deviation (SD), n=9 per group.
2-way ANOVA confirms variation present in dataset p <0.05. Bonferroni post-test analysis to
compare groups, * p < 0.05, p<0.01, ***p<0.001.
No significant difference between control group and GR only group.
Significant decrease in cortical thickness between control group and A02 (p<0.01 **).
Significant decrease in cortical thickness between Control and dual group (p<0.001 ***).
Significant decrease in cortical thickness between fluctuating oxygen and dual group (p<0.01 **).
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To determine the effect of superficial cortical thinning on cell number and cell
density, total labelled nuclei within a 100|Jm diameter box placed in the centre of the
motor cortex overlying the superficial cortical layers were counted and compared
between groups (Chapter 3, Figure 18).
Figure 34 illustrates the number of nuclei counted within the 100|Jm diameter box
overlying layers II-IV. This measurement is of limited value as it does not take
account of brain volume differences between the groups, but illustrates that numbers
of neurons within a set region are reduced in the fluctuating oxygen group in
comparison to the other study groups. Of note, as described in Chapter 4, there was
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Figure 34 - Cell nuclei in 100pm diameter box in superficial layers II-IV
Nuclei number in superficial layers II-IV within a lOOmicron diameter box in Ml against study group.
GR = growth restriction only, 02 = oxygen only, GR + 02 = Dual. Data shows mean ± standard
deviation (SD), n=9 per group. 2-way ANOVA confirms variation present in dataset p <0.05.
Bonferroni post-test analysis to compare groups, * p < 0.05, p<0.01, ***p<0.001.
No significant difference in nuclei number between Control group and GR group (p>0.05).
Significantly reduced number of nuclei in the A02 group in comparison to control (p<0.05 *).
No significant difference in the number of nuclei between the fluctuating oxygen group and the dual
group.
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A more comparable measure is to consider cell density differences between the
groups, Figure 35. Cell density per square millimetre (mm2) was calculated using the
following equation: (nuclei / 100T) xlOOO, where nuclei = number of nuclei in
lOOum diameter box as presented in Figure 34 and T = cortical thickness as
presented in Figure 33. 100T therefore represents the area of the box.
14-|
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Figure 35 - Cell nuclei / mm2 (Cell density)
Nuclei /mm2 of brain against study group.
GR = growth restriction only, 02 = oxygen only, GR + 02 = Dual.
Data shows mean + standard deviation (SD), n=9 per group. 2-way ANOVA confirms variation
present in dataset p <0.05. Bonferroni post-test analysis to compare groups, * p < 0.05
No significant difference between the control group and GR group (p>0.05).
No difference between the control group and A02 group (p>0.05).
Significant increase in nuclei per mm2 in the dual group (p<0.05).
There was an increase in cell density observed in both growth restricted groups. The
effect on the 'GR only' group did not reach statistical significance. There was no
effect seen in the A02 group, but the addition of fluctuating oxygen caused a
significant increase in nuclei density in the dual group.
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Control (Mean ±SD) 476 ±33.6 417 ± 59.8 8.76 ± 1.1
Growth Resticted (GR) (-10%) (+1%) ** (+12%)
Fluctuating Oxygen (02) I (-15%) I (-15%) (+1%)
Dual (GR+02) I i (-30%) (-8%) T t (+33%)
Figure 33 Figure 34 Figure 35
First column represents superficial layer thickness in microns. The second column is the number of
nuclei in the lOOmicron diameter box across the superficial layers. Third column is the density of
nuclei within the lOOmicron box across the superficial layers
This table summarises the main directional changes in the three study groups relative
to control. The mean raw values of the control group are given. The arrows
represent the statistical findings relative to control. The (%) refers to the percentage
change of study group mean relative to control mean. This table shows:
• In the GR group, a non-significant trend of reduced superficial layer
thickness and an associated increase in cell density with no loss of nuclei.
• In the A02 group, the significant loss in superficial layer thickness is
accompanied by a similar proportional loss of cell number causing no
observed effect on cell density.
• In the dual group, there is highly significant loss in superficial laminar
thickness, a suggestion of a relatively modest loss of nuclei (not statistically
significant) and a highly significant increase in cell density suggesting there
has been loss of the intercellular matrix.
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Although the following schematic diagram is an oversimplification, it is a composite
pictorial representation of these results on superficial layer thickness, cell number
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Figure 36 - Schematic of Superficial Layer thickness in each study group
In comparison to control:
GR group - slightly thinner cortex (not statistically significant), equal number of nuclei, slightly
increased density (not statistically significant).
A02 group - thinner cortex, less nuclei, same cortical density.
Dual group - significantly thinner cortex, slightly less nuclei (not statistically significant), significant
increase in nuclei density.
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5.3.3 Corpus Callosum Thickness
Corpus callosum thickness was measured on level matched sections immediately
caudal to the decussation on 3 sections per pup in each of the groups. Statistical
analysis by 2-way ANOVA did not find any significant variation in corpus callosal
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Figure 37 - Corpus Callosal Thickness immediately caudal to decussation
Corpus callosum thickness (microns) against study group on x axis.
Data shows mean ± standard deviation (SD), n=9 per group.
No variation identified by 2-way ANOVA p>0.05.
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5.4 Discussion
5.4.1 Summary of results
This work shows that using a clinically relevant oxygen profile, postnatal oxygen
adversely affects cortical growth, particularly of the late born superficial laminae,
resulting in a thinned cortex with a maintained density and therefore an overall
reduction in neuronal number. In the context of growth restriction, fluctuating
oxygen caused cortical thinning, an increase in nuclear density and a non-significant
reduction in neuron number. Growth restriction alone was associated with slight
cortical thinning and a non-significant increase in nuclei density. There was no
observed effect of growth restriction or oxygen on corpus callosal thickness.
5.4.2 Brain volume and the Preterm Infant
Previous work has suggested the premature infants are more likely to have a reduced
brain volume at term (Thompson et al. 2007). Thompson et al. used MR1 imaging to
demonstrate specific reductions in the sensorimotor, premotor and orbitofrontal
cortical grey matter in preterm infants at term. Within childhood, even those born at
later gestations between 30-34 weeks without serious neonatal morbidity or cerebral
pathology show global grey matter volume loss (Soria-Pastor et al. 2009) and this
correlates with a reduced intellectual score at age 8-10 years. This volume loss is
also noted in adolescence and one study documented an 8.8% reduction in grey
matter volume on MRI in comparison to term-born controls (Nagy et al. 2009).
Another study reported an 11.8% reduction in grey matter volume in adolescence
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(Nosarti et al. 2002). The increasing volume of the developing brain is secondary to
increases in white matter volume (Zhang et al. 2000), cortical surface area (Rakic
1995), deep grey matter nuclei and the thickness of the cerebral cortex. Volume loss,
therefore, may be a consequence of reductions in white matter, cortical surface area,
deep nuclei or cortical thickness which may reflect loss of cells or connectivity
networks.
5.4.3 Cortical Thickness and the Preterm Infant
As described in Chapter 1, specific areas of the cerebral cortex are specialised in
particular functions and therefore adverse effects on cortical thickness may interfere
with the inherent specialist functions for each cortical area. Cortical thickness has
been explored in ex-preterm adolescents using T1 weighted 3D MRI which
demonstrated thinning of the cortex in multiple cortical areas including temporal,
parietal, frontal and occipital lobes with large areas around the central sulcus,
including the motor cortex, being affected (Martinussen et al. 2005; Nagy et al.
2009). The thinning around the central sulcus was most pronounced in adolescents
who were born at a lower gestational age and birth weight (Nagy et al. 2011).
Although, as previously discussed, the links between cerebral volume loss and poorer
cognitive outcome are well established in preterm infants, there are few specific
studies linking cortical thinning after preterm birth to poor cognitive outcome
(Peterson et al. 2000; Tolsa et al. 2004). One study reported a positive correlation
between thinning of the entorhinal cortex in adolescents born preterm and lower
performance in cognitive and executive function testing (Skranes et al. 2011).
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The entorhinal cortex, located in the medial temporal lobe is the gateway between
the hippocampus and the neocortex and is involved primarily in long-term memory
(Squire et al. 2004). Reduced density of pyramidal neurons in specific cortical layers
leading to altered cortical architecture has been reported in the cerebral cortex
overlying areas of periventricular leukomalacia (Andiman et al. 2010). This work
underlines the concept that white matter necrosis must have destructive
consequences on the developing cortical neurons and their axons. Recent MR1 work
using tractography has shown that thalamocortical connectivity is reduced following
preterm birth. In particular connectivity between the thalamus and the
supplementary and pre-motor areas is significantly reduced in preterm infants at
term-corrected (Ball et al. 2012b). Reduced connectivity of afferent fibres in layer
IV would be in keeping with thinner superficial layers. The supplementary and pre-
motor areas are crucial for planning and performing movements (Picard et al. 1996).
As previously discussed, preterm infants may develop particular problems with
executive functioning and poor motor coordination (Anderson et al. 2004; Saiegal et
al. 2003; Marlow et al. 2005). Recent work in Alzheimers disease using Tl-
weighted MRI have used cortical thinning at discrete regions within the cortex to
predict progression of disease from mild cognitive impairment to Alzheimer's
disease (Eskildsen et al. 2012).
Cortical thinning postnatally is in fact a physiological event within the first 1-2 years
of life as a consequence of synaptic proliferation and pruning (Huttenlocher 1994)
and ongoing myelination of small axons at the inner cortical border so that grey
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matter becomes thinner as the white matter in this area expands (Sowell et al. 2001).
Studies examining cortical thickness in ex-preterm infants in early childhood at age
18-22 months and at age 3-4 years therefore relate the cortical thickening and
reduced surface area found in these infants to a delay in normal cortical maturation
secondary to prematurity (Phillips et al. 2011). Within animal work, cortical
thickness studies have found an increased cortical thickness in a mouse model of
Huntington's disease (Lerch et al. 2008) and have been used to study the effects of
intermittent ethanol exposure of cortical thickness in rats (Lee et al. 2011).
As far as can be determined, there have been no pathological studies of cortical
thickness measurements at birth in preterm infants. In addition, the majority of the
published work on cortical thickness has been carried out using MRI imaging as
opposed to neuropathology and this has generally been in adolescents. Challenges in
MRI measurements of cortical thickness include accurate removal of the skull
overlying the cortical area of interest and modelling the cortical surface in regions
where opposing sulcal surfaces may touch (Giedd et al. 2010). A major strength of
this current work is therefore the use of tissue samples from a lissencephalic species.
This work is novel as there is no published literature as far as can be determined at
present, relating specific neonatal morbidities and events, such as growth restriction
and postnatal oxygen therapy, to cerebral cortical thinning.
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5.4.4 The Effect of Growth Restriction and Oxygen on Brain
Volume, Cortical Thickness and the Corpus Callosum
Bronchopulmonary dysplasia and supplemental oxygen are independent predictors of
poor brain growth and neurodevelopmental outcome in the preterm infant (Short et
al. 2003; Boardman et al. 2007). Studies have shown that intrauterine growth
restriction is associated with a posterior reduction in brain volume while
bronchopulmonary dysplasia is associated with a global reduction in brain volume
(Thompson et al. 2007). The mechanisms underpinning such associations are not
well-established. Experimental models designed to examine the relationship
between oxygen and the brain traditionally employ high concentrations of oxygen
(Nemoto et al. 1987; Sirinyan et al. 2006; Ratner et al. 2007). These models have
offered important insights into the adverse effects of oxygen but such levels are
seldom experienced by neonates in contemporary clinical settings where oxygen
saturations are targeted to a normoxic range. Despite such targets, preterm infants
with ventilation perfusion mismatch and immature respiratory drive frequently
deviate outside the target range into hypoxic and hyperoxic levels (Quine et al.
2009). Little is known about the effects of such milder oxygen fluctuations on the
brain.
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Previous work employing the clinically derived oxygen profile used in this study
induced vascular changes in the rat pup retina comparable to those seen in
retinopathy of prematurity (Cunningham et al. 2000; McColm et al. 2000; McColm
et al. 2004; Dhaliwal et al. 2011) and within the brain, increased cell death,
astrocytosis and reduced expression of myelin basic protein (Sedowofia et al. 2008).
This work has shown that clinically relevant levels of oxygen cause cortical thinning
in 7 day old rat pups with a preservation of cell density. This may be explained by a
loss in neuron number secondary to increased cell death (Felderhoff-Mueser et al.
2004; Gerstner et al. 2008), free radical oxygen damage (Vento et al. 2003; Maltepe
et al. 2009), or increased gliosis (Loeliger et al. 2006). In the context of growth
restriction, the fluctuating oxygen may have precipitated a loss of neuronal
processes, dendrites, synapses and interneurons from the inter-cellular space, hence
the observed increase in nuclei density. Further work examining caspase activity,
markers for oxidative stress, cortical volume analysis and staining for synaptophysin
and markers of interneurons would support clarification of the underlying
mechanism accounting for the thinning and increased density.
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Preterm growth restricted infants are at particular risk of developing both acute and
chronic respiratory morbidities (Zaw et al. 2003). These infants are also at increased
risk of neurological consequences demonstrated by reduced cortical grey matter on
magnetic resonance imaging (MRI) at term (Tolsa et al. 2004) and poor
neurodevelopmental outcome in childhood (Yanney et al. 2004).
Within the context of growth restriction, the reduction in brain weight was
accompanied by a mild, non-significant decrease in cortical laminar thickness, and a
corresponding mild, increase in cell density within the cortex. It is not possible to
define from this study if there was reduced cortical volume, loss of specific
intercellular components, loss of white matter or enlarged ventricles. Clearly
however, within the context of fluctuating hyperoxia, growth restriction is a
detrimental prerequisite to normal laminar growth in rodents. Previous work does
report that growth restricted offspring of dams fed a low protein diet during gestation
were found to have increased cortical apoptosis, reduced synapses and a reduced
numbers of both cortical neurons and glia (Liu et al. 2011). This study also
suggested some of these effects could be mitigated by administration of the essential
amino acid taurine which inhibits apoptosis and promotes neuronal survival.
The superficial cortical layers in humans have a larger proportion of late-born
neurons than other species (Hill et al. 2005). The precursor superficial neurons travel
from the cell proliferating zones, through the subplate, and deep cortical layers to
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take their place in the superficial layers. The high proportion of superficial cortical
neurons in humans allows a more complex architecture of inter-neuronal connections
to support vast neuronal communication, key to human cognitive ability.
It was found that cortical thinning was more profound in the late born superficial
layers although deep layer thinning was seen in the dual group exposed to both
growth restriction and oxygen. Proliferation of neuronal progenitors destined for the
cerebral cortex is complete by E16 in rats and migration occurs from E16 until E19
(Bayer et al. 1991b). Deep layer V and VI migration is largely complete by EI8 and
24 - 28 weeks gestation in humans (Bayer et al. 1991b; Kostovic et al. 2006). The
low protein diet was introduced on E15. The deep layer thinning observed may be
explained by a preconditioning effect of growth restriction upon neurons yet to
complete migration from the cell proliferating regions.
Maternal compensation may explain why there was no or minimal effect of growth
restriction on the deeper layers but a more significant effect seen in the late born
superficial layers. There may also be a decrease in circulating growth factors such as
IGF-1 as a consequence of growth restriction (Randhawa et al. 2005). Such growth
factors have neurotrophic effects and are crucial to normal cerebral development
(Popken et al. 2005) and are discussed in greater detail in Chapter 7. Given the
larger proportion of superficial neurons in humans, it is possible that effects seen on
cortical thickness in rodents are significantly amplified in humans.
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The corpus callosum, the major inter-hemispheric channel that connects the majority
of cortical areas, is smaller in children, adolescents and adults who were born
preterm (Nosarti et al. 2004; Caldu et al. 2006). MR1 work has demonstrated that
particularly in the posterior corpus callosum, fractional anisotropy was lowered,
diffusivity increased and connectivity reduced in preterm infants at term. In
addition, the shape of the corpus callosum in the ex-preterm infants was found to be
more circular as previously reported in states of pathology including Alzheimer's
disease and schizophrenia (Tomaiuolo et al. 2007; Thompson et al. 2010).
Increasing white matter maturation in the developing brain is associated with
increasing fractional anisotropy and overall decreased diffusivity reflecting
increasing fibre density and myelination (Huppi et al. 1998). The findings in the
preterm infant brain at term suggest prematurity has an effect on the macrostructure
and microstructure of the corpus callosum, where higher diffusivity levels represent
ongoing immaturity of the white matter tracts. In particular, intraventricular
haemorrhage and white matter injury have been associated with abnormalities in the
integrity of corpus callosum (Thompson et al. 2012).
The thickness of the corpus callosum was measured at its midpoint between the
hemispheres at 20-40 microns caudal to the initial rostral decussation. From the
most recent literature, changes in corpus callosum have been documented as
posterior and therefore more posterior measurements in the coronal sections may
have identified differences in thickness between the study groups.
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The literature reports reductions in cross-sectional area of the corpus callosum as
opposed to thinning and therefore a weakness of this study's technique is the
inability to comment on corpus callosum area as measurements were made in the
coronal dimension only. Differences have been suggested by MRI studies
(Thompson et al. 2010) in the sub regions of the corpus callosum as summarised in
Figure 38. In this study, a single measurement was made in the genus of the rat
corpus callosum as shown in Figure 39 and would therefore not detect regional
Figure 38 - Schematic sagittal view of human corpus callosum
MRI studies show that for term infants, anisotropy is highest in the splenium which is latest to
develop, then in the genu which forms before the splenium and lowest in the body which is the first
region of the corpus callosum to develop.
variation.





Measurements made on coronal section 20-40 microns caudal to corpus callosum decussation.
In this study, superficial thinning was observed in the motor cortex of the fluctuating
oxygen groups with the most significant thinning observed in the dual group also
exposed to growth restriction. A reduction in nuclei number was implied by the
results in the A02 group and therefore a corresponding reduction in associated white
matter fibres may have been expected. In support of the negative findings however,
a recent study examining perinatal correlates with corpus callosum structure did not
find any association between corpus callosum area and presence of
bronchopulmonary dysplasia or growth restriction at birth (Thompson et al. 2012).
The disruption caused to brain development by premature birth causes alterations in
corpus callosum integrity but to date the only perinatal variables found to be
associated with this are IVH and white matter injury (Thompson et al. 2012), neither
of which have been demonstrated in the study model. Furthermore, in keeping with
previous literature, when infants without obvious white matter injury or IVH were
studied, changes were only found in the posterior body (isthmus) and splenium of the
corpus callosum (Hasegawa et al. 2011).
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The explanation for this most likely lies in the developmental phases of the corpus
callosum. The splenium is the last subregion to under its growth spurt which takes
place in the third trimester and after birth (Volpe, 2001), enhancing it vulnerability to
preterm delivery.
5.5 Summary
This work shows that a clinically relevant oxygen profile impairs cortical growth,
particularly of the late born superficial laminae, resulting in a thinned cortex with
maintained density and suggests an overall reduction in neuronal number. In the
context of growth restriction, fluctuating oxygen caused cortical thinning, an increase
in nuclear density and a nonsignificant reduction in neuron number. Growth
restriction alone was associated with slight cortical thinning and a non-significant
increase in nuclei density. There was no observed effect of growth restriction or
oxygen on corpus callosal thickness but measurements made in more rostral sections
may have shown callosal thinning.
146
Chapter 6:
Growth Restriction and Postnatal Oxygen
Exposure on the Transcription Factor




Within the highly organised laminar structure of the cerebral cortex there are many
different neuronal subtypes. Each layer or lamina is characterised by neuronal
subtypes with distinct morphology, patterns of connectivity and gene expression.
The formation of the laminae in the developing cortex is dependent on the precise
proliferation and migration of specific cortical neuron subtypes. When precursor
cells within the proliferating zones (ventricular zone (VZ) and subventricular zone
(SVZ) as discussed in Chapter 1) commit to a definitive cellular fate, specific
transcription factors are expressed within the neural cell and direct the cell to
undergo key cellular events specific to the subtype function. Expression of these
specific transcription factors allows particular cell subtypes to be identified and
studied.
As outlined in Chapter 1, deep layers V and VI of the cortex generally contain large
projection neurons which project axons to subcortical targets including the thalamus,
striatum, pons, spinal cord and the contralateral cerebral hemisphere (Molnar et al.
2006). Layer IV is the major site to receive thalamic input and superficial layers II-
IV are generally composed of smaller neurons that form more localised intra-cortical
connections (Gilbert et al. 1979; Lewis et al. 2002). It is thought that upper layer
neurons are a recent addition to evolutionary cerebral development, important to
cognition and higher functioning in mammals and especially humans (Aboitiz et al.
2003) and that deep layer VI and V projection neurons serve similar functions to
pyramidal neurons in a more primitive cortex.
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The preterm infant brain may suffer both injury and interruption of normal
development (Volpe JJ, 2009b). Damage to white matter structures, particularly the
internal capsule and the finding of PVL, is associated with motor deficits, including
cerebral palsy. It has been shown that axonal injury occurs in the white matter
beyond the insult focus, therefore contributing to the white matter volume reduction
(Haynes et al. 2008). This suggests that PVL-related brain injury causes disruption
to particular types of neuron such as the corticospinal projection neurons originating
from layer V of the motor cortex. Grade III / IV intraventricular haemorrhage and
hydrocephalus also cause white matter damage and will impact on specific neural
cell types (Hack et al. 2000). It is now recognised that damage to developing white
matter, even in the form of diffuse noncystic PVL, does not occur in isolation, but
has significant implications for the development of other brain areas including the
overlying cortex, where complexity is reduced, and the thalamus (Nasgasunder et al.
2012). The thalamus feeds and receives crucial input to and from the cortex via
white matter fibres such as the corticothalamic tracts originating in layer VI of the
cortex (Volpe JJ, 2009b). Furthermore, in perinatal ischaemic stroke, hemiparesis is
more likely if there is simultaneous damage to the posterior limb of the internal
capsule, the basal ganglia and the motor cortex (Boardman et al. 2005); reinforcing
the concept that white matter injury is linked to impaired grey matter function and
together is associated with poorer neurological outcome. As discussed previously,
cognitive deficits are now recognised as highly prevalent in the ex-preterm
population at school-age and occur both in the presence and absence of focal
parenchymal white matter lesions (Volpe, 2009b).
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Previous work in preterm infants has suggested a correlation between poor cortical
growth in the perinatal period and increased cognitive deficit at ages 2 and 6 years
(Rathbone et al. 2011), linking integrity of neuronal populations and their
connectivity with cognition. The development of cortico-cortical connectivity in
humans is most active during the later stages of gestation from 33 weeks and
continues postnatally. This involves completion of migration, dendrite maturation
and synaptogenesis (Kostovic et al. 2006).
In Chapter 1, the effect of preterm birth and perinatal factors such as growth
restriction and oxygen on neurodevelopmental outcome, cognitive function, imaging
and pathological correlates have previously been discussed (Ajayi-Obe et al. 2000;
Vento et al. 2003; Inder et al. 2005). In an attempt to define whether particular
subtypes are more vulnerable to damage, the effects of growth restriction and
fluctuating oxygen on specific neuronal subtypes within the developing cortex are
now examined.
Four transcription factors were selected as markers of the major neuronal subtypes in
the motor cortex. Transcription factor Cut-like-1 (Cux-1) is selectively expressed in
the pyramidal neurons of the neocortex superficial layer progenitors and projection
neurons (Cubelos et al. 2010a; Li et al. 2010). Callosal interhemispheric projection
neurons are specified by Special AT-rich sequence-binding protein 2 (Satb2) in
superficial and deep layers of the cortex (Fame et al. 2010). Corticospinal neurons in
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layer V express Chicken ovalbumin upstream promoter transcription factor-2 (Ctip2)
(Shoemaker et al. 2010) and transcription factor T-box brain 1 (Tbrl) promotes
identity of corticothalamic neurons (McKenna et al. 2011). These are summarised
below in Table 11 and Figure 40.
Table 11 - Neuronal subtype and corresponding marker transcription factor.
Neuronal Subtype Transcription Factor


















Figure 40 - Neuronal subtype markers and location in the cortex.
Each transcription factor is specific for a neuronal subtype within the discrete layers. Method
established by Dr Georgala et al. in work examining embryological cortical development, see section
3.6.
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The aim of this study is to determine the effect of growth restriction and postnatal
fluctuating hyperoxia on specific neuronal subtypes in the motor cortex. Given the
effects noted on laminar thickness in the superficial layers in Chapter 5, it was
hypothesised that markers of superficial neurons, Cuxl and Satb2 would be more
susceptible to these environmental conditions than the markers of deep layer
neurons, Ctip2 and Tbrl. It was however considered important to measure deep




Rat brains were obtained from the animals in each study group as described in
Chapter 2. Pups were perfused with fixative, the brain treated with fixative,
cryoprotected and then snap-frozen in 2-methylbutane (section 2.6.2). Coronal
cryosections at 20(Jm thickness were obtained as described in section 3.6.1.
Comparable sections at the level of the motor cortex were selected and
immunohistochemistry with primary antibodies, fluorescently labelled secondary
antibodies and counterstain was performed (section 3.6.2). Imaging capture was
achieved by confocal laser scanning microscope. Adobe photoshop was used to
perform blinded total nuclei and transcription factor labelled nuclei counts within a
100|Jm diameter box placed in the centre of the motor cortex. Proportions of
transcription factor labelled nuclei relative to total nuclei were compared between
study groups.
During the immunohistochemistry step, there were initial challenges in optimising
antigen retrieval. Fixation of the tissue to preserve morphology can lead to loss of
immunoreactivity of many antigens. This is secondary to unpredictable cross-linking
of proteins within the tissue (Key and Boenisch, 2006). 'Antigen retrieval'
describes the process of restoring immunoreactivity without destroying epitopes (Shi
et al. 1991). The most common technique used is applying heat near the boiling
point of water in the presence of a citrate buffer at pH6.0 which protects protein from
heat-induced denaturation (Cattoretti, 1994).
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In this current study, microwave retrieval was initially attempted for 20 mins; 5 min
intervals at 50% power. However despite good quality immunofluorescent staining,
the brain sections became disrupted and large areas were lost from the slides. A
steaming protocol was then trialled where slides were pre-immersed in citrate and
placed in an enclosed steamer at 90°C for 15-25 mins (range of times attempted).
The brains sections remained on the slides, but staining was poor. The microwave
protocol was then reverted back to and optimal staining was achieved using the




The specificity of staining for all the secondary antibodies was examined as shown in
Figure 41. The microscope settings were unaltered between images. This confirms
the secondary antibody used for the selected primary antibody was specific in all
cases.
Superficial laminae x20 Deep laminae x10





C - No Satb2 primary^MD - No Satb2 primary G - No Tbr1 primary ^Hh - No Tbr1 primary
II/III II/III v H
VI
Figure 41 - Secondary only controls for transcription factor primary antibodies
A - Cux primary absent with 568nm secondary (red) - no nuclear staining.
B - Cux primary absent with 488nm secondary (green, Satb2) & Topro-3 nuclear counterstain (blue).
C - Satb2 primary absent with 488nm secondary - no nuclear staining.
D - Satb2 primary absent with 568nm secondary (red, Cuxl) & Topro-3 nuclear counterstain (blue).
E - Ctip2 primary absent with 568nm secondary (red) - no nuclear staining.
F- Ctip2 primary absent 488nm secondary (green,Tbrl) & Topro-3 nuclear counterstain (blue).
G -Tbrl primary absent with 488nm secondary - no nuclear staining.
H -Tbrl primary absent with 568nm secondary (red, Ctip2) & Topro-3 nuclear counterstain (blue).
II/III, IV, V, VI correspond to cortical layers.
There was no misplaced staining, confirming that migration of neurons to the correct
layer had taken place and that the ontological process of cortical lamination was not
affected by environmental influences.
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In particular, in view of the deep to superficial pattern of cortical development where
superficial cells migrate through the deep layers, it was confirmed that there was no
evidence of Cuxl staining in the deep layers in any of the study groups as shown in
Figure 42 (Dual group). The bright red spots represent artefact and did not
correspond to a nuclei.
B
ii/iii




Figure 42 - Cuxl staining absent from deep cortical layers (xlO magnification).
A - Cuxl staining present in superficial layers II/1II and IV. No Cuxl staining in deep layers V & VI.
B - Overlay of Cuxl staining, Satb2 staining (green) and Topro-3 nuclear stain (blue). Satb2 and
Topro-3 staining present in all layers, including deep layers V and VI.
Bright red areas represent artefact.
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6.3.1 Deep layer nuclei
Three transcription factors, Tbrl expressed primarily in corticothalamic projection
neurons in layer VI, Ctip2 expressed in corticospinal projection neurons in layer V
and Satb2 expressed in layers V and VI were selected as markers of nuclei in the
deep layers of the motor cortex. The proportion of neurons positively labelled with
subtype transcription factor within the deep cortical layers was compared between
each of the study groups. Table 12 shows the mean and SD in each study group for
Ctip2 in layer V and Tbrl in layer IV and demonstrates that the proportion of
labelled neurons was not affected by exposure to GR or 02.
Table 12- Proportions of Ctip2 and Tbrl in deep cortical layers
Study Group Ctip2 / Layer V nuclei (mean+SD) Tbrl/Layer VI nuclei (mean±SD)
RA 18% 0.28 ± 0.04 0.50 ± 0.04
A0218% 0.27 ±0.03 0.49 ± 0.04
RA 9% 0.27 ±0.04 0.53 ± 0.06
AQ2 9% 0.27 ±0.03 0.50 ±0.05
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Figure 43 - Deep cortical layer labelled nuclei
Proportion of positively labelled nuclei against Study group (x axis). Data presented as mean ±SD.
2-vvay ANOVA demonstrates no significant variation in dataset p >0.05.
Graphs A and B demonstrate no difference between study groups in the proportion of nuclei
expressing Tbri (layer VI), or Ctip2 (layer V), in the rodent cerebral cortex.
6.3.2 Callosal Nuclei
Callosal neurons, identified by transcription factor Satb2 are present in all layers of
the cortex. The proportion of neurons positively labelled relative to the total number
of neurons within the superficial and deep layers respectively are shown in Table 13.
Table 13 - Proportions of Satb2 in deep and superficial cortical layers
Study Group Satb2/ Layer V &VI nuclei (mean±SD) Satb2/ Layer ll-IV nuclei (meaniSD)
RA 18% 0.58 ± 0.01 0.67 ±0.01
A0218% 0.59 ± 0.02 0.66 ±0.01
RA 9% 0.58 ± 0.05 0.68 + 0.02
A02 9% 0.59 ± 0.03 0.66 ±0.03











































Figure 44 - Callosal nuclei in superficial and deep cortical layers
Proportion of positively labelled nuclei against Study group (x axis). Data presented as mean ±SD.
2-vvay ANOVA demonstrates no significant variation in dataset p >0.05.
Graphs demonstrate no difference between study groups in the proportion of Satb2 positive nuclei in
the rodent cerebral cortex.
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6.3.3 Superficial layer nuclei
Significant differences were noted in the proportion of labelled Cuxl nuclei in
superficial layers II-IV. Table 14 presents the proportion of positive nuclei relative
to the total and the mean value and SD in each study group of Cuxl positive (Cuxl+)
nuclei and total nuclei in II-IV.
Table 14 - Cuxl positive nuclei in layers II-IV
Study Group Cuxl/Total nuclei (mean+SD) Cuxl nuclei (mean+SD) Total II-IV nuclei (mean+SD)
RA 18% 0.5210.05 215132.22 417159.8
A02 18% 0.4610.04 163.8118.27 355.6138.2
RA 9% 0.4910.03 206.2130.47 421.81 74.08
A02 9% 0.3410.03 129.9114.42 383.6 + 41.25
> 300-i
Control A02 GR Dual
Figure 45 - Cuxl+ nuclei in Layers II-IV
Cuxl+ nuclei in 100pm diameter box overlying layers II-IV of motor cortex (Ml) against study group
on x axis. Each data-point represents an average of 3 counts per pup. Each different colour represents
a different litter, confirming no major outliers between the litters in each study group.
The values for each group are normally distributed by D'Agostino and Pearson omnibus normality
test. Data shows mean ± standard deviation (SD), n=9 per group.
Figure 45 shows spread of data. Statistical analysis not shown here — see Figure 46.
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Statistical analysis by 2-way ANOVA suggested significant variation within the
study groups which were then compared using Bonferroni post-tests. A significant
difference was noted in the proportion of Cuxl expressing nuclei in the fluctuating
oxygen group in comparison to control, p < 0.01 by 2-way ANOVA and a marked
reduction in the proportion of Cuxl nuclei was observed in the dual study group
exposed to both growth restriction and oxygen, p < 0.001. Within the fluctuating
oxygen groups, growth restriction further impaired nuclear expression of Cuxl as
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Figure 46 - Proportion of Cuxl+ nuclei in layers II-IV.
Proportion of Cuxl positive nuclei against study group on x axis.
Data shows mean ± standard deviation (SD), n=9 per group.
2-way ANOVA confirms variation present in dataset p <0.05. Bonferroni post-test analysis to
compare groups, **p<0.01, ***p<0.001.
The proportion of Cuxl labelled nuclei was reduced in both groups exposed to fluctuating oxygen,
and the greater effect seen in the dual group also exposed to growth restriction.
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6.4 Discussion
6.4.1 Summary and context of findings
In this study, neuronal subtype populations in the cortical layers were examined and
it was found that there was no observed effect of growth restriction or oxygen on the
proportion of neurons expressing transcription factors marking deep layer neurons.
Similarly, there was no effect of the environmental conditions on the proportion of
Satb2 positive nuclei as a marker of callosal neurons in the superficial layers.
However, there were significant effects observed in the proportion of superficial
neurons expressing transcription factor Cuxl:
• Fluctuating oxygen (A02) caused a significant reduction in the
proportion of Cuxl expressing neurons (Cuxl+).
• The reduction in Cuxl+ was most marked in the dual group where
pups were also growth restricted.
In previous experiments using this rodent model it was shown that A02 does not
affect gross brain weight (Table 6 and Figure 25), but does cause superficial cortical
thinning with a preservation of cell density (Figures 32, 33, 35, 36 and Tables 9 and
10). This implies there may be a loss of cells from cortical layers II-IV in this group.
A reduction in the proportion of Cuxl nuclei in these superficial layers does not
confirm or refute cell loss but does mean that expression of this transcription factor
by neurons in the superficial cortex is affected.
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In the dual group pre-exposed to growth restriction and then A02, a reduction in
gross brain weight was observed (Table 6 and Figures 24 and 25), significant cortical
thinning but with a proportional increase in layer 1I-IV cell density and a suggestion
(although not statistically significant) of cell loss from these layers (Figures 31, 32,
33, 35 and Tables 9 and 10). The marked reduction in the proportion of Cuxl
expressing neurons similarly suggests disruption to superficial neurons within the
superficial layers.
6.4.2 Aetiology of Reduced Cux1 +
The reduction in the proportion of Cuxl+ expressing neurons seen in the A02 and
dual study groups has not been established in this study, however two mechanisms
are hypothesised:
A - Reduced Cux-1 expression by superficial neurons present in cortex, or,
B - Loss of Cux-1 expressing neurons through failed migration or cell death.
A - Reduced Cux-1 Expression
There are a number of markers in addition to Cux-1 which specify post-mitotic cells
in layers II-IV, including transcription factors Cux-2 and LIM homeobox 2 (Lhx2).
Cux-1 was selected for its specificity to superficial layer projection neurons.
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Neurons expressing Cux-1 are negative for interneuron markers suggesting Cuxl
specifically labels pyramidal projection neurons whereas Cux2+ neurons have also
been shown to co-express interneuron markers (Nieto et al. 2004). Lhx2 is expressed
throughout cerebral development and provides an example of how a single
transcription factor can have differing roles at specific time points in development.
In addition to specifying postmitotic superficial cortical neurons, Lhx2 is also
involved in the embryonic onset of neurogenesis within the proliferating VZ and
SVZ and also in establishing neocortical identity of all cortical layers (Monuki et al
2001). Despite Cux-1 therefore being the most specific transcription factor for
superficial neurons, expression of one of the other markers in place of Cux-1 may
indicate preserved function. There is evidence form Cuxl knockout and knockdown
rodent studies that Cux-2 may compensate for Cux-1 (Nieto, 2004). Identification of
proportions of nuclei positively expressing Cux-2 and / or Lhx2 would elucidate
whether exposure to growth restriction and oxygen fluctuation affected (1) absolute
numbers of superficial neurons and (2) preferential expression of key transcription
factors by these neurons.
Identifying other cell types present in the superficial layers including interneurons
and glial cells would also intimate whether there may be increased proportions of
other post-mitotic cells. Animal work in a baboon model has previously linked
respiratory support to the development of cortical gliosis and the persistence of radial
glia within the cortex (Loeliger et al. 2006) and staining for glial cell types may
therefore provide further information.
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B - Loss of or failed migration of Cuxl+ neurons
A reduction in Cux-1 expression particularly when combined with a reduction in
other superficial layer transcription factors might be explained by a reduction in
neurons within the superficial layers. This may occur through a process of cell death
or through failure of neuronal migration during the later stages of cortical
development. These hypotheses were not explored in this study, but measuring
markers of cell death such as caspase-3 would provide evidence of cell death and
could be supplemented with dual staining of neurons, astrocytes and microglia to
fully characterise the cellular response. In the absence of cell death, the integrity of
neuronal migration could be examined using Bromodeoxyuridine (BrdU) birthdate
labelling to dams around the time of superficial neuronal migration (in rats E16-E18,
Figure 4) and the laminar distribution of BrdU labelled cells examined at P7 along
with laminar specific markers (Georgala et al. 2011). BrdU is incorporated into cells
during S phase of the cell cycle, i.e. proliferating cells undergoing DNA replication.
There was no evidence found of Cux-1 staining in the deep layers V or VI or in the
subplate thereby excluding arrested migration of Cux-1 expressing cells (Figure 41).
The identities of the individual progenitor populations that give rise to many
projection neuron subtypes are largely unknown (Molyneaux et al. 2007). It is
known that both Cux-1 and 2 are expressed by superficial layer progenitors in the
proliferating SVZ but not the VZ from E13-E17 during the time of superficial neuron
generation (Nieto et al. 2004). Therefore it is possible that the introduction of the
low protein diet had an effect on the SVZ neurons that was not significantly seen in
this model in the context of growth restriction alone but was with the additional
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insult of postnatal oxygen fluctuation. There is evidence that pups of dams fed a low
protein diet in pregnancy had lower numbers of dendrites and lower cortico-cortico
evoked potentials (Resnick et al. 1982) which fits with reduced connectivity.
Although Cux-1 specifies post-mitotic superficial projection neurons, there are many
other crucial transcription factors upstream of Cuxl in determining superficial
neuron fate. In particular, Paired-box-6 (Pax-6) has multiple roles throughout
development including establishing the identity of cortical progenitors and
determining cortical arealisation (Muzio et al. 2002). In Pax6 mutants, deep-layer
neurons are produced normally. The thickness of superficial cortical layers is
however reduced and there is a global decrease in superficial layer neurons including
a reduction in Cux-1 and Cux-2 expressing neurons (Nieto et al. 2004). In addition,
it has been shown that overexpression of Pax-6 is equally damaging to cortical
development and causes a reduced number of superficial neurons with no effect on
laminar fate (Georgala et al. 2010). Recent work has shown that intermittent hypoxia
(alternating 21% and 10% oxygen) increases the expression of Pax6 in neurons from
the SVZ in P4 mice (Ross et al. 2012). It is therefore possible that the fluctuating
hyperoxia / hypoxia profile caused disruption to Pax6 expression which in turn
affects Cux-1 subtype identity and superficial layer thickness. There are no
published reports documenting the effect of protein / nutrient restriction and
subsequent growth restriction on gene expression of cortical transcription factors. As
discussed in Chapter 5, one group reports that a low protein diet is associated with
increased apoptosis, decreased synaptic density and fewer neurons (Liu et al. 2011).
166
In addition, as referenced above, offspring of dams fed a low protein diet have also
been shown to have lower numbers of dendrites and lower cortico-cortico evoked
potentials (Resnick et al. 1982). Although a statistically significant effect on cortical
thickness in the 'GR only' group was not observed, there was a mild reduction in
thickness and increased nuclear density, suggesting some loss of intercellular matrix.
The additional insult of A02 may further affect neuronal subtype integrity reducing
Cuxl expression with further impact on the extracellular matrix (Cubelos et al.
2010b).
One of the main strengths of this study is the clarity of the effect on the proportional
expression of Cux-1 on the background of no effect seen in the other transcription
factors. This demonstrates the Cux-1 effect as convincing and is in keeping with the
detrimental effects already observed on cortical thickness in the preceding Chapter.
The superficial cortical layers are hugely expanded in humans in comparison to
rodents and therefore effects seen in animal models hold crucial keys to
understanding adverse effects on superficial layers in humans.
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6.4.3 Consequences of reduced Cux1
Cux-l is expressed in most tissues of the body (Nepveu, 2001) and expression and
activity is regulated through the cell cycle. Cux-l is involved in cell cycle
progression and cell motility and has roles in the control of cell proliferation and
differentiation (Sansregret et al. 2008). As a transcription factor, Cuxl acts as both
a gene repressor and activator and it is not yet clear how this is determined
(Sansregret et al. 2008). The gene was first studied in the Drosophila (Cut-like 1)
(Nepveu, 2001). The human homologue was initially found to be CCAAT-
displacement protein (CDP) and is now known as Cux-l in keeping with other
mammals. Cux-l knock-out studies in mice demonstrate a number of findings based
on the effect caused by the knock-out on the protein. At the mildest end, a truncated
protein causes wavy hair, curly whiskers and impaired lactation resulting in a high
death rate in the litters (Tufarelli et al. 1998). The wavy hair was due to disrupted
hair follicle morphogenesis. A further knock-out mouse model showed that
homozygotes had a high death rate soon after birth, demonstrated failure to thrive
secondary to muscle wasting, loss of body fat and thin bones and had curly whiskers
and hair loss. The pups also had an increased risk of bacterial infection as a result of
increased apoptosis of B cells in the bone marrow and T cells in the thymus (Sinclair
et al. 2001). The third knock-out mouse model defined the cause of the high lethality
observed in the other models as being a consequence of delayed lung development
causing respiratory failure (Ellis et al. 2001). In humans, increased expression of
Cuxl has been reported in tumours of breast and pancreatic origin with roles in
tumour initiation and progression (Michl et al. 2005; Ripka et al. 2010) and Cuxl has
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also been implicated in the aetiology of autosomal dominant polycystic kidney
disease due to its role in maintaining microtubule dynamics (Alcalay et al. 2008).
It is only recently that Cux-1 and Cux-2, both related homeobox genes, have been
identified as having key roles in cortical brain development (Cubelos et al. 2010b; Li
et al. 2010). Expression of Cux transcription factors specifies superficial neuronal
cell identity and Cux2 is specifically required for proliferation of superficial layer
neurons in the SVZ (Cubelos et al. 2010b; Cubelos et al. 2008). Knock-out studies
of Cux-1 and Cux-2 show that in the absence of either gene, there is reduced
complexity of dendritic branching, simpler dendritic tree morphology, reduced
dendritic spines, all elements required for interneuronal communication and the
establishment of cortical circuitry (Cubelos et al. 2010a, Cubelos et al. 2010b).
Given the high mortality associated with the Cux-1 knock-out, behavioural testing
could only be observed in the Cux-2 knock-out mice who demonstrated working
memory deficits (Cubelos et al. 2010b). An in-vitro experiment suggested
contradictory findings where increased intracellular level of Cuxl reduced the
dendritic complexity of cultured cortical pyramidal neurons (Li et al. 2010). This
was an in vitro study in contrast to cortical neurons in vivo which function as part of
a global cortical system. It is likely that the positive effects of Cux-1 on dendritic
growth are likely to depend on the synaptic inputs to a given neuron (Hulea et al.
2012).
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The reduced proportion of Cux-1 neurons in the superficial cortical layers in the A02
and dual study groups of our model has implications for the dendritic integrity in the
superficial cortical layers of these pups. Dendritic integrity is crucial in cortico-
cortical circuitry and given that the superficial layers are generally considered to be
the seat of higher cognitive functioning, deficits in such circuits will inevitably have
consequences for function and behaviour.
6.4.4 Implications for humans
Cux genes are homeobox genes, widely conserved between species. Much less work
has been done on Cux genes in humans, but it is known that Cux proteins are specific
markers for the superficial layers in the human cortex, namely layers II and III and
are expressed into adulthood (Arion et al. 2007). Human studies of nonsyndromic
children with developmental delay have consistently reported dendritic abnormalities
at post-mortem examination (Dierssen et al. 2006). This observation dates back to
the 1970s, when researchers reported "dendritic spine dysgenesis" in children with
nonspecific developmental delay to describe the appearance of long, thin, immature
dendritic spines in contrast to short stubby dendritic spines found in children without
learning difficulties (Purpura, 1974). In addition, other researchers reported reduced
dendritic branching and complexity in children with developmental delay and
seizures (Huttenlocher, 1974). More recent studies link the morphological shape of
dendritic spines to memory function (Segal, 2005).
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As far as can be ascertained, there are no specific studies in the literature examining
dendritic morphology in preterm infants. Dendritic spines, as well as cortico-cortical
connections, and synapses all develop during the neonatal period (Kostovic et al.
2007). There is however a substantial literature linking preterm birth to a reduction
in cerebral cortical grey matter volume, and cortical thinning in adolescence
affecting specific brain areas (Inder et al. 2005; Kapellou et al. 2006; Nagy et al.
2011; van Kooij et al. 2012). Loss of tissue may reflect either cell loss or loss of
intercellular matrix containing intracellular connections. Specific areas of cortex
affected by preterm birth include sensorimotor, premotor and orbitofrontal cortical
grey matter (Thompson et al. 2007). In addition, recent MRI work indicates that
reduced thalamic volume in preterm infants is a predictor for reduced cortical
volume, reduced volume of both the frontal and temporal lobes and the hippocampus
(Ball, 2012a). A subsequent study by the same research group used tractography
MRI studies to demonstrate reduced thalamocortical connectivity specifically
affecting the premotor and supplementary motor areas and the lateral frontal cortex
(Ball, 2012b). Preterm infants with reductions in cortical and deep grey matter
volume have an increased risk of poor neurodevelopmental outcome at 1 year (Inder
et al. 2005) and a reduced intellectual score at age 8-10 years (Soria-Pastor et al.
2009). Such cognitive deficits may be a consequence of the premature interruption
of cortical development and the effect of subsequent perinatal events on cortico-
cortico superficial neuron connectivity and cortical circuitry involving other key
cognitive structures such as the thalamus.
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6.5 Summary
This Chapter has described that within the superficial cortical layers, postnatal
fluctuating oxygen causes a reduction in the proportional expression of Cuxl, a
transcription factor key to the integrity of intracortical connectivity. In the context of
pre-existing growth restriction, the reduction in Cuxl expression is more severe.
Although the mechanism underlying the reduction have not been established in this
work, inactivation of transcription factor expression by existing cells, failure of
migration or cell death may be responsible. A reduction in Cuxl expression may lead




The Effect of Growth Restriction & Postnatal
Oxygen Exposure on Trophic Factors
in the Developing Brain
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7.1 Introduction
In this study, four key trophic factors for fetal cerebral growth were selected to
investigate the effects of growth restriction and postnatal oxygen therapy on cerebral
growth factor expression within the animal model. Trophic factors are substances
provided in limited quantities by target cells to control the development and survival
of specific groups of neurons in normal brain development. These factors regulate
neuronal numbers by ensuring the survival of the correct number of neurons and
allowing selective death of neurons not required (Bear et al. 2001). In Chapter 1, a
description of the role of each of the trophic factors in brain development was given.
In this section, a literature review of the specific effects of oxygen and growth
restriction on each trophic factor is presented.
1 - Insulin-like Growth Factor I (IGF-I) is a peptide involved in neuronal progenitor
proliferation, development and survival.
2 - Brain Derived Neurotrophic Factor (BDNF) is a neurotrophin, part of a family of
intercellular messengers which promote survival and differentiation of specific cell
subpopulations during neural development.
3 - Fibroblast growth factor (FGF) has significant trophic effects important to
neurogenesis and also acts as an angiogenic factor.
4 - Vascular Endothelial growth factor (VEGF) is a signalling protein, key to
vasculogenesis and angiogenesis.
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Trophic factors involved in brain development work in concert with one another and
therefore the effect on any individual growth factor has sequential effects on other
trophic factors and therefore the developing neurons each factor regulates.
7.1.1 Insulin-like Growth Factor I (IGF-I)
IGF-I has pleiotrophic effects on brain development. It is produced by the fetal liver,
locally by cortical and other CNS neurons and by endothelial cells of the cerebral
vasculature. Previous work in a similar rodent model examining the effect of growth
restriction and oxygen on early retinal blood vessel growth demonstrated delayed
retinal vascularisation, particularly in pups exposed to fluctuating oxygen. This poor
retinal vascularisation was associated with poor weight gain (Dhaliwal et al. 2011).
Other studies have linked poor retinal vascularisation in ROP to low levels of
circulating IGF-I, and that low levels of IGF-I are associated with more severe ROP
(Hellstrom A, Low IGF-I suppresses VEGF-survival signalling, Pre Natl Acad Sci,
2001).
IGF-I - Relationship to Growth restriction & Oxygen
Studies of IGF-I mutations in humans are associated with intrauterine growth
restriction, microcephaly and learning impairment (Walenkamp et al. 2005). The
placenta produces a growth hormone which differs from mainstream Growth
Hormone (GH) by 13 amino acids. This is only present in the maternal circulation
but is reportedly low in IUGR pregnancies. The role of placental GH in relation to
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regulation of the fetal IGF system is poorly understood (Westwood M, 2001).
Infants who are small for gestational age (SGA) have lower levels of IGF-I in cord
blood (Davidson et al. 2006). Such SGA infants also have reduced cerebral cortical
volume and impaired cognition in comparison to appropriately grown preterm infants
(Tolsa et al. 2004). Given the pleiotrophic roles IGF-I plays in the developing brain,
it would seem plausible that lower levels in SGA infants may affect normal cerebral
development with particular reference to the key role played in progenitor
proliferation, development and survival.
In preterm infants, supplemental oxygen therapy has been demonstrated as an
independent risk factor for impaired brain growth and loss of brain tissue volume at
term (Boardman et al. 2007). Infants with bronchopulmonary dysplasia (BPD) have
been shown to have lower concentrations of serum IGF-I (Lofqvist et al. 2012).
From in vitro models, there is evidence that IGF-I is protective to cortical neurons
exposed to hypoxia and re-oxygenation (Huang et al. 2012). IGF-I expression is
reduced in the retinal vessels of rodent pups exposed to 75% oxygen who developed
retinopathy of prematurity (Lofqvist et al. 2009). In hypoxic-ischaemic neonatal
brain injury models, IGF-I mRNA expression is increased in regions where delayed
neuronal and glial cell loss occur. The IGF-I was found to be produced by reactive
microglia and astrocytes adjacent to surviving neurons encircling the area of
ischaemia (Beilharz et al. 1998). Recent work has shown that exogenous IGF-I
delivered to neonatal rats with an LPS-induced acute brain inflammatory response
causes reduced neuronal cell loss (Pang et al. 2010). In rodent models of traumatic
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brain injury, low IGF-I serum levels correlate with a poorer cognitive outcome
(Ozdemir et al. 2012) and IGF-I administration after traumatic brain injury in rats is
neuroprotective (Rubovitch et al. 2010).
It was hypothesised that growth restriction and oxygen fluctuation will have an
adverse effect on IGF-I expression in the developing brain and on circulating levels
within the serum.
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7.1.2 Brain-Derived Neurotrophic Factor (BDNF)
BDNF has a neuroprotective role in the developing brain. Preterm infants have been
found to have lower levels than term infants (Malamitsi-Puchner et al. 2004) and
BDNF serum levels correlate with several antenatal and postnatal factors that
influence neurodevelopmental outcome (Rao et al. 2010).
BDNF - Relationship to Growth Restriction & Oxygen
It has been previously argued that growth restriction does not have a specific effect
on BDNF because of the brain-sparing effect (Malamitsi-Puchner A et al. 2004).
However there is literature to support a link between nutrient intake and BDNF
expression in the brain where dietary restriction is associated with increased levels of
BDNF (Lee et al. 2002) and a high fat diet causes reduced levels of BDNF perhaps
due to an increase in free radicals as a consequence of the high fat diet (Wu et al.
2004). Oxidative stress has also been previously reported to reduce BDNF levels
(Wu et al. 2006). It was therefore hypothesized that fluctuating oxygen would have
an adverse effect and growth restriction a positive effect on BDNF expression in the
brain.
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7.1.3 Fibroblast Growth Factor-2 (FGF2)
FGF-2 is highly expressed in both the developing and mature brain. FGF-2 is one of
22 members of the fibroblast growth factor family and has important roles in early
cerebral patterning and as a trophic factor for neuronal and particularly glial
progenitors in the SVZ (Tao et al. 1997; Kuhn et al. 1997). More recently, the role
FGF-2 and other members of the fibroblast growth factor family play in
synaptogenesis has become appreciated (Li A et al. 2002). FGF-2 also acts in
concert with VEGF as a potent angiogenic factor (Kalghatgi et al. 2009). Within the
developing and adult brain, FGF-2 promotes the development of learning and
memory (Graham et al. 2010).
FGF2 - Relationship to Growth restriction & Oxygen
The protein restriction diet used in the experimental model is known to cause an
increase in maternal glucocorticoids (Langley-Evans et al. 1994). Prenatal exposure
to glucocorticoids has been shown to cause an acute upregulation in FGF-2
expression in specific brain regions (Molteni et al. 2001). Placental expression
(Barut et al. 2010) and circulating FGF-2 levels from the umbilical vein (Wallner et
al. 2007) are increased in SGA infants. Following ischaemic injury by unilateral
ligation of the carotid artery, FGF-2 administered systemically prevents ischaemic
related damage (Nozaki et al. 1993). This suggests that despite the abundant local
expression of FGF-2 throughout the developing brain, circulating levels of FGF-2 are
important for neuroprotection.
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Following perinatal asphyxic episodes in rat pups, FGF-2 expression in the
hippocampus was increased and persisted postnatally until P30. This was suggested
to represent the activation of neuroprotective mechanisms (Morales et al. 2008).
Modifications of oxygen tension have also been shown to increase FGF-2 mediated
in vitro rat neuroblast cell proliferation and dopamine release (Jensen et al. 2011),
low oxygen tension (3%) was the favoured environment for FGF-2 mediated
neuronal proliferation and high oxygen tension (20%) more advantageous for FGF2
driven dopamine release, suggesting environmental oxygen affects FGF2 function.
It was hypothesised that FGF2 is up-regulated in response to the stress of growth
restriction and fluctuating hyperoxia with mild hypoxia.
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7.1.4 Vascular Endothelial Growth Factor (VEGF)
Vascular Endothelial Growth Factor is a signalling protein necessary for normal
blood vessel formation and development. Low levels of VEGF in the brain are not
only associated with impaired vasculogenesis and angiogenesis (Ruhrberg C et al.
2003), but also impaired neuronal proliferation, survival and migration (Haigh et al.
2003), indicating a crucial role for VEGF in cerebral development. Within the brain
of newborn rats, VEGF has been shown to guide the migration of neural progenitors
in the subventricular zone of the cortex (Zhang et al. 2003).
VEGF - Relationship to Growth Restriction & Oxygen
One of the underlying abnormalities in the placentas associated with growth
restricted infants is abnormal angiogenesis and inadequate terminal villi formation
(Ahmed et al. 2000). An imbalance of angiogenic and anti-angiogenic factors
including VEGF and VEGF receptors have been found in placentas from IUGR
pregnancies (Jarvenpaa et al. 2007; Wallner et al. 2007) suggesting an intimate
relationship between VEGF homeostasis and IUGR.
VEGF is up-regulated by hypoxic-inducible factor (HIF-1) and in studies of
retinopathy of prematurity, much of the damage caused to the retina is by VEGF
induced neovascularisation (Hellstrom et ai. 2001). The new blood vessels are
disorganised and weak and may cause bleeding within the retina. Hyperoxia is
181
inhibitory to VEGF function. Previous work has shown that fluctuating oxygen
environments are more damaging to the retina than constant hyperoxia, considered
due to the switching on and off of the hypoxic driven VEGF expression causing
inefficient and chaotic neovascularisation (York et al. 2004; Penn et al. 1994).
Within the neonatal lung, disrupted VEGF signalling impairs alveolar development
and contributes to the development of BPD (Abman et al. 2010).
It was hypothesised that fluctuating hyperoxia and growth restriction downregulate
VEGF expression in the developing brain which, in view of the neurotrophic effects,
may have adverse effects on neuronal development.
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7.2 Methods
Brain sections were obtained as described in section 2.4. Due to the fragility and
small size of the P7 brains, dissection of discrete brain regions, e.g. hippocampus
was not possible. The brains were therefore split into 4 sections:
Anterior Cerebrum - containing rostral cerebral cortex, partial dorsal
hippocampus, rostral corpus callosum.
Posterior Cerebrum - containing caudal cerebral cortex, thalamus,
hypothalamus, partial midbrain, majority of hippocampus and caudal corpus
callosum.
Brainstem - containing partial midbrain, pons and medulla.
Cerebellum.
From each brain section, RNA was extracted, quantified and quality checked as
per section 3.1. Reverse transcription to cDNA and then quantitative PCR was
performed using validated primers and probes for rat for IGF-I, BDNF, FGF-2
and VEGF (TaqMan Gene Expression Assays, Life Technologies). Refer to
sections 3.1 - 3.4 for further details. Significance analysis was performed on raw
ACt values. Data is plotted as fold change 2~AAC' in comparison to control group.




7.3.1 Insulin-like Growth Factor-1 (IGF-I)
Data was analysed by 2-way ANOVA which confirmed variation within the groups.
Bonferroni post-tests confirmed a significant difference between the control group
and each study group and between the growth restricted groups:
Table 15 — Serum IGF-I levels in 4 study groups
Comparison mean ±SD p value
Control & oxygen fluctuation group 224.7±8.4 versus 192.4±6.9 p =0.011
Control & growth restricted group 224.7±8.4 versus 96.3±3.2 p< 0.0001
Control & dual group 224.7±8.4 versus 75.9 ±4.5 p< 0.0001
Growth restricted group & dual group 96.3±3.2 versus 75.9 ±4.5 p= 0.0004
At P7, there was a significant reduction in circulating IGF-I in the serum of both
groups of growth restricted pups. Both groups of pups exposed to oxygen also have
lower circulating IGF-I. The group of pups exposed to both growth restriction and

















Figure 47 - P7 Serum IGF-I protein levels
Quantity of circulating serum IGF-I (ng/ml) at P7 in control group, oxygen fluctuation group, growth
restriction group and dual group exposed to both growth restriction and oxygen fluctuation, n = 30
pups from 3 litters per group. Data from each group is normally distributed by D'Agostino and
Pearson normality test. Data shown as mean ± SD. 2-way ANOVA confirmed significant variation
between the datasets, P<0.05. There is a significant difference between the Control group and each
study group by Bonferroni post-tests; *p<0.05, ***p<0.00l, ***p<0.001 respectively. Within the
growth restricted groups, there was a further reduction in serum protein in the pups exposed to oxygen
**p<0.01.
Within the developing brain, there was no difference in IGF-I expression between














Normally grown Growth restricted
Figure 48 - Expression of IGF-I in brain sections
Expression of IGF-I mRNA relative to control group against study group on x axis.
Data shown as mean 2"AACt ± SD, n=3 (9 pups from 3 litters) per group.
No variation was identified by 2-way ANOVA between the groups on any of the four brain sections.
Above data from posterior cerebrum section of the brain. Data from other brain sections not shown.
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7.3.2 Brain Derived Neurotrophic Factor (BDNF)
There was no effect of growth restriction or fluctuating oxygen seen on the anterior,




















Normally Grown Growth restricted
Figure 49 - Expression of BDNF in posterior cerebrum
Expression of BDNF mRNA relative to control group against study group on x axis.
Data shown as mean 2"aac'± SD, n=3 (9 pups from 3 litters) per group.
No variation was identified between groups by 2-way ANOVA.
This data represents the posterior cerebrum section. Data from other brain regions not shown.
The BDNF expression results within the brainstem are summarised in Table 16 and
shown graphically in Figure 50.
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Table 16 - BDNF Expression in Brainstem






Data was analysed by 2-way ANOVA and Bonferroni post-tests for multiple
comparisons. There was an incrementally graded increase in the expression of
BDNF across the groups with the highest expression seen in the dual group exposed





















Figure 50 - BDNF Expression in brainstem
Expression of BDNE mRNA in brainstem: fold change relative to control group against study group
on x axis. Data presented as mean 2"Aact±SD, n=3 (9 pups from 3 litters per group).
2-way ANOVA confirms variation present in dataset, P<0.05. Bonferroni post-test analysis identified
increased BDNF expression in the oxygen only pups (**p<0.0l), growth restricted only pups (***p
<0.00l) and in dual group pups (***p<0.00l) in comparison to control.
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7.3.3 Fibroblast Growth Factor-2 (FGF2)




























Figure 51 - Expression of FGF2 in the posterior cerebrum
Expression of FGF-2 mRNA at P7 relative to control group against study group.
Data presented as mean 2"AACt±SD, n=3 (9 pups from 3 litters per group).
2-vvay ANOVA did not identify variation between groups.
Above data represents the posterior cerebrum section. Data from other brain regions not shown.
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7.3.4 Vascular Endothelial Growth Factor (VEGF)
Expression of VEGF is mildly reduced in the dual group exposed to growth
restriction and oxygen in both the anterior and posterior cerebrum. There was no
reduction seen in any of the groups in either the brainstem or cerebellum.
Table 17 - VEGF expression in Anterior and Posterior cerebrum sections
Mean±SD
Group VEGF Anterior Cerebrum VEGF Posterior Cerebrum
RA 18% 0.9910.1 0.9810.1
A02 18% 0.9810.1 1.010.05
RA 9% 1.0610.08 1.110.07


















Normally grown Growth restricted
Figure 52 - Expression of VEGF in the anterior cerebrum
Expression of VEGF mRNA at P7 relative to control group against study group.
Data presented as mean 2 aACt±SD, n=3 (9 pups from 3 litters per group).
2-vvay ANOVA identified variation between datasets, Bonferroni post-test analysis identified reduced
expression in dual group exposed to both growth restriction and oxygen in comparison to GP group,



















Normally grown Growth restriction
Figure 53 - Expression of VEGF in the posterior cerebrum
Expression of VEGF mRNA at P7 relative to control group against study group.
Data presented as mean 2 aaCl±SD, n=3 (9 pups from 3 litters per group).
2-vvay ANOVA identified variation between datasets, Bonferroni post-test analysis identified reduced
expression in dual group in comparison to A02 group and GR group, *p<0.05. Data from posterior
cerebrum.
In the rostral and caudal cerebrum, expression of VEGF in the dual group was
slightly reduced in comparison to the other study groups, p<0.05.
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7.4 Discussion
Proliferation and cell fate determination in the developing brain are regulated by
complex interactions between a large number of growth factors as well as
transcription factors and neurotransmitters. The most important growth factor in
determining total body growth is IGF-I.
7.4.1 Insulin-Like Growth Factor -1
The reduction in circulating serum IGF-I that was observed in growth restricted pups
is in keeping with the literature in both animal studies (Hellstrom et al. 2001) and
with what is known about IGF-I levels in small for gestational age (SGA) infants
(Davidson et al. 2006). This is not surprising given the effects which IGF-I has over
the control of total body growth demonstrated by knock-out animal experiments,
where birth weights of IGF-I knock-out rodents are 40% lower than wild type
rodents (Liu JP et al. 1993). Similarly in humans, mutations of IGF-I cause severe
intrauterine growth restriction (Walenkamp et al. 2005). Deficient levels of IGF-I
can occur following preterm birth and this predisposes to retinal vessel loss and ROP
(Zepeda-Romero et al. 2012). Animal studies of exogenous administration of IGF-I
have shown positive effects on ROP prevention and particular benefit for total body
growth (Hellgren et al. 2011). No beneficial effects on brain weight were observed
and behaviour studies have not been reported. Preterm human studies have shown a
beneficial effect of administering fresh-frozen plasma (FFP) containing IGF-I and
IGFBP-3 from adult donors (Hansen-Pupp et al. 2009) and intravenous preparation
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of IGF-I/IGFBP-3 (Lofqvist et al. 2009) on IGF-I and IGFBP-3 levels and is well
tolerated. Any beneficial effect on growth or neurological outcome has not been
determined.
All six IGF-binding proteins are present in plasma (Randhawa et al. 2005). IGF-I is
bound to these proteins in plasma which limits the availability of IGF-I to the IGF-
IR. The IGFBPs are under the control of a family of proteases that cleave the
binding proteins into inactive fragments. These proteases thereby allow IGF
peptides to exert their growth promoting effects (Collett-Solberg et al. 1996). The
ELISA assay used in the determination of IGF-I within each study group was an
IGFBP blocked assay so that total circulating IGF-I was measured as opposed to
only that which is unbound in the circulation. The effect of growth restriction on
total circulating IGF-I within the model can be commented on, acknowledging that
some of this will be bound to plasma proteins. It has been previously reported that
1GFBP1 is high in the cord blood of growth restricted babies, and that IGFBP1 is
negatively correlated with birth weight, suggesting that IGF-I is less available in
these infants (Ostlund et al. 1997). IGFBP3 is present in the highest quantity in
plasma and circulates as part of a complex with IGF-I. IGFBP3 has been reported to
be reduced by 50% in IUGR babies (Giudice et al. 1995), but it is not clear whether
this is a primary effect on IGF-I or on IGFBP3. An effect on both as part of the 'IGF
system' seems more likely given that IGFBP3 overexpression in transgenic mice is
associated with a reduction in birth weight due to a reduction in circulating IGF-I
(Modric et al. 2001). Determination of IGFBP levels in the model may have
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provided more detail on this matter but the interaction between the IGF peptides and
IGFBPs is constantly dynamic (Popken et al. 2005) and therefore the true unbound
circulating fraction of IGF-I is difficult to ascertain reliably.
It has been shown that fluctuating oxygen has an effect on circulating IGF-I in the
model with a reduction in serum IGF-I in both groups exposed to oxygen.
Exogenous oxygen is associated with the development of BPD and a recent study has
demonstrated that lower levels of IGF-I levels in preterm infants was associated with
the subsequent development of BPD (Lofqvist et al. 2012). The P7 body weight of
the oxygen only group was not reduced in the study, whereas the P7 body weight of
the dual study group was significantly smaller than all other groups (refer Section
4.3), indicating that supplemental oxygen may affect total body growth. There is
evidence that IGF-I correlates with the period of catch up growth following initial
poor weight gain, or weight loss, often observed in growth restricted preterm infants
(Hansen-Pupp et al. 2011). There is also some evidence from work in zebrafish that
hypoxia increases IGFBP1 expression which is inhibitory to IGF-I action (Kajimura
et al. 2005). The serum levels measured in the current study reflect total IGF-I as
above, as opposed to unbound IGF-I. The oxygen profile used is hypoxic for 11% of
the 7 days, normoxic for 4% and hyperoxic for 85%. Hyperoxia or the fluctuation
between hyperoxia and hypoxia are the most likely determinants of the effect on
IGF-I. The final component of the IGF system is the IGF-IR receptor, a
transmembrane cell surface receptor. It is possible therefore that there is a direct
effect of oxygen toxicity on IGF-I or its receptor. Levels of oxygen reactive species
in the model were not measured but this may prove prudent towards explaining the
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reduction in serum IGF-I seen in response to fluctuating oxygen. Preterm infants
have reduced antioxidant defences and are therefore vulnerable to oxidative damage
(Taglialatela et al. 1998; Kuster et al. 2011).
The conservation of IGF-I expression across all study groups in all brain areas was
unexpected. IGF-I plays a significant role in the developing brain in the proliferation
of neural progenitors (Popken et al. 2004), inhibition of apoptosis (D'Ercole et al.
2002) and neuron development (Niblock et al. 2000). However local production of
IGF-I by neurons is considered more important to neuronal function than circulating
IGF-I (Russo et al. 2005) and suggests a brain sparing effect on IGF-I expression
within the brain, in the context of low circulating levels. It is also possible that
endogenous IGFBPs were able to compensate for lower circulating levels by
ensuring adequate concentrations within the brain.
These results do not yet explain why brain weight was reduced in the growth
restricted pups. It is important to note that we have looked at IGF-I gene expression
and not quantity of protein within the brain, the latter of which may have been
significantly reduced during the period of restriction. In addition, the other
components of the IGF system were not measured, namely the IGFBPs or the IGF-IR
which are all expressed within the brain and regulate IGF-I activity and function
(D'Ercole et al. 2002). Further work to quantify each of these components would
complete the picture.
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7.4.2 Brain-Derived Neurotrophic Factor
BDNF is a growth factor with key roles in neuroprotection. High levels generally
correlate with a state of well being and health (Gomez-Pinilla et al. 2008) and
suppressed levels are found in disease states such as depression and schizophrenia
where these are associated with adverse effects on cognition (Autry et al. 2012). It
is also reported that both diets high in saturated fats and oxidative stress have adverse
effects of on BDNF levels and subsequently on cognition (Wu et al. 2004). Whereas
dietary restriction of calories enhances BDNF levels in mice (Lee J et al. 2002) and
calorie restriction has been shown to extend lifespan in animal models (Varady et al.
2008). Consumption by the dams in the current study was not measured because of
inaccuracies of weighing of chow. It is therefore not possible to comment on the
caloric intake of the dams, however the low protein diet was isocaloric. In contrast
to the animal studies, adequate caloric intake is crucial for preterm infant weight gain
and inadequate weight gain is associated with impaired cognitive development
(Casey, 2008). Caloric intake by preterm infants in the neonatal period can be
challenging because of low calorie intravenous infusions, low calorie content of
breast milk and significantly increased energy requirements of preterm infants.
Increased expression of BDNF was found in the brainstem of the pups exposed to
oxygen, growth restriction and most significantly, the dual study exposed to both
growth restriction and oxygen. The effect of growth restriction is in keeping with the
previous work as above, where dietary restriction, albeit protein as opposed to caloric
restriction, up-regulates BDNF expression (Lee et al. 2002). These studies in adult
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mice demonstrated no effect of BDNF on proliferation of neural cell precursors but
significantly increased survival of newly generated cells and therefore enhanced
neurogenesis. The exact mechanism is undefined, but it is suggested that dietary
restriction induces a mild metabolic stress response which increases BDNF
expression. The enhanced effect of fluctuating oxygen on brainstem expression of
BDNF in the study model may reflect a further stress response. The brainstem is rich
with BDNF (Katoh-Semba et al. 2003) and it is known that BDNF is required for the
normal development of the central respiratory centres in the brainstem (Balkowrec et
al. 1998). In a model of Rett Syndrome, methyl-CpG-binding protein 2 (mecp2) null
mice and control mice were subjected to intermittent hypoxia and the effects on the
respiratory centre in the brainstem examined. It was found that intermittent hypoxia
fluctuated with normoxia and caused upregulation of bdnf in the control group, but
not the mecp2 null mice, as mecp2 is required for BDNF expression (Vermehren-
Schmaedick et al. 2012). In the study oxygen profile, 11% of the 7 day period was
spent in hypoxia. It is therefore possible that the upregulated BDNF expression in
our model was secondary to the fluctuations between hyperoxia and hypoxia. The
growth restricted pups exposed to oxygen had the highest levels of BDNF expression
suggesting a synergistic effect of stress caused by oxygen fluctuation and growth
restriction on BDNF gene expression. This may represent a neuroprotective
response to protect the vital structures within the brainstem.
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7.4.3 Fibroblast Growth Factor - 2
Prenatal exposure to glucocorticoids causes an upregulation of cerebral FGF-2
mRNA in the hippocampus of adult rats but no other discrete brain area (Molteni et
al. 2001). Rats exposed to prenatal glucocorticoids and then an acute stress event
shortly after birth show acute increases in FGF-2 in the hippocampus and prefrontal
cortex but these are blunted responses in comparison to rats that were not exposed to
prenatal glucocorticoids. This may represent a reduction in glucocorticoid receptors
in these brain areas as has been previously proposed (Barbazanges et al. 1996) and
suggests that prenatal exposure to stress may alter expression of trophic factors
important to the structure and function of the developing brain. It has also been
reported that in addition to neurotrophic effects, FGF2 has apoptotic effects at
specific times in development (Yagami et al. 2010). When FGF2 is injected into the
lateral ventricles of rat embryos at E20.5, total number and density of glial cells are
increased with no effect on neurons (Vaccarino et al. 1999).
However in the study model no effect was seen on FGF-2 expression in any of the
brain areas examined. This is most likely because the experimental design was not
sufficiently sensitive to detect changes in gene expression within discrete structures
of the brain. As described in section 2.6.3, the brains from the rat pups were divided
into four sections; 'anterior cerebrum', 'posterior cerebrum', brainstem and
cerebellum. The anterior and posterior sections contain parts of discrete structures,
e.g. the hippocampus. In Chapter 5, adverse effects on laminar growth
predominantly affected the superficial layers of the cerebral cortex.
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Any changes in gene expression in the hippocampus or specific regions of the cortex
would be masked by overall gene expression in the large section of brain. This also
holds true for BDNF and IGF-1. The specific effects found on the expression of
BDNF in the brainstem exemplify the advantages of studying distinct dissected brain
areas. At P10, it is more likely that dissection of discrete brain areas would also be
possible. Using micro-dissection techniques and handling the brain on ice-cold
surfaces may also have improved the success of regional dissection (Chiu et al. 2007)
and allowed further conclusions to be drawn on the effect of the environmental
conditions studied on growth factor expression. The work by Lodygensky et al, 2008
also documented brain volume alterations in association with intrauterine growth
restriction. In particular for preterm infants, IUGR is associated hippocampal
volume loss (Lodygensky et al. 2008) and therefore regional dissection would have
also allowed volumetric comparisons between discrete brain areas to assess the effect
of protein restriction and oxygen fluctuation.
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7.4.4 Vascular Endothelial Growth Factor
Expression of VEGF in the anterior and posterior cerebrum was reduced in the dual
study group exposed to growth restriction and fluctuating oxygen. As described
below, the absence effect observed between the other groups does not necessarily
mean that growth restriction and oxygen did not have transient effects on VEGF
expression and therefore function.
VEGF is sensitive to changes in oxygen environment. The underlying mechanism
for the proliferative retinopathy in rats and preterm infants in association with
fluctuating oxygen is thought to be the on / off switching of VEGF in response to
hypoxia driven H1F-1 alpha, causing neovascularisation and weak vessels which are
prone to leak (York et al. 2004; Penn et al. 1994). Within the brain, it is therefore
likely there would be both up- and down-regulation of VEGF pathways during the 7
day period of oxygen fluctuation in the model. This suggests VEGF is a dynamic
factor, intimately responsive to the environment. In addition, within the literature,
there is ambiguity as to whether VEGF is up- or down-regulated in IUGR
pregnancies. There is clearly an effect and disordered vasculogenesis within the
placenta has been reported but this is poorly understood (Wallner et al. 2007;
Jarvenpaa et al. 2007). The expression of VEGF within the brain at P7 is therefore
unlikely to reflect the true profile of VEGF response in the model.
The reduced expression of VEGF in the anterior and posterior cerebral sections of
the dual group may be explained by the increased vulnerability of this group as
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demonstrated by increased levels of the neuroprotective trophic factor BDNF. In
addition, there is evidence from human studies that growth restricted infants have
reduced antioxidant reserve (Toy et al. 2009) and therefore cellular components
within this group may be more vulnerable to damage. Within the brain, VEGF has
roles in nerve growth and survival (Haigh et al. 2003) and therefore low levels may
disrupt these roles.
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7.4.5 Interaction between Trophic Factors in the Developing
Brain
The existence of multiple trophic factors in individual brain areas suggests that
neural development can be modulated by changes in any one of these factors. It is
also likely that these growth factors interact in ways that have not yet been described
and understood.
In-vitro experiments have confirmed that IGF-I and FGF-2 have additive growth
promoting effects in maintaining survival of a larger number of neurons when added
together (Torres-Aleman et al. 1990). Furthermore, in studies of mouse immature
striatal cells, the presence of IGF-I allowed FGF and Epidermal Growth Factor
(EGF) to induce proliferation of immature cells and development into mature cells,
whereas when IGF-I was not present, neither EGF nor FGF were induced to cause
cell proliferation or differentiation (Arsenijevic et al. 2001).
In knockout mouse studies and preterm studies of retinopathy of prematurity,
adequate levels of IGF-I are crucial to VEGF-induced retinal vessel development via
the induction of HIF-la (Hellstrom et al 2001; Smith et al. 2005). Low levels of
circulating IGF-I are associated with impaired VEGF signalling in the developing
lung leading to impaired alveolar development and an increased risk of BPD, hence
proposing a link between SGA infants and the likelihood of developing BPD
(Lofqvist et al. 2012). Within the brain of newborn rats, VEGF has been shown to
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guide the migration of neural progenitors in the subventricular zone of the cortex but
can only achieve this is in the presence of FGF-2 (Zhang et al. 2003).
Within neuroblastoma tumour cells, BDNF increases VEGF expression by increasing
promoter activity, causing increased angiogenesis and metastasis (Nakamura et al.
2006). Therefore despite the recognised neuroprotective roles of BDNF, increased
expression is not without implications.
VEGF and FGF-2 are positive regulators of angiogenesis. Both are increased in the
placenta of growth restricted infants in response to hypoxia and inadequate
uteroplacental perfusion which impairs placenta function leading to a growth
restricted fetus (Barut et al. 2010). Within the aging brain, protein levels of IGF-I,
FGF-2 and VEGF in the hippocampus are all reduced by middle age in rats,
reinforcing the importance each of these factors plays in maintaining neuronal
function, the close link between neurogenesis and angiogenesis and emphasizing the
effect reducing levels of one factor potentially has on the others (Shetty et al. 2005).
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Angiogenesis
Figure 54 - Interaction of growth factors considered in this study
7.5 Summary
In this study the effects of the environmental influences of growth restriction and
postnatal fluctuating oxygen on circulating levels of IGF-I protein and gene
expression of IGF-I, BDNF, FGF-2 and VEGF in the developing brain in a rodent
model were examined. An association was found between reduced circulating IGF-I
and fluctuating oxygen. In the context of growth restriction, fluctuating oxygen was
associated with a more significant reduction in IGF-I. Within the brain, gene
expression of IGF-I and FGF-2 was largely conserved across groups and within the
sections of the brain studied. This may reflect insensitivity in the methodology used
as the design was not sufficiently sensitive to detect changes in discrete structures,
for example, the hippocampus. An increase in BDNF expression in all study groups
in comparison to control was detected within the brainstem. This is likely to reflect
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increased metabolic stress caused by the set conditions and a neuroprotective
response by BDNF in view of the key structures located in the brainstem. VEGF
expression was reduced in the study group exposed to both growth restriction and
oxygen fluctuation suggesting a synergistic effect of the environmental conditions. It
is likely that even subtle changes in the expression of each of these trophic factors
has subsequent effects on other factors that each interacts with, leading to a
combined effect on the developing brain that may be amplified beyond the reduced





Intrauterine life lays the foundation for growth and wellbeing in infancy, through
childhood and into adulthood. Both fetal brain and somatic growth are complex
processes dependent on the genotype and epigenotype of the fetus, maternal health
and availability of nutrients, growth factors and oxygen to the fetus. Intrauterine
insults such as hypoxia or infection will have a negative impact on the in utero
environment. Growth restriction is a common precipitant of preterm delivery and
such infants often require respiratory support in the form of oxygen or ventilation.
Growth restricted infants are at increased risk of poor neurodevelopmental outcome
and the relative contributions of antenatal effects and postnatal insults on brain
development, such as oxygen therapy are not clear.
In this thesis, the independent and combined effects of pre- and postnatal growth
restriction and a clinically derived fluctuating oxygen profile on the developing brain
of a rodent model is explored.
In each of the following sections, results are first summarised and placed in context




8.1.1 The effects of growth restriction on body weight
In the experimental animal model, it was found that administering a 9% low protein
diet to rat dams induced pre- and post-natal somatic growth restriction in the
offspring. At birth, the growth restricted pups were 13% lighter than the control
pups. The underlying mechanism to explain this somatic growth restriction is likely
to be a combination of decreased substrate delivery to the fetoplacental unit,
impaired uterine artery blood flow (Gao H et al. 2012), a reduction in maternal
glucose, insulin and progesterone levels (Fernandez-Twinn et al. 2003) and fetal
exposure to higher levels of maternal glucocorticoids (Langley-Evans et al. 1994).
At postnatal day 7 in the animal model, the effect of postnatal growth restriction was
marked with growth restricted pups being 35% lighter than control pups. This
increase in restriction may be mediated by a reduction in total milk volume during
lactation as has been reported in previous nutrition restriction models (Rosso et al.
1980) or perhaps a reduction in total milk protein.
8.1.2 The effects of growth restriction on brain weight
Brain weight was reduced in the growth restricted pups at P7. This is in contrast to
the outcome achieved from 60% calorie restriction where despite a reduction in body
weight, brain weight was not significantly different to the control pups (Agale et al.
2010). This may suggest a specific effect of postnatal protein restriction on brain
growth and cross-fostering experiments would be required to determine if antenatal
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growth restriction alone is sufficient to cause a reduction in brain weight. Evidence
suggests there is a fetal programming element to the effect of low protein diet on the
developing brain where more severe, prolonged protein restriction is associated with
increased likelihood of impaired brain growth (Resnick et al. 1982).
As a percentage of body weight, both growth restricted study groups preserved brain
weight relative to body weight. This mirrors the clinical situation where
asymmetrical growth restriction in preterm infants is most common. Asymmetrical
growth restriction has been renamed 'nutritional IUGR' by some authors (Cox et al.
2009) to reflect the failure of nutrient supply to the fetus toward the last trimester of
pregnancy. In contrast, symmetrical IUGR reflects reduced growth potential and a
smaller fetus with fewer cells, reflecting onset of growth restriction much earlier in
the course of pregnancy where rate of growth is determined by cycles of cell division
(Cox, 2009).
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8.1.3 The effect of growth restriction on cortical thickness &
neuronal subtypes
In the context of growth restriction alone, a statistically nonsignificant reduction in
cortical thickness was seen with a corresponding statistically nonsignificant increase
in cell density and no effect on neuron number. This may suggest a loss of stroma or
neuronal connectivity. Previous work has shown that protein deprivation has adverse
effects on dendritic branching complexity and synaptic spine number in the
hippocampus (Diaz-Cintra et al. 1991) and in the cerebral cortex (Benitez-Bribiesca
et al. 1999; Jones et al. 1981). The transcription factor Cux-1 is involved in directing
superficial neurons to undergo maturational changes including dendritic branching
and synaptogenesis. No reduction in the proportion of Cuxl expressing neurons in
superficial neurons of the growth restricted group was detected. In addition, prenatal
protein malnutrition in rats has been shown to negatively impact cerebral electrical
activity (De Frias et al. 2010), again suggesting adverse effects of reduced protein on
cortical circuitry.
Cerebral MRI scanning of preterm growth restricted infants at term shows reduced
intracranial and cerebral cortical grey matter volume in comparison to term born
controls (Tolsa et al. 2004). In particular grey matter is reduced in the frontal,
parietal and temporal regions (Padilla et al. 2011). Infants who are born growth
restricted are at increased risk of long-term cognitive impairments, and increased
behavioural problems (O'Keeffe et al. 2003; Noeker 2005; Geva et al. 2006; Padilla
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et al. 2011). These findings therefore suggest that preterm growth restricted infants
have structural and functional brain differences in comparison to term born infants.
The growth restricted pups in this study did have a reduced brain weight compared to
controls and a suggestion of loss of intercellular matrix despite normal proportions of
Cuxl expressing neurons in the superficial layers. The study contained 9 pups from
3 litters per study group and therefore may not be sufficiently powered to detect
small differences in cortical thickness or neuronal number. The reduced brain weight
suggests there was loss of material from the brains in the growth restricted group
which may include components involved in intercellular connections such as
dendritic branching and synaptic spines (Georgieff et al. 2007). There is evidence
from imaging studies to suggest growth restriction is also associated with reduced
white matter volume which may be associated with enlarged ventricles and may also
contribute to reduced brain weight (Padilla-Gomes NF et al. 2007; Pad ilia et al.
2011; Tolsa et al.2004).
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8.1.4 The effect of growth restriction on expression trophic
factors in the brain
It was found that circulating IGF-I was significantly reduced in the growth restricted
group at P7 providing an explanation for the 35% reduction in body weight. Within
the brain, gene expression of IGF-I in each section was conserved across the study
groups, suggesting preservation of brain IGF-I. Local production of IGF-I by
neurons is considered more important to neuronal function than circulating IGF-I
(Russo et al. 2004). These results suggest a brain-sparing effect on IGF-I expression
within the brain, in the context of low circulating levels. It is also possible that
endogenous IGFBPs were able to compensate for lower circulating levels by
ensuring adequate concentrations within the brain. In addition, the methodology
employed would not detect small changes in discrete structures such as the
hippocampus.
No effect of growth restriction was observed on the gene expression of FGF-2 or
VEGF within the brain. This may again be related to the methodology used as
changes in FGF-2 expression may have been expected in the hippocampus where
prenatal stress causes an increase in hippocampal and prefrontal cortex expression
(Molteni et al. 2001). VEGF is a dynamic factor that has been shown to be both
raised and reduced in the context of growth restriction (Jarvenpaa et al. 2007;
Wallner et al.2007).
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Expression of BDNF was significantly increased within the brainstem section only
and is likely to reflect the increased metabolic stress caused by the growth restriction
and a neuroprotective response by BDNF in view of the key structures located in the
brainstem. This is in keeping with the literature which supports a link between
dietary restriction and increased levels of BDNF (Lee J et al. 2002).
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8.2 Fluctuating Oxygen
8.2.1 The effect of A02 on body & brain weight
There was no independent effect observed of the fluctuating oxygen profile on
somatic or overall brain growth in the model, in keeping with previous researchers
using the same oxygen profile (Sedowofia, 2007, Pilley E, 2010). This was despite a
reduction in circulating IGF-I and preservation of IGF-I expression in the brain of the
A02 group. The fluctuating oxygen profile used has been previously shown to result
in cell death, astrocytosis and reduced expression of myelin basic protein (Sedowofia
et al. 2008). Therefore, although the weight did not change, other structural elements
may have been altered.
8.2.2 The effect of A02 on cortical thickness
The clinically relevant oxygen profile was shown to adversely affect cortical growth.
This effect was on the superficial cortical layers II-IV, involved in intracortical
circuitry, with no effect observed on the thickness of deep layers V and VI. There
was a suggestion of a reduced number of nuclei in the context of preserved cell
density in the A02 group suggesting a direct effect of oxygen on neuron survival.
This is in keeping with several previous studies and may be explained by increased
cell death (Felderhoff-Mueser et al. 2004; Yis et al. 2008; Gerstner et al. 2008), or
free radical oxygen damage (Vento et al. 2003; Vento et al. 2005; Maltepe et al.
2008).
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8.2.3 The effect of A02 on neuronal subtypes
Fluctuating oxygen caused a significant reduction in the proportion of Cuxl
expressing cells. This means that in addition to a mild reduction in total nuclei in
response to oxygen, oxygen reduces the proportion of neurons which express Cuxl.
There are no clear reports in the literature of direct effects of oxygen on Cuxl
expression, however, a recent study has shown that intermittent hypoxia (alternating
21% and 10% oxygen) increases the expression of transcription factor paired-box-6
(Pax6) in the SVZ (Ross et al. 2012). Pax6 has key roles in fundamental brain
patterning and cortical development. It crucial for normal superficial neuron
migration, cortical integrity and Cuxl expression (Nieto et al. 2004; Georgala et al.
2010) and therefore disrupted levels secondary to oxygen fluctuation may impair
superficial neuron migration and Cuxl function.
8.2.4 The effect of A02 on trophic factors
As discussed in 8.2.1, circulating IGF-I was reduced following exposure to oxygen
and brain expression levels of IGF-I was preserved across groups. There was no
specific effect of fluctuating oxygen on FGF-2 and significantly, no effect on VEGF.
Within the retina, fluctuating oxygen induces chaotic blood vessel development
(York et al. 2004) due to the hyperoxia-/hypoxia-driven off and on switching of
VEGF. Serum levels of VEGF or brain protein levels may have been more
informative as gene expression may not reflect the rapid alternating levels of this
growth factor. As in the case of growth restriction, BDNF was raised in the
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brainstem in comparison to control, suggesting the brainstem has instituted a
neuroprotective function in response to perceived stress caused by the oxygen.
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8.3 Dual Exposure: growth restriction & fluctuating
oxygen
8.3.1 The dual effect: body, brain weight & trophic factors
Within the context of growth restriction, body weight was further reduced by
fluctuating oxygen. The significantly reduced circulating levels of IGF-I in this
group may account for this. In addition, in humans, growth restricted infants have
reduced antioxidant capacity in comparison to term born infants (Toy et al. 2009)
and therefore cellular components in the dual group may be more susceptible to
oxidative damage. In contrast, the absolute brain weight of the dual group was not
reduced relative to the growth restricted only group; however brain weight relative to
body weight was preserved to a greater extent. This was in the context of constant
IGF-I and FGF-2 expression but significantly increased levels of BDNF in the
brainstem. It is unlikely our method of measuring gene expression would detect
small increases within discrete areas of the brain. Nonetheless, BDNF has roles in
neuroprotection, cell proliferation and axonal outgrowth (Rao et al. 2009) and
therefore may contribute to the preservation of brain weight within this model.
As a marker for the institution of neuroprotective mechanisms, the incremental
expression of BDNF to three times the levels seen in the control group, suggests the
combined effect of pre-/postnatal growth restriction and postnatal oxygen fluctuation
enhances the vulnerability of the brain before the development of protective
mechanisms.
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The reduced expression of VEGF in the anterior and posterior cerebral sections of
the dual group reinforces the increased vulnerability of this group to oxidative
damage which may be explained by reduced antioxidant reserve (Toy et al. 2009).
Within the brain, VEGF has roles in nerve growth and survival (Haigh et al. 2003)
and in addition, animal studies have shown that low levels of VEGF are associated
with increased apoptosis and adverse effects on neuron migration within the VZ and
SVZ with subsequent effects on cortical thickness. The reduced VEGF may
therefore be implicated in the cortical thinning observed in this group.
8.3.2 The dual effect: cortical thickness & neuronal subtypes
Within the context of growth restriction and oxygen fluctuation, severe cortical
thinning occurred. This was more significant in the superficial cortical layers but
also noted in the deep layers. Cell density was significantly increased in the dual
study group, suggesting loss of intracellular matrix. As discussed above for growth
restriction alone, previous work has shown that protein deprivation negatively
impacts dendritic branching complexity and synaptic spine number in both the
hippocampus and the cerebral cortex causing lower sensory cortico-cortical and
thalamo-cortical evoked potentials (Resnick et al. 1982; Diaz-Cintra et al. 1991,
Benitez-Bribiesca et al. 1999; Jones et al. 1981). The increase in cell density in the
GR group did not reach statistical significance, however the increase in cell density
in the dual group was highly significant, suggesting the added insult of postnatal
oxygen fluctuation had a profound effect on extracellular space and perhaps
structures such as dendritic branches and synaptic spines. As described above,
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fluctuating oxygen alone was not associated with any changes in cell density in
comparison to control; however there is evidence from animal models that hypoxia is
associated with reduced density of dendrites in the cerebellum (Rees et al. 1999).
The periods of hypoxia within the model in concert with the susceptibility induced
by prenatal growth restriction may have been sufficient to impair the development of
intercellular processes and connections.
In keeping with this, the significantly reduced proportion of Cuxl in the dual group
is consistent with disrupted dendritic branching, reduced dendritic spines and
interrupted circuitry in the developing cortex of the model (Cubelos et al. 2010a;
Cubelos et al. 2010b).
There are suggestions from the roles of Cuxl elsewhere in the body that this
transcription factor acts to protect cells from cell death. In the bone marrow and
thymus, reduced levels of Cuxl have been shown to increase apoptosis (Sansregret et
al. 2008) and increased levels of Cuxl within pancreatic tumours protect against
apoptosis (Ripka et al. 2010a). In addition, treatment of cells with IGF-I has been
shown to increase Cuxl expression within those cells. It is therefore possible that
low levels of circulating IGF-I are implicit in the reduced expression of Cuxl in the
cerebral cortex of the dual group. This reduced expression may increase the
vulnerability of cerebral cortex cells to cell death which this work suggests occurs in
219
response to fluctuating oxygen in the context of both normal growth and growth
restriction.
There was a statistically non-significant reduced neuron number in the dual group
coexisting with a thinned cortex and increased cell density. As discussed above, low
VEGF expression in the developing rodent brain causes reduced neuronal
proliferation, increased apoptosis and aberrant neuronal migration from the VZ and
SVZ reflected in a decreased cortical thickness (Haigh et al. 2003). Although no
aberrant migration from the proliferating zones was noted in the model, it is possible
that some superficial neurons fail to express Cuxl and therefore do not migrate from
the cell proliferating zones. This would contribute to a loss in total cell number and
proportion of positively expressing Cuxl neurons.
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8.4 Future Directions
The results of the studies undertaken for this thesis have raised a number of questions
and further work is required to address these.
8.4.1 The oxygen profile & markers of oxidative damage
within the cortex
One of the major strengths of this work is the physiological oxygen profile used.
Measuring markers of oxidative stress caused by such a physiological profile would
not only unravel the mechanism underlying findings such as the reduction in
circulating serum IGF-I (sections 7.4.1 and 7.5.1), but would contribute to general
understanding of the impact such physiological treatments may have on developing
body systems. It is widely appreciated that preterm infants have low antioxidant
reserves and there is a need to validate biomarkers of oxidative stress so this can be
monitored in the clinical situation (Perrone et al. 2012).
As described in Chapter 2, the profile is hyperoxic (above 21%) for 85% of the 7
days, hypoxic (below 21%) for 11% of the 7 days and the other 4% is spent at room
air. To delineate the mechanistic role of the effect of hyperoxia or hypoxia in the
model, fluctuating profiles which are either hyperoxic or hypoxic could be
developed. This would allow findings such as which oxygen environment
underpinned the upregulation of BDNF in the brainstem (section 7.5.2) and if
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hypoxia was the underlying cause of increased cell density and reduced Cuxl
expression in the dual group (section 8.3.2) to be clarified.
8.4.2 Growth Factor Systems - Ligands, receptors and
binding proteins
A strength of the work on growth factors was the concurrent measurement of IGF-I
in the serum and IGF-I cerebral expression, allowing the brain-sparing effect of gene
expression to be appreciated fully. As discussed in section 7.5.1, there are many
other components of the IGF system and measurement of each of these components
would complete the picture of how the various elements interact within the
physiological model.
8.4.3 Regional brain studies
To further define the effect of the environmental conditions on growth factors,
detailed dissection of discrete brain areas is required. In particular, studies looking at
growth factor expression in regions such as the hippocampus, a brain area affected
by growth restriction (Jahnke et al. 2007) and implicated in volumetric and cognitive
assessments of ex-preterm infants (Nosarti et al. 2002). In addition, regional studies
of gene expression in the thalamus and other deep grey structures would provide
further information because these are also associated with reduced volume in the
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context of preterm birth and morbidities such as bronchopulmonary dysplasia (Jobe
et al. 2010; Thompson et al. 2007).
The lamination study examined the motor cortex only. During the third trimester,
areas undergoing rapid development and thus vulnerable to damage by preterm birth
include the hippocampus, visual and auditory cortices (Georgieff et al. 2007). It
would therefore be important to consider the effects of both growth restriction and
oxygen on other areas of the cortex, for example, the visual cortex as visual
impairment in preterm infants shows a higher prevalence than can be explained by
focal retinal or white matter brain lesions (O'Connor et al. 2007) and in the
somatosensory, premotor and lateral frontal cortical grey matter, all shown to be
altered by preterm birth (Thompson et al. 2007; Ball et al. 2012b)
Despite thinning of the posterior corpus callosum being an observation reported in
preterm infants (Thompson et al. 2012), corpus callosal thinning was not observed in
response to the environmental conditions in the model of fullterm rodent pups. This
may have been a consequence of the sections measured being too rostral and so to
test this hypothesis, matched caudal sections could be stained and measured using the
same technique as in section 3.7.1.
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In Chapter 5, the thickness of laminae II - VI was studied as these layers contain the
vast majority of postnatal cortical neurons. The subplate is the most prominent
transient layer in human development (Kostovic et al. 2006) and is the site where the
majority of afferent neurons, particularly from the thalamus, temporarily reside to
establish synapses and participate in cellular interactions that are crucial for
subsequent cortical development and connectivity. The subplate synaptic
compartment is undergoing significant developmental maturation at the time of
preterm birth (Volpe et al. 2009b). The subplate is much smaller in rodents (Bayer
and Altman, 1991); however an assessment of thickness would indicate effects in the
rodent model which would be extrapolated to be more profound in the larger subplate
region of the human.
As outlined in Chapter 1, layer I is largely a non-cellular layer, generated early in
development and initially called the marginal zone, see Figure 2. The major cell type
in layer I are the Cajal-Retzius cells which produce Reelin and have been shown in
knockout rodent studies to be crucial for normal migration and lamination in both the
cerebral cortex and hippocampus (Frotscher et al. 1998; Dixit et al. 2011). It would
be hypothesized that this layer is unaffected by the environmental conditions due to
early formation in cortical development. However changes in this layer would have
significant implications for cortical neuron migration. Attempts to quantify thickness
of this layer suggested similar effects to the superficial layers; however variation in
thickness along the length precluded robust statistical conclusions.
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8.4.4 Markers of cell death
As discussed previously, increased cell death may be a significant consequence of
oxygen fluctuation and may underpin the consequences of reduced circulating IGF-1,
reduced cortical thickness with preserved cell density and decreased proportion of
Cuxl+ neurons within the cortex in response to fluctuating oxygen. Studies
examining cell death markers such as caspase-3 and TUNEL would allow further
definition of the exact effect of the fluctuating oxygen profile in the cerebral cortex
of the model. Caspase-3 has been previously shown to be increased in the white
matter of day 14 postnatal rats in response to the same oxygen profile (Sedowofia et
al. 2008).
8.4.5 Other cerebral cell types
The Topro-3 stain is a non-specific nuclear stain. Other cell types in the cortex such
as microglia, oligodendrocytes and astrocytes will therefore have been stained with
Topro-3 and included in the nuclear counts. Specific temporal markers to identify
these cell types could be used, for example anti-brain lipid binding protein (BLBP) is
a marker for young astrocytes (Ma et al. 2012). The two major categories of cortical
neurons are (1) projection neurons that are glutamatergic and extend axons to distant
intracortical, subcortical and subcerebral targets and (2) interneurons that are GABA-
nergic and make local connections (Molyneaux et al. 2007). In this study only
projection neurons have been considered and clearly interneurons are fundamental to
cortico-cortical communication. Immunohistochemical staining of this subtype of
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neuron would provide further information on the integrity of neuronal circuits,
particularly studied at later time points when significant numbers within the cortex
can be reliably determined. In addition, there is considerable afferent input to the
cortex which makes a significant contribution to the cerebral neural networks and
connectivity. The importance of thalamocortical connectivity in preterm
development has been previously discussed. Thalamic axons carry the majority of
sensory input to the cortex and almost all areas of the cortex receive some form of
thalamic input (Molnar et al. 2003). Thalamic neurons are one of the first afferent
axon types to reach the subplate of the cerebral cortex where crucial connections are
made before migration to predominantly layer IV (Kostovic et al. 2006).
Thalamocortical fibres in fixed rodent brains could be studied using well established
carbocyanine dye methods (Carme Auladell et al. 2000).
8.4.6 Cortical Migration
As previously discussed, the effect of oxygen on cortical thickness, neuron number
and Cuxl expression may be related to impaired neuronal migration. Dual pulse
labelling with BrdU and EdU labelling would allow superficial cortical neurons to be
marked and their trajectory through the cortex studied by immunohistochemistry at
defined postnatal ages (Georgala et al. 2010). As discussed in Chapter 1, radial glial
cells act as progenitors for all neuronal cell types. Recent evidence suggests that
radial glia in mice have distinct fate potential from early in gestation including glia
which are destined for only superficial layer identity (Franco et al. 2012). Further
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study by histological staining of the radial glia would allow a greater understanding
of migration within the model.
8.4.7 Developmental Time Points
As discussed in Chapter 1, the rat cortex is most comparable to a human newborn
cortex at P10 and therefore studying the cortex at this postnatal age and beyond
would provide further information on the ongoing effects caused by the
environmental conditions. At P10, it is more likely that dissection of discrete brain
areas would also be possible. Using micro-dissection techniques and handling the
brain on ice-cold surfaces may also improve the success of regional dissection (Chiu
et al. 2007).
8.4.8 Magnetic Resonance Imaging
The use of MR imaging to correlate histopathological findings in the rodent model
with imaging findings would allow inferences to be made regarding rarely available
neuropathology in preterm infants and with spectroscopy may give insight into the
metabolic environment of the brain.
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8.4.9 Behaviour Testing
Placing structural findings in context of behaviour studies is crucial to interpreting
the significance of results on functional outcome and to determine if there are long-
term consequences to cortical thinning, Cuxl reduction or growth factor disruption.
In preterm infants, growth restriction is associated with cognitive impairments,
poorer memory, increased behavioural problems and reduced motor scores
(O'Keeffe et al. 2003; Noeker 2005; Eshel et al. 2006; Leitner et al. 2007).
Neurobehavioral experiments could therefore be performed at six weeks postnatal
age when the rodent pups are fully grown and tests of cognition, exploratory
behaviour and memory performed.
8.4.10 Development of Cortical Systems
Recent imaging studies support the concept that preterm birth has specific effects on
developing neural systems in the immature brain, for example the thalamocortical
system where volume reduction in the thalamus is shown to be linked to volume loss
in the cortex and hippocampus (Ball et al. 2012a). In infants with the classic preterm
brain pathology of PVL, thalamic volume is reduced in correlation with PVL severity
and it is suggested that the reduced the thalamic volume accounts for the cognitive
deficits demonstrated by children with PVL because of the extensive
interconnections between the cerebral cortex and the thalamus (Nagasunder et al.
2011). In keeping with Volpe's concept of the 'Encephalopathy of Prematurity', it is
now widely recognised that focal and diffuse white matter injury in preterm infants is
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associated with adverse effects on other developing brain areas including the
thalamus, basal ganglia, brainstem, cerebellum and cerebral cortex (Volpe 2009a).
The major strengths of this thesis are findings of specific effects on neural systems
within the developing brain. Future work could include an assessment of deep grey
matter, and a comparison of the sizes of other key cerebral regions between groups.
The effect of preterm birth on the developing neural systems is the focus of current
neonatal research in the literature. The findings of markedly reduced cortical
thickness at birth as a consequence of specific neonatal morbidities and events, such
as growth restriction and postnatal oxygen therapy, is novel and warrants further
investigation as to whether this is a regional effect on the motor cortex or a global
effect with significant implications for cortico-cortico connectivity and function.
The reduced proportions of Cuxl positive superficial neurons is an original finding
with no previous reports in the literature of reduced superficial neuron subtype
specificity in association of common perinatal environmental insults. Dendritic
integrity is crucial in cortico-cortico circuitry and given the superficial layers are
generally considered to be the seat of higher cognitive functioning; deficits in such
circuits will inevitable have consequences for function and behaviour.
By achieving a more complete understanding of how the brain responds to injury and
interruptions to normal development, perinatologists can be guided to deliver optimal
care and avoid the development of neurological deficits by preterm survivors. There
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are opportunities for therapeutic interventions, such as antioxidants or the
administration of exogenous growth factors, but clearly experimental work would be
required in these areas before clinical studies could be performed.
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8.5 Conclusion
In conclusion, the work of thesis indicates that common perinatal events such as
growth restriction and oxygen therapy, have significant effects on the specific
systems underlying cortico-cortical communication and this may have implications
for neuronal development and cognitive processing. Future work is required to
delineate long term consequences of these effects and to understand the underlying
mechanisms before specific therapies or modification of practice can be undertaken
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